{
  "usdmVersion": "4.0",
  "generatedAt": "2026-01-23T05:14:13.588575",
  "generator": "Protocol2USDM v6.5.0",
  "study": {
    "id": "eb93e7ed-6b67-4c8a-8bc0-5803f9c9314b",
    "instanceType": "Study",
    "versions": [
      {
        "id": "d5effe71-d505-4b05-b040-a31b56774053",
        "instanceType": "StudyVersion",
        "versionIdentifier": "1.0",
        "studyDesigns": [
          {
            "id": "3297f453-7fd0-475d-862d-5be6b27f9a34",
            "name": "Study Design",
            "rationale": "Protocol-defined study design for investigating efficacy and safety",
            "instanceType": "InterventionalStudyDesign",
            "blindingSchema": {
              "id": "c4ff3491-1e63-4da2-bda4-4833a36cfe5a",
              "standardCode": {
                "id": "1e1544f5-3bf8-425f-a1cc-710fc04ec49f",
                "code": "Double Blind",
                "codeSystem": "http://www.cdisc.org",
                "codeSystemVersion": "2024-09-27",
                "decode": "Double Blind",
                "instanceType": "Code"
              },
              "instanceType": "AliasCode"
            },
            "randomizationType": {
              "code": "Randomized"
            },
            "arms": [
              {
                "id": "aabb2efd-59d0-4f15-af93-8abc2c3e7756",
                "name": "AZD7442",
                "instanceType": "StudyArm",
                "dataOriginDescription": "Collected",
                "description": "Single 600 mg dose of AZD7442 administered as 2 separate IM injections of 300 mg each (AZD8895 and AZD1061) on Day 1.",
                "type": {
                  "id": "C174266",
                  "code": "C174266",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Investigational Arm",
                  "instanceType": "Code"
                },
                "dataOriginType": {
                  "id": "6563e011-2e5e-4962-9c8a-02827315147a",
                  "code": "C70793",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Collected",
                  "instanceType": "Code"
                }
              },
              {
                "id": "fb1146cc-387a-4f2b-ba69-1c9427fecf60",
                "name": "Placebo",
                "instanceType": "StudyArm",
                "dataOriginDescription": "Collected",
                "description": "Single IM dose of placebo administered on Day 1.",
                "type": {
                  "id": "C174268",
                  "code": "C174268",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.12e",
                  "decode": "Placebo Control Arm",
                  "instanceType": "Code"
                },
                "dataOriginType": {
                  "id": "7fd56780-c311-4b97-ac96-afa3c03905ba",
                  "code": "C70793",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Collected",
                  "instanceType": "Code"
                }
              }
            ],
            "studyCohorts": [
              {
                "id": "d8629a05-2ce9-40da-b937-ce54dc491205",
                "name": "Cohort 1",
                "instanceType": "StudyCohort",
                "characteristic": "Participants undergoing intensive testing for virological and immunological status (includes sentinel group)."
              },
              {
                "id": "ceea9ce8-53f6-4471-99a4-fd13e87fc1ee",
                "name": "Cohort 2",
                "instanceType": "StudyCohort",
                "characteristic": "Participants followed primarily for clinical outcomes."
              }
            ],
            "studyCells": [
              {
                "id": "669cb21f-d502-4b55-b00a-3d53f81ee3c7",
                "armId": "aabb2efd-59d0-4f15-af93-8abc2c3e7756",
                "epochId": "53a15c62-adac-44cd-b692-c18c47a15dff",
                "elementIds": [
                  "a527aeb8-606e-498e-afc3-fb281f546d08"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "e53d336f-0a84-4f44-ab89-256854342733",
                "armId": "aabb2efd-59d0-4f15-af93-8abc2c3e7756",
                "epochId": "a8d0739e-57f0-42e7-b817-e8a5df8ad89d",
                "elementIds": [
                  "9bda22c9-6b17-4c33-aa6a-0e368504ac78"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "e73f03f3-d8c8-46f0-a222-d45454562337",
                "armId": "aabb2efd-59d0-4f15-af93-8abc2c3e7756",
                "epochId": "bbe0336e-1237-4e88-9048-2ff87e699180",
                "elementIds": [
                  "4f710095-350e-437a-80ce-44e77bfe99e8"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "7c823618-1dd9-4f21-8827-4a70d8163501",
                "armId": "aabb2efd-59d0-4f15-af93-8abc2c3e7756",
                "epochId": "407cbfba-c82b-4293-8544-c438221afbb1",
                "elementIds": [
                  "f352b1f1-e789-43f1-989c-01bebc0336c0"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "d19016fc-9584-475b-86a5-c1056145802e",
                "armId": "fb1146cc-387a-4f2b-ba69-1c9427fecf60",
                "epochId": "53a15c62-adac-44cd-b692-c18c47a15dff",
                "elementIds": [
                  "8d9f9f9c-1981-4a62-952e-0b286b695c2d"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "b60fa589-cf2d-47ae-8a15-05835a5ba1a3",
                "armId": "fb1146cc-387a-4f2b-ba69-1c9427fecf60",
                "epochId": "a8d0739e-57f0-42e7-b817-e8a5df8ad89d",
                "elementIds": [
                  "c8188fa8-253b-4374-b581-20386ad4aa17"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "c2be9d4a-c1e3-41f5-8f27-3d8589f4987a",
                "armId": "fb1146cc-387a-4f2b-ba69-1c9427fecf60",
                "epochId": "bbe0336e-1237-4e88-9048-2ff87e699180",
                "elementIds": [
                  "0b540c70-649c-4099-9503-5a3350615324"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "31754994-56dc-4289-a3ab-f4eaa14bb4ad",
                "armId": "fb1146cc-387a-4f2b-ba69-1c9427fecf60",
                "epochId": "407cbfba-c82b-4293-8544-c438221afbb1",
                "elementIds": [
                  "c28cc4cf-191c-4fac-8b93-c8aa36dbe6da"
                ],
                "instanceType": "StudyCell"
              }
            ],
            "studyElements": [
              {
                "id": "a527aeb8-606e-498e-afc3-fb281f546d08",
                "name": "AZD7442 - Screening",
                "instanceType": "StudyElement",
                "description": "Treatment period for AZD7442 during Screening"
              },
              {
                "id": "9bda22c9-6b17-4c33-aa6a-0e368504ac78",
                "name": "AZD7442 - Treatment and Intensive Follow-up",
                "instanceType": "StudyElement",
                "description": "Treatment period for AZD7442 during Treatment and Intensive Follow-up"
              },
              {
                "id": "4f710095-350e-437a-80ce-44e77bfe99e8",
                "name": "AZD7442 - Limited Follow-up",
                "instanceType": "StudyElement",
                "description": "Treatment period for AZD7442 during Limited Follow-up"
              },
              {
                "id": "f352b1f1-e789-43f1-989c-01bebc0336c0",
                "name": "AZD7442 - Early Discontinuation Visit",
                "instanceType": "StudyElement",
                "description": "Treatment period for AZD7442 during Early Discontinuation Visit"
              },
              {
                "id": "8d9f9f9c-1981-4a62-952e-0b286b695c2d",
                "name": "Placebo - Screening",
                "instanceType": "StudyElement",
                "description": "Treatment period for Placebo during Screening"
              },
              {
                "id": "c8188fa8-253b-4374-b581-20386ad4aa17",
                "name": "Placebo - Treatment and Intensive Follow-up",
                "instanceType": "StudyElement",
                "description": "Treatment period for Placebo during Treatment and Intensive Follow-up"
              },
              {
                "id": "0b540c70-649c-4099-9503-5a3350615324",
                "name": "Placebo - Limited Follow-up",
                "instanceType": "StudyElement",
                "description": "Treatment period for Placebo during Limited Follow-up"
              },
              {
                "id": "c28cc4cf-191c-4fac-8b93-c8aa36dbe6da",
                "name": "Placebo - Early Discontinuation Visit",
                "instanceType": "StudyElement",
                "description": "Treatment period for Placebo during Early Discontinuation Visit"
              }
            ],
            "maskingRoles": [
              {
                "id": "41eaaa05-1200-4d0d-b588-715c30eac823",
                "text": "Subject is masked in this Double Blind study",
                "isMasked": true,
                "instanceType": "Masking"
              },
              {
                "id": "e3dc6ba4-b1ef-4516-8645-fec3c4c966fa",
                "text": "Investigator is masked in this Double Blind study",
                "isMasked": true,
                "instanceType": "Masking"
              },
              {
                "id": "1dc52c14-52ea-461f-8c3d-ca9dcd2ba252",
                "text": "Caregiver is masked in this Double Blind study",
                "isMasked": true,
                "instanceType": "Masking"
              },
              {
                "id": "7166c4e9-aae6-47c9-b47a-a950cf3846b7",
                "text": "Data Analyst is masked in this Double Blind study",
                "isMasked": true,
                "instanceType": "Masking"
              }
            ],
            "eligibilityCriteria": [
              {
                "id": "aa4759fb-a1b9-4107-9931-bbf6d1c026da",
                "identifier": "1",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "b05cc249-8720-44d3-9e3c-0ce74487868c",
                "instanceType": "EligibilityCriterion",
                "name": "Age requirement",
                "nextId": "9083b8d6-80d1-44a6-89bb-b676795dd8e1"
              },
              {
                "id": "9083b8d6-80d1-44a6-89bb-b676795dd8e1",
                "identifier": "2",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "76fdca09-823e-4974-bedc-fe00ee81aaf4",
                "instanceType": "EligibilityCriterion",
                "name": "SARS-CoV-2 infection confirmation",
                "previousId": "aa4759fb-a1b9-4107-9931-bbf6d1c026da",
                "nextId": "ea39305b-d762-4da5-a41f-be84a0a7fac8"
              },
              {
                "id": "ea39305b-d762-4da5-a41f-be84a0a7fac8",
                "identifier": "3",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "4426ab23-6000-4df5-8635-7de88f2eb48e",
                "instanceType": "EligibilityCriterion",
                "name": "WHO Clinical Progression Scale score",
                "previousId": "9083b8d6-80d1-44a6-89bb-b676795dd8e1",
                "nextId": "e4da2000-f587-4d99-ae4c-349852834750"
              },
              {
                "id": "e4da2000-f587-4d99-ae4c-349852834750",
                "identifier": "4",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "ea9bca90-ec08-4040-9b40-07fa8df21924",
                "instanceType": "EligibilityCriterion",
                "name": "Symptom onset timing",
                "previousId": "ea39305b-d762-4da5-a41f-be84a0a7fac8",
                "nextId": "7460e14e-e2e4-4920-869c-fc2435950cf7"
              },
              {
                "id": "7460e14e-e2e4-4920-869c-fc2435950cf7",
                "identifier": "5",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "eaba9859-5892-4d5b-8b01-ad065c2bc3ca",
                "instanceType": "EligibilityCriterion",
                "name": "Current symptoms",
                "previousId": "e4da2000-f587-4d99-ae4c-349852834750",
                "nextId": "396ad614-5995-45a1-b081-12ae65f7811a"
              },
              {
                "id": "396ad614-5995-45a1-b081-12ae65f7811a",
                "identifier": "6",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "0f62467c-de44-4f1a-8a7d-9a58db731b6b",
                "instanceType": "EligibilityCriterion",
                "name": "Oxygen saturation",
                "previousId": "7460e14e-e2e4-4920-869c-fc2435950cf7",
                "nextId": "a5eed067-2fe4-4a53-a7e1-8c8ed156ee88"
              },
              {
                "id": "a5eed067-2fe4-4a53-a7e1-8c8ed156ee88",
                "identifier": "7",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "d110e501-830d-4b47-a752-89807e1cadc9",
                "instanceType": "EligibilityCriterion",
                "name": "Trial participation restriction",
                "previousId": "396ad614-5995-45a1-b081-12ae65f7811a"
              },
              {
                "id": "16b6f9d0-6c0c-4f6d-92e1-0595844fbde9",
                "identifier": "4",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "7103ba26-d847-4cb2-b3b6-43072eb1cd10",
                "instanceType": "EligibilityCriterion",
                "name": "Prior COVID-19 vaccine or mAb",
                "nextId": "60b95d38-7c77-4de6-8722-866a9012cd2e"
              },
              {
                "id": "60b95d38-7c77-4de6-8722-866a9012cd2e",
                "identifier": "5",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "2cbd8e46-3c5f-4907-8340-8766f2a88109",
                "instanceType": "EligibilityCriterion",
                "name": "Mechanical ventilation",
                "previousId": "16b6f9d0-6c0c-4f6d-92e1-0595844fbde9",
                "nextId": "f885b846-2c1a-457e-98b8-992b51d912ac"
              },
              {
                "id": "f885b846-2c1a-457e-98b8-992b51d912ac",
                "identifier": "6",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "c75cb07a-6e70-48ef-aeca-58fa7caf2116",
                "instanceType": "EligibilityCriterion",
                "name": "Bleeding disorder",
                "previousId": "60b95d38-7c77-4de6-8722-866a9012cd2e",
                "nextId": "058ec631-8150-4657-b06c-3fb1cc5ead87"
              },
              {
                "id": "058ec631-8150-4657-b06c-3fb1cc5ead87",
                "identifier": "7",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "8591354c-f6cd-4a04-bdb6-b356f756ef82",
                "instanceType": "EligibilityCriterion",
                "name": "Other significant disease",
                "previousId": "f885b846-2c1a-457e-98b8-992b51d912ac",
                "nextId": "8c021ea3-7b82-4be7-981a-4aabb2584897"
              },
              {
                "id": "8c021ea3-7b82-4be7-981a-4aabb2584897",
                "identifier": "8",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "9df66f66-597f-48db-9d56-7b6e9f3dd4c4",
                "instanceType": "EligibilityCriterion",
                "name": "Allergy or hypersensitivity",
                "previousId": "058ec631-8150-4657-b06c-3fb1cc5ead87",
                "nextId": "ee4ee4f5-e633-42aa-a950-8f0ef5309752"
              },
              {
                "id": "ee4ee4f5-e633-42aa-a950-8f0ef5309752",
                "identifier": "9",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "f3b200ca-e7cb-4852-9ece-032ade546cfb",
                "instanceType": "EligibilityCriterion",
                "name": "Recent surgery or life-threatening comorbidity",
                "previousId": "8c021ea3-7b82-4be7-981a-4aabb2584897",
                "nextId": "05a9bc36-607f-4983-8317-d08186622ba0"
              },
              {
                "id": "05a9bc36-607f-4983-8317-d08186622ba0",
                "identifier": "10",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "740a26b3-49d9-491e-8620-989d5799d0cd",
                "instanceType": "EligibilityCriterion",
                "name": "Prohibited medication",
                "previousId": "ee4ee4f5-e633-42aa-a950-8f0ef5309752",
                "nextId": "3deb3fd4-e49f-46bf-9902-9d1a5e72472b"
              },
              {
                "id": "3deb3fd4-e49f-46bf-9902-9d1a5e72472b",
                "identifier": "11",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "73dfc624-56f3-4e94-a55b-2d6abf5caf3f",
                "instanceType": "EligibilityCriterion",
                "name": "Convalescent plasma",
                "previousId": "05a9bc36-607f-4983-8317-d08186622ba0",
                "nextId": "5c4bbbfe-42a1-4aed-843b-e7152ae9f0f8"
              },
              {
                "id": "5c4bbbfe-42a1-4aed-843b-e7152ae9f0f8",
                "identifier": "12",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "98ded995-efff-4bc2-817c-92c14554dc84",
                "instanceType": "EligibilityCriterion",
                "name": "Steroid use",
                "previousId": "3deb3fd4-e49f-46bf-9902-9d1a5e72472b",
                "nextId": "ebd154b3-a5f7-466f-9974-28e9eb2f669d"
              },
              {
                "id": "ebd154b3-a5f7-466f-9974-28e9eb2f669d",
                "identifier": "13",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "47d50c37-e8dd-4172-bddf-f4f0c3d92904",
                "instanceType": "EligibilityCriterion",
                "name": "Recent IMP receipt",
                "previousId": "5c4bbbfe-42a1-4aed-843b-e7152ae9f0f8",
                "nextId": "0ea87464-480a-4e62-be36-20543e4a024b"
              },
              {
                "id": "0ea87464-480a-4e62-be36-20543e4a024b",
                "identifier": "14",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "e325c180-4a23-42c8-a1db-45b28f921eab",
                "instanceType": "EligibilityCriterion",
                "name": "Investigator judgment",
                "previousId": "ebd154b3-a5f7-466f-9974-28e9eb2f669d",
                "nextId": "ea666ded-4980-4af9-b1ae-bdc0ed677cd5"
              },
              {
                "id": "ea666ded-4980-4af9-b1ae-bdc0ed677cd5",
                "identifier": "15",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "fbb0c1ab-565c-45b7-8753-44c514de142d",
                "instanceType": "EligibilityCriterion",
                "name": "Previous randomization",
                "previousId": "0ea87464-480a-4e62-be36-20543e4a024b",
                "nextId": "1efe45ae-40b9-4e67-ac8e-deb369918190"
              },
              {
                "id": "1efe45ae-40b9-4e67-ac8e-deb369918190",
                "identifier": "16",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "6dc8a355-093e-447a-a2d1-c4b782e4c8eb",
                "instanceType": "EligibilityCriterion",
                "name": "Pregnancy or breastfeeding",
                "previousId": "ea666ded-4980-4af9-b1ae-bdc0ed677cd5",
                "nextId": "d0822bb6-363d-47a7-a71d-8356f3f6941e"
              },
              {
                "id": "d0822bb6-363d-47a7-a71d-8356f3f6941e",
                "identifier": "17",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "a2b786c6-e411-49a0-b2c1-e4aba306f9d5",
                "instanceType": "EligibilityCriterion",
                "name": "Recent blood draw",
                "previousId": "1efe45ae-40b9-4e67-ac8e-deb369918190",
                "nextId": "79429720-ac80-4547-bfb7-ea9f130f1192"
              },
              {
                "id": "79429720-ac80-4547-bfb7-ea9f130f1192",
                "identifier": "18",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "368e5c23-904c-4d30-9db2-c797f69f0bfa",
                "instanceType": "EligibilityCriterion",
                "name": "Sponsor or site staff",
                "previousId": "d0822bb6-363d-47a7-a71d-8356f3f6941e",
                "nextId": "8a9cbc2f-b2a9-4a36-96b4-674545e10474"
              },
              {
                "id": "8a9cbc2f-b2a9-4a36-96b4-674545e10474",
                "identifier": "19",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "8f9fd424-3d39-47cf-8334-d298f1e2249c",
                "instanceType": "EligibilityCriterion",
                "name": "Lack of capacity for consent",
                "previousId": "79429720-ac80-4547-bfb7-ea9f130f1192"
              }
            ],
            "population": {
              "id": "eab805dd-a0e2-495b-b6a3-6ce4fe856550",
              "name": "Study Population",
              "includesHealthySubjects": false,
              "criterionIds": [
                "aa4759fb-a1b9-4107-9931-bbf6d1c026da",
                "9083b8d6-80d1-44a6-89bb-b676795dd8e1",
                "ea39305b-d762-4da5-a41f-be84a0a7fac8",
                "e4da2000-f587-4d99-ae4c-349852834750",
                "7460e14e-e2e4-4920-869c-fc2435950cf7",
                "396ad614-5995-45a1-b081-12ae65f7811a",
                "a5eed067-2fe4-4a53-a7e1-8c8ed156ee88",
                "16b6f9d0-6c0c-4f6d-92e1-0595844fbde9",
                "60b95d38-7c77-4de6-8722-866a9012cd2e",
                "f885b846-2c1a-457e-98b8-992b51d912ac",
                "058ec631-8150-4657-b06c-3fb1cc5ead87",
                "8c021ea3-7b82-4be7-981a-4aabb2584897",
                "ee4ee4f5-e633-42aa-a950-8f0ef5309752",
                "05a9bc36-607f-4983-8317-d08186622ba0",
                "3deb3fd4-e49f-46bf-9902-9d1a5e72472b",
                "5c4bbbfe-42a1-4aed-843b-e7152ae9f0f8",
                "ebd154b3-a5f7-466f-9974-28e9eb2f669d",
                "0ea87464-480a-4e62-be36-20543e4a024b",
                "ea666ded-4980-4af9-b1ae-bdc0ed677cd5",
                "1efe45ae-40b9-4e67-ac8e-deb369918190",
                "d0822bb6-363d-47a7-a71d-8356f3f6941e",
                "79429720-ac80-4547-bfb7-ea9f130f1192",
                "8a9cbc2f-b2a9-4a36-96b4-674545e10474"
              ],
              "instanceType": "StudyDesignPopulation",
              "description": "Target population defined by eligibility criteria"
            },
            "objectives": [
              {
                "id": "9feb7459-3fdc-471e-829f-f5e06ae1e45e",
                "name": "Primary Efficacy Objective",
                "text": "To detect a RRR of in the incidence of severe COVID-19/death in the AZD7442 group compared to the placebo group",
                "level": {
                  "id": "C85826",
                  "code": "C85826",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Trial Primary Objective",
                  "instanceType": "Code"
                },
                "endpointIds": [
                  "47191c9c-8350-435a-a77d-bedcb7c3b915"
                ],
                "instanceType": "Objective"
              },
              {
                "id": "3edad9ba-556d-40b9-91f9-890c4503f740",
                "name": "Secondary Efficacy Objective",
                "text": "To evaluate the efficacy of AZD7442 compared to placebo in the primary analysis population",
                "level": {
                  "id": "C85827",
                  "code": "C85827",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Trial Secondary Objective",
                  "instanceType": "Code"
                },
                "endpointIds": [
                  "17f4cbb6-ef49-4a4b-9b5d-8e117b25f840"
                ],
                "instanceType": "Objective"
              },
              {
                "id": "7a3d9942-599b-417e-8372-021b49ef2599",
                "name": "Safety Objective",
                "text": "To evaluate the safety and tolerability of a single IM dose of AZD7442",
                "level": {
                  "id": "C85827",
                  "code": "C85827",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Trial Secondary Objective",
                  "instanceType": "Code"
                },
                "endpointIds": [
                  "112f69bd-b3bd-4d6b-9b0c-84210ac901d4"
                ],
                "instanceType": "Objective"
              }
            ],
            "endpoints": [
              {
                "id": "47191c9c-8350-435a-a77d-bedcb7c3b915",
                "name": "Primary Efficacy Endpoint",
                "text": "A composite of either severe COVID-19 or death from any cause through Day 29. Severe COVID-19 is characterized by a minimum of either pneumonia (fever, cough, tachypnea, or dyspnea, AND lung infiltrates) or hypoxemia (SpO2 < 90% in room air and/or severe respiratory distress) and a WHO Clinical Progression Scale score of 5 or higher",
                "level": {
                  "id": "C98772",
                  "code": "C98772",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Primary Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Efficacy"
              },
              {
                "id": "17f4cbb6-ef49-4a4b-9b5d-8e117b25f840",
                "name": "Secondary Efficacy Endpoint",
                "text": "Incidence of severe COVID-19/death in the primary analysis population",
                "level": {
                  "id": "C98781",
                  "code": "C98781",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Secondary Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Efficacy"
              },
              {
                "id": "112f69bd-b3bd-4d6b-9b0c-84210ac901d4",
                "name": "Safety Endpoint",
                "text": "Safety data through Day 8 from the participants in the sentinel group and monitoring for hypersensitivity reactions",
                "level": {
                  "id": "C98781",
                  "code": "C98781",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Secondary Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Safety"
              }
            ],
            "estimands": [
              {
                "id": "da6e2ae0-c936-460c-ad05-8cec894d0e48",
                "name": "Primary Efficacy Estimand",
                "populationSummary": "Adult patients with COVID-19 at high-risk of progression (modified full analysis set) Summary measure: Relative Risk Reduction (RRR) using CMH method.",
                "analysisPopulationId": "bbb55453-1a64-4d9d-aafa-c3ce34f26335",
                "variableOfInterestId": "47191c9c-8350-435a-a77d-bedcb7c3b915",
                "interventionIds": [
                  "33dbd71f-6c6e-402e-a368-b142a8ad6305"
                ],
                "intercurrentEvents": [
                  {
                    "id": "08e148e1-23d4-43e2-bfea-8b850c9a099d",
                    "name": "Death from any cause",
                    "text": "Death occurring through Day 29",
                    "strategy": "Composite",
                    "instanceType": "IntercurrentEvent"
                  },
                  {
                    "id": "f320aa23-bb91-44fe-b4b1-330eed0263b4",
                    "name": "Treatment discontinuation",
                    "text": "Participant discontinues study or intervention prior to Day 29",
                    "strategy": "Treatment Policy",
                    "instanceType": "IntercurrentEvent"
                  }
                ],
                "instanceType": "Estimand",
                "treatment": "AZD7442 600 mg IM single dose vs Placebo",
                "analysisPopulation": "Adult patients with COVID-19 at high-risk of progression (modified full analysis set)",
                "variableOfInterest": "A composite of either severe COVID-19 or death from any cause through Day 29",
                "summaryMeasure": "Relative Risk Reduction (RRR) using CMH method"
              },
              {
                "id": "88182580-0cf0-4087-a16b-d962e7ca4b29",
                "name": "Secondary Efficacy Estimand",
                "populationSummary": "Adult patients with COVID-19 (primary analysis population) Summary measure: Relative Risk Reduction (RRR).",
                "analysisPopulationId": "529fbf9d-eccf-4a7e-9077-693eceeb182e",
                "variableOfInterestId": "17f4cbb6-ef49-4a4b-9b5d-8e117b25f840",
                "interventionIds": [
                  "302fde15-fc0c-4fe4-8163-5a86e80acb93"
                ],
                "intercurrentEvents": [
                  {
                    "id": "50b5ab74-6d9f-44f3-8886-d27ab7d37b53",
                    "name": "Death from any cause",
                    "text": "Death occurring during the analysis period",
                    "strategy": "Composite",
                    "instanceType": "IntercurrentEvent"
                  }
                ],
                "instanceType": "Estimand",
                "treatment": "AZD7442 600 mg IM single dose vs Placebo",
                "analysisPopulation": "Adult patients with COVID-19 (primary analysis population)",
                "variableOfInterest": "Incidence of severe COVID-19 or death",
                "summaryMeasure": "Relative Risk Reduction (RRR)"
              },
              {
                "id": "984dd14e-f1ba-44a6-a641-2f761f51cf2c",
                "name": "Safety Estimand - Sentinel Group",
                "populationSummary": "First 20 participants dosed (Sentinel Group) Summary measure: Incidence and frequency of adverse events.",
                "analysisPopulationId": "41208359-933b-475a-8241-f0b7330209e4",
                "variableOfInterestId": "112f69bd-b3bd-4d6b-9b0c-84210ac901d4",
                "interventionIds": [
                  "2a0d738a-88b5-4ab7-925d-346273cb4d9c"
                ],
                "intercurrentEvents": [
                  {
                    "id": "bbe3b8dd-041a-4c04-b2d8-1401ea61ff61",
                    "name": "Treatment discontinuation",
                    "text": "Discontinuation of monitoring before Day 8",
                    "strategy": "While on Treatment",
                    "instanceType": "IntercurrentEvent"
                  }
                ],
                "instanceType": "Estimand",
                "treatment": "AZD7442 600 mg IM single dose vs Placebo",
                "analysisPopulation": "First 20 participants dosed (Sentinel Group)",
                "variableOfInterest": "Safety data and hypersensitivity monitoring through Day 8",
                "summaryMeasure": "Incidence and frequency of adverse events"
              }
            ],
            "scheduleTimelines": [
              {
                "id": "b95100eb-f116-4ace-905c-026bd71eba1e",
                "name": "Main Schedule Timeline",
                "mainTimeline": true,
                "instanceType": "ScheduleTimeline",
                "entryCondition": "Subject enrolled in study",
                "entryId": "4c75eaa7-3762-4f1b-98d7-1663c7f7f59a",
                "instances": [
                  {
                    "id": "4c75eaa7-3762-4f1b-98d7-1663c7f7f59a",
                    "activityIds": [
                      "bb2882cb-e26c-4ba3-8f91-3223cba1bd64"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_1@enc_1",
                    "encounterId": "d252ca4e-d8bc-46a1-8627-11bb6c8f9ca7",
                    "epochId": "53a15c62-adac-44cd-b692-c18c47a15dff"
                  },
                  {
                    "id": "19118760-8ced-4d98-93ab-43689ce00ece",
                    "activityIds": [
                      "9ec5c9ea-56b6-46be-b5c8-ec7ba9f47f27"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_2@enc_1",
                    "encounterId": "d252ca4e-d8bc-46a1-8627-11bb6c8f9ca7",
                    "epochId": "53a15c62-adac-44cd-b692-c18c47a15dff"
                  },
                  {
                    "id": "722dd99a-b711-4521-8583-5aea68bac27a",
                    "activityIds": [
                      "f3661f47-91e3-45f1-94a3-635bb32dda75"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_3@enc_1",
                    "encounterId": "d252ca4e-d8bc-46a1-8627-11bb6c8f9ca7",
                    "epochId": "53a15c62-adac-44cd-b692-c18c47a15dff"
                  },
                  {
                    "id": "3a86bdc7-0537-46d2-90b0-4eb39e1c9f42",
                    "activityIds": [
                      "d5d6d1e6-c026-4306-8182-991d56a0a4fc"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_4@enc_1",
                    "encounterId": "d252ca4e-d8bc-46a1-8627-11bb6c8f9ca7",
                    "epochId": "53a15c62-adac-44cd-b692-c18c47a15dff"
                  },
                  {
                    "id": "4acf5329-775e-47ae-8f46-bcd87ad47802",
                    "activityIds": [
                      "781656ca-5f56-4043-b07d-ddbb0f78e6a3"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_5@enc_1",
                    "encounterId": "d252ca4e-d8bc-46a1-8627-11bb6c8f9ca7",
                    "epochId": "53a15c62-adac-44cd-b692-c18c47a15dff"
                  },
                  {
                    "id": "29efbf20-1f79-4bb8-9144-8ec70ac0ae70",
                    "activityIds": [
                      "aa7c07f8-70e3-4a85-92ce-319099a03a0b"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_6@enc_1",
                    "encounterId": "d252ca4e-d8bc-46a1-8627-11bb6c8f9ca7",
                    "epochId": "53a15c62-adac-44cd-b692-c18c47a15dff"
                  },
                  {
                    "id": "d40fe1d6-2441-4f4b-a4e9-c83d84b3cdaa",
                    "activityIds": [
                      "ebdc9523-b5b9-433e-9c3d-b6b54fd1b783"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_7@enc_1",
                    "encounterId": "d252ca4e-d8bc-46a1-8627-11bb6c8f9ca7",
                    "epochId": "53a15c62-adac-44cd-b692-c18c47a15dff"
                  },
                  {
                    "id": "e1dc039b-6616-45d5-8668-0c4315800abc",
                    "activityIds": [
                      "a44b76fc-8fcb-4150-a051-fa257f2be1e2"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_8@enc_1",
                    "encounterId": "d252ca4e-d8bc-46a1-8627-11bb6c8f9ca7",
                    "epochId": "53a15c62-adac-44cd-b692-c18c47a15dff"
                  },
                  {
                    "id": "4f5152a5-07d4-44c2-a2f5-cfc5c96ea654",
                    "activityIds": [
                      "14d48173-9e23-42e2-9c17-c84cfcc8c4ff"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_9@enc_1",
                    "encounterId": "d252ca4e-d8bc-46a1-8627-11bb6c8f9ca7",
                    "epochId": "53a15c62-adac-44cd-b692-c18c47a15dff"
                  },
                  {
                    "id": "8113f5cd-3f2a-415c-ad4e-96a07ac8caee",
                    "activityIds": [
                      "14d48173-9e23-42e2-9c17-c84cfcc8c4ff"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_9@enc_2",
                    "encounterId": "3a742776-e1b9-469a-b806-fe6e76f7c89a",
                    "epochId": "a8d0739e-57f0-42e7-b817-e8a5df8ad89d"
                  },
                  {
                    "id": "9118b45a-e239-4477-a8a0-2ddb0dfb0936",
                    "activityIds": [
                      "14d48173-9e23-42e2-9c17-c84cfcc8c4ff"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_9@enc_3",
                    "encounterId": "f3d42466-bf99-4020-9991-f923debee047",
                    "timingId": "3be3f3cd-f50f-4230-9db9-e6eafd77a2a9",
                    "epochId": "a8d0739e-57f0-42e7-b817-e8a5df8ad89d"
                  },
                  {
                    "id": "80c91380-9178-43cd-9d6c-188988c567fc",
                    "activityIds": [
                      "14d48173-9e23-42e2-9c17-c84cfcc8c4ff"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_9@enc_4",
                    "encounterId": "54ee062e-d240-42a2-af7b-a0ce5624e026",
                    "timingId": "f45979fe-b575-4f1e-a106-d22d3a598c37",
                    "epochId": "a8d0739e-57f0-42e7-b817-e8a5df8ad89d"
                  },
                  {
                    "id": "c1fc3681-362c-40f9-8dde-57c9cefca197",
                    "activityIds": [
                      "14d48173-9e23-42e2-9c17-c84cfcc8c4ff"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_9@enc_6",
                    "encounterId": "d6400cc1-5469-4d21-b5de-905945b9a613",
                    "timingId": "1905dc15-3dab-41a2-93c0-a095d281348e",
                    "epochId": "a8d0739e-57f0-42e7-b817-e8a5df8ad89d"
                  },
                  {
                    "id": "ed5fa3dc-9677-45ea-8cc0-008c2f3d1539",
                    "activityIds": [
                      "14d48173-9e23-42e2-9c17-c84cfcc8c4ff"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_9@enc_7",
                    "encounterId": "39535a6e-fc3a-43bc-b1c4-2a7df8f19de1",
                    "timingId": "746fecab-dbb9-43d9-9131-22ceb5949735",
                    "epochId": "a8d0739e-57f0-42e7-b817-e8a5df8ad89d"
                  },
                  {
                    "id": "444274b4-de6c-4329-8959-6ae2c7f73bfe",
                    "activityIds": [
                      "14d48173-9e23-42e2-9c17-c84cfcc8c4ff"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_9@enc_8",
                    "encounterId": "58669afc-486b-4204-a8a0-db747d808012",
                    "timingId": "38d37bc0-4d73-470f-ad1b-e676212585e3",
                    "epochId": "a8d0739e-57f0-42e7-b817-e8a5df8ad89d"
                  },
                  {
                    "id": "cb72fa74-bbd2-41d2-8caa-ce6dd983b3d5",
                    "activityIds": [
                      "14d48173-9e23-42e2-9c17-c84cfcc8c4ff"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_9@enc_9",
                    "encounterId": "bef7e138-7d40-4397-9816-675a22361c99",
                    "epochId": "a8d0739e-57f0-42e7-b817-e8a5df8ad89d"
                  },
                  {
                    "id": "a6c8bacb-25e4-4c36-8e42-ae88e164ad76",
                    "activityIds": [
                      "14d48173-9e23-42e2-9c17-c84cfcc8c4ff"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_9@enc_10",
                    "encounterId": "9416a6fe-b01e-4f52-a1e9-f3496d581a00",
                    "epochId": "a8d0739e-57f0-42e7-b817-e8a5df8ad89d"
                  },
                  {
                    "id": "ecaa7efa-e8c8-4a59-bd50-2530f30c01c7",
                    "activityIds": [
                      "2ea5e748-5a90-410d-a17b-44c09b746eb0"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_10@enc_1",
                    "encounterId": "d252ca4e-d8bc-46a1-8627-11bb6c8f9ca7",
                    "epochId": "53a15c62-adac-44cd-b692-c18c47a15dff"
                  },
                  {
                    "id": "fde61893-fc2f-48c3-b266-3fcfa04e927e",
                    "activityIds": [
                      "2ea5e748-5a90-410d-a17b-44c09b746eb0"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_10@enc_10",
                    "encounterId": "9416a6fe-b01e-4f52-a1e9-f3496d581a00",
                    "epochId": "a8d0739e-57f0-42e7-b817-e8a5df8ad89d"
                  },
                  {
                    "id": "8e8a2bcc-8721-4e13-905c-fb3d0786032b",
                    "activityIds": [
                      "95330b64-a79b-4169-a7d1-7d62795c54b7"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_11@enc_2",
                    "encounterId": "3a742776-e1b9-469a-b806-fe6e76f7c89a",
                    "epochId": "a8d0739e-57f0-42e7-b817-e8a5df8ad89d"
                  },
                  {
                    "id": "bdfd9507-dd4a-4d42-9b1d-16fb61f237cd",
                    "activityIds": [
                      "95330b64-a79b-4169-a7d1-7d62795c54b7"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_11@enc_3",
                    "encounterId": "f3d42466-bf99-4020-9991-f923debee047",
                    "timingId": "3be3f3cd-f50f-4230-9db9-e6eafd77a2a9",
                    "epochId": "a8d0739e-57f0-42e7-b817-e8a5df8ad89d"
                  },
                  {
                    "id": "fc149382-f172-4735-a489-72533257c674",
                    "activityIds": [
                      "5b92d203-1d22-4ffa-b75a-6d37da2e44ec"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_12@enc_2",
                    "encounterId": "3a742776-e1b9-469a-b806-fe6e76f7c89a",
                    "epochId": "a8d0739e-57f0-42e7-b817-e8a5df8ad89d"
                  },
                  {
                    "id": "560f82fc-cca4-401a-9769-e330d35d44c6",
                    "activityIds": [
                      "a03d9030-cf77-451c-8c77-92c7067cbd1f"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_14@enc_2",
                    "encounterId": "3a742776-e1b9-469a-b806-fe6e76f7c89a",
                    "epochId": "a8d0739e-57f0-42e7-b817-e8a5df8ad89d"
                  },
                  {
                    "id": "6d317a77-651f-4d1c-ad50-c12c87dd5c15",
                    "activityIds": [
                      "5fe922e9-278e-41a7-bd92-3ffff658cc95"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_17@enc_1",
                    "encounterId": "d252ca4e-d8bc-46a1-8627-11bb6c8f9ca7",
                    "epochId": "53a15c62-adac-44cd-b692-c18c47a15dff"
                  },
                  {
                    "id": "1a785601-efce-4e31-9ca0-1d51c5d948f8",
                    "activityIds": [
                      "5fe922e9-278e-41a7-bd92-3ffff658cc95"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_17@enc_2",
                    "encounterId": "3a742776-e1b9-469a-b806-fe6e76f7c89a",
                    "epochId": "a8d0739e-57f0-42e7-b817-e8a5df8ad89d"
                  },
                  {
                    "id": "2ff90873-e190-43b2-a271-d31a0ccefc31",
                    "activityIds": [
                      "741e5aba-b42a-4fe4-ab71-f718d558e4b9"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_21@enc_2",
                    "encounterId": "3a742776-e1b9-469a-b806-fe6e76f7c89a",
                    "epochId": "a8d0739e-57f0-42e7-b817-e8a5df8ad89d"
                  },
                  {
                    "id": "8f130c10-a59e-436c-a9b7-291414b99276",
                    "activityIds": [
                      "df14be25-83dc-4d61-b863-7ab5bf3d1501"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_27@enc_2",
                    "encounterId": "3a742776-e1b9-469a-b806-fe6e76f7c89a",
                    "epochId": "a8d0739e-57f0-42e7-b817-e8a5df8ad89d"
                  },
                  {
                    "id": "afb8b524-d6b3-47a1-994e-385fb96742d3",
                    "activityIds": [
                      "82d81992-06f3-4318-af87-e3b275cadd4e"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_28@enc_2",
                    "encounterId": "3a742776-e1b9-469a-b806-fe6e76f7c89a",
                    "epochId": "a8d0739e-57f0-42e7-b817-e8a5df8ad89d"
                  },
                  {
                    "id": "b12fb3b4-67dc-4c52-abe7-08edafcb6f7c",
                    "activityIds": [
                      "3bfd3ab7-4798-42b2-ac6b-ca0507b20595"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_29@enc_2",
                    "encounterId": "3a742776-e1b9-469a-b806-fe6e76f7c89a",
                    "epochId": "a8d0739e-57f0-42e7-b817-e8a5df8ad89d"
                  },
                  {
                    "id": "52a8f1f7-3524-440a-a439-8b65ae2b37d3",
                    "activityIds": [
                      "9880e31f-1d37-4c32-9741-7b9111bb98b3"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_31@enc_2",
                    "encounterId": "3a742776-e1b9-469a-b806-fe6e76f7c89a",
                    "epochId": "a8d0739e-57f0-42e7-b817-e8a5df8ad89d"
                  },
                  {
                    "id": "b5760e36-7974-4752-973a-573027538501",
                    "activityIds": [
                      "20d687ab-2944-4a0f-b2d8-c4e45628deab"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_32@enc_2",
                    "encounterId": "3a742776-e1b9-469a-b806-fe6e76f7c89a",
                    "epochId": "a8d0739e-57f0-42e7-b817-e8a5df8ad89d"
                  },
                  {
                    "id": "8dcb3ffc-597a-40ac-9abf-959dcec183d1",
                    "activityIds": [
                      "37b3881e-fb81-4eb0-8957-637327bc87d9"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_33@enc_11",
                    "encounterId": "e2e1bb19-1ce3-4b2f-bd4d-c9da997c1021",
                    "epochId": "a8d0739e-57f0-42e7-b817-e8a5df8ad89d"
                  },
                  {
                    "id": "2553a110-8ebc-4ad6-b9f5-f108a8ed914a",
                    "name": "InformedConsent",
                    "description": "Event anchor: InformedConsent",
                    "activityIds": [
                      "bb2882cb-e26c-4ba3-8f91-3223cba1bd64"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "extensionAttributes": [
                      {
                        "id": "9ddc1e51-c6bb-45ba-90e5-7096d0204028",
                        "url": "http://example.org/usdm/anchorClassification",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "Event"
                      },
                      {
                        "id": "061aa1b0-71cc-4781-b3fd-9b32eb1f6308",
                        "url": "http://example.org/usdm/intraDayOrder",
                        "instanceType": "ExtensionAttribute",
                        "valueInteger": 10
                      }
                    ],
                    "epochId": "a8d0739e-57f0-42e7-b817-e8a5df8ad89d",
                    "scheduledDay": 1
                  },
                  {
                    "id": "2337d56f-cb68-4f0a-bb44-b965bc9e5e3b",
                    "name": "Screening",
                    "description": "Visit anchor: Screening",
                    "encounterId": "d252ca4e-d8bc-46a1-8627-11bb6c8f9ca7",
                    "epochId": "a8d0739e-57f0-42e7-b817-e8a5df8ad89d",
                    "activityIds": [],
                    "instanceType": "ScheduledActivityInstance",
                    "extensionAttributes": [
                      {
                        "id": "9ddc1e51-c6bb-45ba-90e5-7096d0204028",
                        "url": "http://example.org/usdm/anchorClassification",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "Visit"
                      },
                      {
                        "id": "061aa1b0-71cc-4781-b3fd-9b32eb1f6308",
                        "url": "http://example.org/usdm/intraDayOrder",
                        "instanceType": "ExtensionAttribute",
                        "valueInteger": 20
                      }
                    ],
                    "scheduledDay": 1
                  },
                  {
                    "id": "292c9e1e-dfd0-4530-baec-4410dac5a91a",
                    "name": "FirstDose",
                    "description": "Event anchor: FirstDose",
                    "activityIds": [
                      "44718c7f-1ff2-4383-9cef-8b9881c4fc7b"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "extensionAttributes": [
                      {
                        "id": "9ddc1e51-c6bb-45ba-90e5-7096d0204028",
                        "url": "http://example.org/usdm/anchorClassification",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "Event"
                      },
                      {
                        "id": "061aa1b0-71cc-4781-b3fd-9b32eb1f6308",
                        "url": "http://example.org/usdm/intraDayOrder",
                        "instanceType": "ExtensionAttribute",
                        "valueInteger": 60
                      }
                    ],
                    "epochId": "a8d0739e-57f0-42e7-b817-e8a5df8ad89d",
                    "scheduledDay": 1
                  },
                  {
                    "id": "27b14a7c-c894-4d15-9f01-776625cd1acc",
                    "name": "Day1",
                    "description": "Visit anchor: Day1",
                    "encounterId": "d252ca4e-d8bc-46a1-8627-11bb6c8f9ca7",
                    "epochId": "a8d0739e-57f0-42e7-b817-e8a5df8ad89d",
                    "activityIds": [],
                    "instanceType": "ScheduledActivityInstance",
                    "extensionAttributes": [
                      {
                        "id": "9ddc1e51-c6bb-45ba-90e5-7096d0204028",
                        "url": "http://example.org/usdm/anchorClassification",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "Visit"
                      },
                      {
                        "id": "061aa1b0-71cc-4781-b3fd-9b32eb1f6308",
                        "url": "http://example.org/usdm/intraDayOrder",
                        "instanceType": "ExtensionAttribute",
                        "valueInteger": 80
                      }
                    ],
                    "scheduledDay": 1
                  },
                  {
                    "id": "c81e870c-23c5-4dcc-b174-b171816175b8",
                    "name": "Anchor: Day 3 Visit Window",
                    "activityIds": [],
                    "encounterId": "d252ca4e-d8bc-46a1-8627-11bb6c8f9ca7",
                    "instanceType": "ScheduledActivityInstance",
                    "extensionAttributes": [
                      {
                        "id": "36a32de0-2c3a-42e1-8d5e-3127f27dfa97",
                        "url": "http://example.org/usdm/instanceSource",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "execution_model"
                      },
                      {
                        "id": "66611c53-6e14-4209-a0e0-8d81553db470",
                        "url": "http://example.org/usdm/anchorClassification",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "Visit"
                      }
                    ],
                    "epochId": "53a15c62-adac-44cd-b692-c18c47a15dff"
                  },
                  {
                    "id": "c66a35b0-2bc4-4467-92c4-c700c79ab7e2",
                    "name": "Anchor: Day 6 Visit Window",
                    "activityIds": [],
                    "encounterId": "d252ca4e-d8bc-46a1-8627-11bb6c8f9ca7",
                    "instanceType": "ScheduledActivityInstance",
                    "extensionAttributes": [
                      {
                        "id": "cfcca706-588c-4a84-97e7-3738b6dfdb04",
                        "url": "http://example.org/usdm/instanceSource",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "execution_model"
                      },
                      {
                        "id": "859c44d3-b65c-4900-ba7b-bed804e8fc38",
                        "url": "http://example.org/usdm/anchorClassification",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "Visit"
                      }
                    ],
                    "epochId": "53a15c62-adac-44cd-b692-c18c47a15dff"
                  },
                  {
                    "id": "7f290bde-0ede-4baf-b9d4-8bac3b64a12a",
                    "name": "Anchor: Day 8 Visit Window",
                    "activityIds": [],
                    "encounterId": "d252ca4e-d8bc-46a1-8627-11bb6c8f9ca7",
                    "instanceType": "ScheduledActivityInstance",
                    "extensionAttributes": [
                      {
                        "id": "4f5d086b-bdf5-4a12-949a-439ab8a14b4b",
                        "url": "http://example.org/usdm/instanceSource",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "execution_model"
                      },
                      {
                        "id": "21930d3d-018a-49b3-9527-dc43461a2363",
                        "url": "http://example.org/usdm/anchorClassification",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "Visit"
                      }
                    ],
                    "epochId": "53a15c62-adac-44cd-b692-c18c47a15dff"
                  },
                  {
                    "id": "0711a292-9eb0-430c-88bc-1d9531948fc1",
                    "name": "Anchor: Day 15 Visit Window",
                    "activityIds": [],
                    "encounterId": "d252ca4e-d8bc-46a1-8627-11bb6c8f9ca7",
                    "instanceType": "ScheduledActivityInstance",
                    "extensionAttributes": [
                      {
                        "id": "52ca5ddd-38ac-4037-b2a3-7e491c25731d",
                        "url": "http://example.org/usdm/instanceSource",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "execution_model"
                      },
                      {
                        "id": "e20de99c-bdc0-40f7-9029-4fcef59fa3ba",
                        "url": "http://example.org/usdm/anchorClassification",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "Visit"
                      }
                    ],
                    "epochId": "53a15c62-adac-44cd-b692-c18c47a15dff"
                  },
                  {
                    "id": "073ba115-532a-41bf-8e39-d3ca94ed73af",
                    "name": "Anchor: Day 29 Visit Window",
                    "activityIds": [],
                    "encounterId": "d252ca4e-d8bc-46a1-8627-11bb6c8f9ca7",
                    "instanceType": "ScheduledActivityInstance",
                    "extensionAttributes": [
                      {
                        "id": "eee815c0-3c82-4c53-baaf-26b24231b7ec",
                        "url": "http://example.org/usdm/instanceSource",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "execution_model"
                      },
                      {
                        "id": "75a89233-49e7-4f63-aec2-b38f91b064fd",
                        "url": "http://example.org/usdm/anchorClassification",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "Visit"
                      }
                    ],
                    "epochId": "53a15c62-adac-44cd-b692-c18c47a15dff"
                  },
                  {
                    "id": "ea634d80-804c-4ab1-853e-206f5305e94e",
                    "name": "Anchor: Day 85/169/366/457 Visit Windows",
                    "activityIds": [],
                    "encounterId": "d252ca4e-d8bc-46a1-8627-11bb6c8f9ca7",
                    "instanceType": "ScheduledActivityInstance",
                    "extensionAttributes": [
                      {
                        "id": "0bbeda56-bef9-4419-ac1b-b9f66c57699c",
                        "url": "http://example.org/usdm/instanceSource",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "execution_model"
                      },
                      {
                        "id": "29bebb40-5a50-4255-b15b-14fa4e6ba418",
                        "url": "http://example.org/usdm/anchorClassification",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "Visit"
                      }
                    ],
                    "epochId": "53a15c62-adac-44cd-b692-c18c47a15dff"
                  }
                ],
                "timings": [
                  {
                    "id": "3be3f3cd-f50f-4230-9db9-e6eafd77a2a9",
                    "name": "Day 3 Visit Window",
                    "type": {
                      "id": "5fd75a43-0138-40bf-8861-3630e62a9768",
                      "code": "C71148",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Fixed Reference",
                      "instanceType": "Code"
                    },
                    "value": "P3D",
                    "valueLabel": "Day 3",
                    "relativeToFrom": {
                      "id": "175a6212-0937-4a6a-a537-2aa5a0a5a741",
                      "code": "C71155",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "First Dose",
                      "instanceType": "Code"
                    },
                    "relativeFromScheduledInstanceId": "c81e870c-23c5-4dcc-b174-b171816175b8",
                    "instanceType": "Timing",
                    "windowLower": "-P1D",
                    "windowUpper": "P1D"
                  },
                  {
                    "id": "f45979fe-b575-4f1e-a106-d22d3a598c37",
                    "name": "Day 6 Visit Window",
                    "type": {
                      "id": "f4a696f1-ade9-410c-bf75-c94b73c0a4a4",
                      "code": "C71148",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Fixed Reference",
                      "instanceType": "Code"
                    },
                    "value": "P6D",
                    "valueLabel": "Day 6",
                    "relativeToFrom": {
                      "id": "902286bd-f926-47f9-8a59-e8f20460168e",
                      "code": "C71155",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "First Dose",
                      "instanceType": "Code"
                    },
                    "relativeFromScheduledInstanceId": "c66a35b0-2bc4-4467-92c4-c700c79ab7e2",
                    "instanceType": "Timing",
                    "windowLower": "-P1D",
                    "windowUpper": "P1D"
                  },
                  {
                    "id": "1e0f9550-a7a0-4ed1-a749-97c22cf14a5a",
                    "name": "Day 8 Visit Window",
                    "type": {
                      "id": "1198ba37-3b19-42a0-8154-7752fc85bbff",
                      "code": "C71148",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Fixed Reference",
                      "instanceType": "Code"
                    },
                    "value": "P8D",
                    "valueLabel": "Day 8",
                    "relativeToFrom": {
                      "id": "50fd49a5-8b3a-46f5-8826-bec7bf11d050",
                      "code": "C71155",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "First Dose",
                      "instanceType": "Code"
                    },
                    "relativeFromScheduledInstanceId": "7f290bde-0ede-4baf-b9d4-8bac3b64a12a",
                    "instanceType": "Timing",
                    "windowLower": "-P1D",
                    "windowUpper": "P1D"
                  },
                  {
                    "id": "1905dc15-3dab-41a2-93c0-a095d281348e",
                    "name": "Day 15 Visit Window",
                    "type": {
                      "id": "5e1c1ba7-19a4-479d-b39f-19d527ca470e",
                      "code": "C71148",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Fixed Reference",
                      "instanceType": "Code"
                    },
                    "value": "P15D",
                    "valueLabel": "Day 15",
                    "relativeToFrom": {
                      "id": "45655a5e-2f5e-40aa-a2f5-198439ba91be",
                      "code": "C71155",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "First Dose",
                      "instanceType": "Code"
                    },
                    "relativeFromScheduledInstanceId": "0711a292-9eb0-430c-88bc-1d9531948fc1",
                    "instanceType": "Timing",
                    "windowLower": "-P2D",
                    "windowUpper": "P2D"
                  },
                  {
                    "id": "746fecab-dbb9-43d9-9131-22ceb5949735",
                    "name": "Day 29 Visit Window",
                    "type": {
                      "id": "9b4db826-13d9-491d-9b67-a4abc34df849",
                      "code": "C71148",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Fixed Reference",
                      "instanceType": "Code"
                    },
                    "value": "P29D",
                    "valueLabel": "Day 29",
                    "relativeToFrom": {
                      "id": "bb8cf602-3e03-4399-906a-9faa8613d091",
                      "code": "C71155",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "First Dose",
                      "instanceType": "Code"
                    },
                    "relativeFromScheduledInstanceId": "073ba115-532a-41bf-8e39-d3ca94ed73af",
                    "instanceType": "Timing",
                    "windowLower": "-P4D",
                    "windowUpper": "P4D"
                  },
                  {
                    "id": "38d37bc0-4d73-470f-ad1b-e676212585e3",
                    "name": "Day 85/169/366/457 Visit Windows",
                    "type": {
                      "id": "197b0f1d-f11b-4e2e-af04-ebb3abd9105f",
                      "code": "C71148",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Fixed Reference",
                      "instanceType": "Code"
                    },
                    "value": "P85D",
                    "valueLabel": "Day 85",
                    "relativeToFrom": {
                      "id": "81ac15e2-8791-4ccc-b4f0-790dbced6f3a",
                      "code": "C71155",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "First Dose",
                      "instanceType": "Code"
                    },
                    "relativeFromScheduledInstanceId": "ea634d80-804c-4ab1-853e-206f5305e94e",
                    "instanceType": "Timing",
                    "windowLower": "-P7D",
                    "windowUpper": "P7D"
                  },
                  {
                    "id": "d9d91f32-d0cd-446e-bacb-583189f53a95",
                    "name": "Vital Signs Post-Dose",
                    "type": {
                      "id": "dde3875f-93e1-40cb-b2ec-6f8366d088cc",
                      "code": "C71150",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "After",
                      "instanceType": "Code"
                    },
                    "value": "PT15M",
                    "valueLabel": "15 minutes",
                    "relativeToFrom": {
                      "id": "46ebb463-1b3f-46f2-9d0b-a910a599415e",
                      "code": "C71155",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "First Dose",
                      "instanceType": "Code"
                    },
                    "relativeFromScheduledInstanceId": "292c9e1e-dfd0-4530-baec-4410dac5a91a",
                    "instanceType": "Timing",
                    "windowLower": "-PT5M",
                    "windowUpper": "PT5M"
                  },
                  {
                    "id": "dd32450e-66f0-4d09-a230-177775677e57",
                    "name": "Surgery Exclusion Window",
                    "type": {
                      "id": "de6b4436-5b37-4a4b-87c4-1aba943449cc",
                      "code": "C71149",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Before",
                      "instanceType": "Code"
                    },
                    "value": "P7D",
                    "valueLabel": "Day 7",
                    "relativeToFrom": {
                      "id": "58c4d019-bf7a-4eb6-b3ea-ad224b1a6741",
                      "code": "C71153",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Study Start",
                      "instanceType": "Code"
                    },
                    "relativeFromScheduledInstanceId": "eafacfc7-0d6e-4c51-a8b0-83b5b1a41d81",
                    "instanceType": "Timing",
                    "windowLower": "-P7D",
                    "windowUpper": "P0D"
                  }
                ],
                "exits": [
                  {
                    "id": "27e273f9-1288-4a20-ac07-2b88c649f15d",
                    "name": "Participant Withdrawal",
                    "exitType": "Early Termination",
                    "instanceType": "ScheduleTimelineExit",
                    "description": "Withdrawal at own request or investigator discretion for safety, behavior, or compliance"
                  },
                  {
                    "id": "efe5686d-de79-41be-ab66-bc43185ca2e5",
                    "name": "Lost to Follow-up",
                    "exitType": "Early Termination",
                    "instanceType": "ScheduleTimelineExit",
                    "description": "Unreachable after 3 telephone calls and a certified letter"
                  },
                  {
                    "id": "6d50c1aa-3f2e-4a87-a2f9-0f4f094bace0",
                    "name": "Study Termination",
                    "exitType": "Early Termination",
                    "instanceType": "ScheduleTimelineExit",
                    "description": "Sponsor termination due to SAEs or specific safety findings related to IMP"
                  }
                ]
              }
            ],
            "encounters": [
              {
                "id": "d252ca4e-d8bc-46a1-8627-11bb6c8f9ca7",
                "name": "Screening (Day -1 or Day 1)",
                "instanceType": "Encounter",
                "type": {
                  "id": "1c64300a-b174-4460-9dc4-128b72d96b33",
                  "code": "C98779",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Screening Visit",
                  "instanceType": "Code"
                },
                "epochId": "53a15c62-adac-44cd-b692-c18c47a15dff",
                "extensionAttributes": [
                  {
                    "id": "40e3071f-9ce0-4179-a25d-f92a4d93fd5f",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "1e468d25-1787-488b-93cc-e102a636c0d8",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "4032cc73-0d82-474c-bd3e-46eaa1580e80",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyDay",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": -1
                  }
                ]
              },
              {
                "id": "3a742776-e1b9-469a-b806-fe6e76f7c89a",
                "name": "Day 1",
                "instanceType": "Encounter",
                "type": {
                  "id": "35845eb0-de89-4162-8dfa-fb94c69c06e9",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "a8d0739e-57f0-42e7-b817-e8a5df8ad89d",
                "extensionAttributes": [
                  {
                    "id": "27b67291-b468-4075-9eb4-9247eec4d8b3",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "f890b6ec-fb32-42bd-93d0-c95797cb9d85",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "04cd4df3-c25e-4d7d-9da9-377eb3f72b98",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyDay",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": 1
                  }
                ]
              },
              {
                "id": "f3d42466-bf99-4020-9991-f923debee047",
                "name": "Day 3",
                "instanceType": "Encounter",
                "type": {
                  "id": "5f5d81be-af70-4ad8-ac72-627cd1e372a4",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "a8d0739e-57f0-42e7-b817-e8a5df8ad89d",
                "extensionAttributes": [
                  {
                    "id": "00096af7-71a9-489b-a49a-61e9b24fb9d5",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "d75a3ab2-bd30-49fe-80a8-c48b5be93415",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "69d0058a-cc94-4f81-9785-7ec08cda727b",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyDay",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": 3
                  }
                ]
              },
              {
                "id": "54ee062e-d240-42a2-af7b-a0ce5624e026",
                "name": "Day 6",
                "instanceType": "Encounter",
                "type": {
                  "id": "f2db2ce4-086f-49c7-939f-0e1b43ecea70",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "a8d0739e-57f0-42e7-b817-e8a5df8ad89d",
                "extensionAttributes": [
                  {
                    "id": "3b272abe-0ff7-4d34-8a14-c50139a4a1cf",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "0fca56b3-ccfe-45d0-aaa1-8f2b4d924277",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "f9dd2a2a-516e-459f-8889-1dea00e30f81",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyDay",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": 6
                  }
                ]
              },
              {
                "id": "92aef1f3-f940-4722-958b-542409a6b855",
                "name": "Day 8",
                "instanceType": "Encounter",
                "type": {
                  "id": "4442a33e-6b7d-4878-a3bf-96a8c08ce01f",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "a8d0739e-57f0-42e7-b817-e8a5df8ad89d",
                "extensionAttributes": [
                  {
                    "id": "d2ce9704-8d7b-4983-b2b6-6e7573b19168",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "6a8251ee-19ad-4179-9e84-f631efa4480c",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "480e743f-250f-48dc-abe3-d7f748629047",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyDay",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": 8
                  }
                ]
              },
              {
                "id": "d6400cc1-5469-4d21-b5de-905945b9a613",
                "name": "Day 15",
                "instanceType": "Encounter",
                "type": {
                  "id": "843979d9-334b-46c1-9ee0-53ac9666d394",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "a8d0739e-57f0-42e7-b817-e8a5df8ad89d",
                "extensionAttributes": [
                  {
                    "id": "9af24426-3a1c-4a2a-8249-62767be7b762",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "87d058cb-b92a-403b-a56a-f59d2fb3e9a1",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "22186cd2-d022-482e-83a6-45702c21f850",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyDay",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": 15
                  }
                ]
              },
              {
                "id": "39535a6e-fc3a-43bc-b1c4-2a7df8f19de1",
                "name": "Day 29",
                "instanceType": "Encounter",
                "type": {
                  "id": "f6b43702-24a8-4a0a-afec-78218775b179",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "a8d0739e-57f0-42e7-b817-e8a5df8ad89d",
                "extensionAttributes": [
                  {
                    "id": "67258a2b-d83e-4ed3-9c45-00f1290575d3",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "ed6d20a6-6c50-48f0-ba46-a8e2d5321ba0",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "c283e452-4795-41ad-9820-de1ceca09510",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyDay",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": 29
                  }
                ]
              },
              {
                "id": "9eb46bce-2b71-4d67-8b74-6df964b7eb79",
                "name": "Early Discontinuation (After Day 29)",
                "instanceType": "Encounter",
                "type": {
                  "id": "b8a7becb-e179-412b-ba48-a990bd63ffea",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "bbe0336e-1237-4e88-9048-2ff87e699180",
                "extensionAttributes": [
                  {
                    "id": "ccf13de7-b087-4c49-81ff-a3e755ca350a",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "e2d4df36-14d8-46e1-8838-3062cdfa6aa8",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "b0b45a59-16ae-47b9-92db-4b243dffea9d",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyDay",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": 29
                  }
                ]
              },
              {
                "id": "b9141621-ac58-4b4b-a8ea-0939ceff1d8c",
                "name": "Early Discontinuation (Before Day 29)",
                "instanceType": "Encounter",
                "type": {
                  "id": "508cb532-4b75-4ed0-9494-e4d031b78ffb",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "bbe0336e-1237-4e88-9048-2ff87e699180",
                "extensionAttributes": [
                  {
                    "id": "38034980-cede-4d8e-a099-4ddcda8c2d41",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "f75ffabf-6f89-4cbe-9864-82ab46e2b2c6",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "9c1d0a59-c4ef-4ce3-9db3-e58361ba6f2a",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyDay",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": 29
                  }
                ]
              },
              {
                "id": "58669afc-486b-4204-a8a0-db747d808012",
                "name": "Day 85",
                "instanceType": "Encounter",
                "type": {
                  "id": "639ea9bd-a1da-4d25-9c9b-d89b6d5abe51",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "a8d0739e-57f0-42e7-b817-e8a5df8ad89d",
                "extensionAttributes": [
                  {
                    "id": "8f37e59d-dac3-4142-a3ff-05a2ecd746b3",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "1cd36f8e-a5cb-4914-ab82-e5803caf93be",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "9cd2c01f-43f8-4d96-bc37-cfe4e1894290",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyDay",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": 85
                  }
                ]
              },
              {
                "id": "bef7e138-7d40-4397-9816-675a22361c99",
                "name": "Day 169",
                "instanceType": "Encounter",
                "type": {
                  "id": "825443c3-5854-4ec9-b679-608727b80e8d",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "a8d0739e-57f0-42e7-b817-e8a5df8ad89d",
                "extensionAttributes": [
                  {
                    "id": "d1d1f48f-42d1-4381-b9b7-d7e70c6ff48c",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "cab850e8-a3ee-4737-b336-373079cf63e1",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "eafe0acd-5fa6-4300-a61a-2888fbfb1366",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyDay",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": 169
                  }
                ]
              },
              {
                "id": "9416a6fe-b01e-4f52-a1e9-f3496d581a00",
                "name": "Day 366",
                "instanceType": "Encounter",
                "type": {
                  "id": "bca77783-ccd0-44ef-a906-93397cb2da17",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "a8d0739e-57f0-42e7-b817-e8a5df8ad89d",
                "extensionAttributes": [
                  {
                    "id": "2f84b820-d29b-45e5-95ee-9597694fd66a",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "f0f5e346-40ad-4334-b0f4-b4ae526ce3bb",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "cc1065eb-27a4-44c0-81a7-abc064fbc882",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyDay",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": 366
                  }
                ]
              },
              {
                "id": "e2e1bb19-1ce3-4b2f-bd4d-c9da997c1021",
                "name": "Day 457",
                "instanceType": "Encounter",
                "type": {
                  "id": "25173586-a4cb-44a2-9874-0c4af2ddc822",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "a8d0739e-57f0-42e7-b817-e8a5df8ad89d",
                "extensionAttributes": [
                  {
                    "id": "7aaa9267-39e9-4065-a4e0-d43716beb492",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "453ac981-d7ce-4943-a030-d76d63614546",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "cffdbb4a-1050-4831-88ad-79c574a25cff",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyDay",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": 457
                  }
                ]
              }
            ],
            "activities": [
              {
                "id": "37b3881e-fb81-4eb0-8957-637327bc87d9",
                "name": "Adverse events",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "6a1ddbfb-4639-463c-990a-82db33768621",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "e8331c15-b131-44de-b578-7714f223dfec",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "0163cd2c-8416-46c9-8476-ac66cabab913",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "9ec5c9ea-56b6-46be-b5c8-ec7ba9f47f27",
                "name": "Assignment SID number",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "27e21136-0897-4c76-8738-7aa835b8f766",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "6b84c8ce-81ba-4af1-b237-4a4dad14382b",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "5dc359de-0226-4825-b6e9-a8e7a0e73dc4",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "781656ca-5f56-4043-b07d-ddbb0f78e6a3",
                "name": "COVID-19 Symptom screen",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "efdf3109-cccc-4e98-9d1c-1e6cd692f51a",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures,soa"
                  },
                  {
                    "id": "f18f5e90-f9f3-49fd-a8d3-3a2b77593168",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "d182925b-57c1-47f3-98b5-fa8c5041950a",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "20d687ab-2944-4a0f-b2d8-c4e45628deab",
                "name": "Check injection sites",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "32922847-d768-45b1-a857-c8605e230397",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "99524aa7-fb32-4b7d-a3c3-920fad3dcb74",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "administration"
                  },
                  {
                    "id": "5c117471-ea45-491b-86c4-9582855764dd",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "14d48173-9e23-42e2-9c17-c84cfcc8c4ff",
                "name": "Clinical assessments",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "a09d025b-797e-44d9-96d9-aa33ddfe335c",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "7d06df19-02a5-4c20-83dd-b0a525ca5fdf",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "af2188fa-fdde-43a6-85c9-6fe27db919be",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "0c32837c-4fdb-4e4d-9695-299ad42de041",
                "name": "Collect/update secondary contacts",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "662f60de-287d-49e9-8815-b70a75e4fbea",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "f783c837-74fc-4f3d-b602-a104686266f9",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "6a76c375-7c0b-4b09-abbf-64c4af2b4504",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "2ea5e748-5a90-410d-a17b-44c09b746eb0",
                "name": "Complete physical examination",
                "instanceType": "Activity",
                "definedProcedures": [],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "4b112f29-f0f8-4876-941b-5e3ea087ed98",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures,soa"
                  },
                  {
                    "id": "17ab580e-0d34-4890-afb3-b063b1659217",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "e69c8af8-cdfd-4307-ae61-ec0bc9dfda0d",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "f78202a9-a925-4437-98ad-32e448c2da73",
                "name": "Concomitant medications",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "4d32e54c-dd5f-4cf1-9dd7-bb3397f8cd50",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "16cc9018-5f54-4fbd-b588-a498f5721844",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "1ff386aa-1474-42a4-ae57-0425376d3f6e",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "f3661f47-91e3-45f1-94a3-635bb32dda75",
                "name": "Documentation of SARS-CoV-2 infection",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "4bd4a0dc-db42-4a81-b40d-0a42338ea1f4",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "defbe332-bcbf-4767-9ff7-8c3e42abf65b",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "9ab67033-198e-4f71-bb5b-35fff76b632f",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "a03d9030-cf77-451c-8c77-92c7067cbd1f",
                "name": "Hematology",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "142f415f-4126-4a84-9518-796aae852bf0",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures,soa"
                  },
                  {
                    "id": "a5a6f9ef-2263-4d8d-a791-8767cc623ec0",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "lab"
                  },
                  {
                    "id": "09bd2568-8a81-4c91-ad59-0a2a96974af4",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "05fb255c-e76c-48c6-bb28-79ae7172d70c",
                "name": "Household infection report",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "a3c268d4-a7a7-4aa2-a751-0efa763cc79f",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "30a60600-2d58-462e-9892-13772f59703b",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "306b583c-a979-426e-89b8-9ef1ace5a86b",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "9880e31f-1d37-4c32-9741-7b9111bb98b3",
                "name": "IMP administration",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "348a7fff-622a-4bdb-af99-3ee00136142d",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "17c4ac66-98ff-49a6-a66f-e1787e7d4369",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "administration"
                  },
                  {
                    "id": "e6641439-e093-4a73-86e2-5b5762f6aeb1",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "bb2882cb-e26c-4ba3-8f91-3223cba1bd64",
                "name": "Informed consent",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "1091caa8-51d3-4318-ac91-39043411d67d",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures,soa"
                  },
                  {
                    "id": "7fa69bd1-b26a-4364-a843-707a4f1fb8a9",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "documentation"
                  },
                  {
                    "id": "b468826e-dc1c-452c-ab06-169b70941cf7",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "b3783f2d-d68e-4029-84bc-56c6aa009d3a",
                "name": "Injection site inspection",
                "instanceType": "Activity",
                "definedProcedures": [
                  {
                    "id": "b3783f2d-d68e-4029-84bc-56c6aa009d3a",
                    "name": "Injection site inspection",
                    "procedureType": "Monitoring",
                    "code": {
                      "id": "fce2945e-b6c4-4e8e-b4de-b733ba12920a",
                      "code": "C25548",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Monitoring",
                      "instanceType": "Code"
                    },
                    "instanceType": "Procedure",
                    "label": "Injection Site Check",
                    "description": "Monitoring for reactions at the site of IMP administration"
                  }
                ],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "a4813ecd-38ac-4c47-924e-6d9d706e091a",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures"
                  },
                  {
                    "id": "2e682fde-64c2-4098-857e-0373751934d9",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "9600c4e5-9d1b-42c6-84c1-b9e0f24e464b",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "c9c26977-2152-4f44-aa3b-c6b14975fd0c",
                "name": "Intramuscular injection",
                "instanceType": "Activity",
                "definedProcedures": [
                  {
                    "id": "c9c26977-2152-4f44-aa3b-c6b14975fd0c",
                    "name": "Intramuscular injection",
                    "procedureType": "Therapeutic Procedure",
                    "code": {
                      "id": "55160c0d-e952-4e2d-a884-b1f0b0f6f582",
                      "code": "C49236",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Therapeutic Procedure",
                      "instanceType": "Code"
                    },
                    "instanceType": "Procedure",
                    "label": "IM Injection",
                    "description": "Administration of IMP as 2 separate injections in the gluteal region"
                  }
                ],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "c76bff0d-8c67-4752-928c-3cbe942b4fd5",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures"
                  },
                  {
                    "id": "1f6990f3-8bf4-4097-ad85-6003fc7b0654",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "7cad09d6-fed6-4d92-a6cf-a4275526c4b8",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "aa7c07f8-70e3-4a85-92ce-319099a03a0b",
                "name": "Medical/medication history",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "4886cff6-1bb3-4374-aee2-982a871727d3",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "6a3e269a-dc2a-4ebe-bff2-457cbad1fa8e",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "999cd8c7-d12a-4217-9a51-bf42b41c7a72",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "bff3b4ac-9208-4f8a-b44f-8cfe2802900f",
                "name": "Mid-turbinate nasal swab",
                "instanceType": "Activity",
                "definedProcedures": [],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "ca008d73-2fa3-443d-9633-f2dec2bf4ca8",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures"
                  },
                  {
                    "id": "f8fad0d5-a83f-4ee0-b97c-20725be35403",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "1439ae24-8fe1-4535-82ee-b5d31e724b14",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "6c4da81a-31f4-4b9a-8441-446c6e0ee3f2",
                "name": "Pharmacokinetics Assessments",
                "instanceType": "Activity",
                "definedProcedures": [
                  {
                    "id": "6c4da81a-31f4-4b9a-8441-446c6e0ee3f2",
                    "name": "Pharmacokinetics Assessments",
                    "procedureType": "Biospecimen Collection",
                    "code": {
                      "id": "6f56aba7-7e09-482c-bbee-62e26ac8846c",
                      "code": "C70793",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Biospecimen Collection",
                      "instanceType": "Code"
                    },
                    "instanceType": "Procedure",
                    "label": "PK Sampling",
                    "description": "Serum collection for determination of drug concentration"
                  }
                ],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "2f211148-32d5-4218-b1c8-d27bcfa3f09e",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures"
                  },
                  {
                    "id": "22a3f639-8e86-448e-985e-32478b1d11e0",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "2d302eba-85d4-4ae0-b504-e5fb64955d8f",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "5fe922e9-278e-41a7-bd92-3ffff658cc95",
                "name": "Pregnancy testing",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "b3a4267f-1ab4-4618-9fd0-34b0ff76e43a",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "6fa6c9ff-7c9c-49d6-9038-4244bf07d57a",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "147e3983-0898-4d0f-8625-f4189ad3b43c",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "9ea536b0-3542-485a-86c6-9e1946e766ff",
                "name": "Pulse Oximetry",
                "instanceType": "Activity",
                "definedProcedures": [
                  {
                    "id": "9ea536b0-3542-485a-86c6-9e1946e766ff",
                    "name": "Pulse Oximetry",
                    "procedureType": "Monitoring",
                    "code": {
                      "id": "c213be87-f582-44e9-9825-fbfe373df8fc",
                      "code": "C25548",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Monitoring",
                      "instanceType": "Code"
                    },
                    "instanceType": "Procedure",
                    "label": "SpO2 Measurement",
                    "description": "Measurement of oxygen saturation in room air"
                  }
                ],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "9824d698-8479-471a-a8b7-6dc93f90b81f",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures"
                  },
                  {
                    "id": "3abf96d2-16a5-4dd9-b466-e0662bbdb6be",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "33ef4cb8-bda4-4364-a77a-943bf0893a1e",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "741e5aba-b42a-4fe4-ab71-f718d558e4b9",
                "name": "Randomization",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "2108c965-f8eb-4a94-8029-ecb690f2e1bd",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "b02eb97f-c0de-48b2-ae5a-025850fa8962",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "documentation"
                  },
                  {
                    "id": "fd5ef88e-8363-4d1f-ac90-55edfbc9e696",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "d5d6d1e6-c026-4306-8182-991d56a0a4fc",
                "name": "Respiratory sample for rapid SARS-CoV-2",
                "instanceType": "Activity",
                "definedProcedures": [],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "423778e0-b807-4996-9c77-85ac955c1fdf",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures,soa"
                  },
                  {
                    "id": "38f04a9d-545f-4c17-bb46-f7033d75887f",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "40a67add-af7c-4ba8-8a11-5e55ffc8a973",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "a5e29af9-cc73-41ed-91ca-04668d9dcf34",
                "name": "Retrieval of participant-reported symptom diary",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "134bf152-3331-4fd1-be83-91424d8231f7",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "e848953e-61c9-4db0-909c-b236658f084c",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "assessment"
                  },
                  {
                    "id": "1bd4d589-3b20-4072-9606-e8c352627499",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "8b87483c-d65d-47b0-8d89-e662fc6b0a62",
                "name": "Return to usual (pre-COVID-19) health",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "527dfb12-a5bf-40ce-aec7-ad7ea0c52427",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "c616aa88-1b9c-4820-b668-91393a16f399",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "0bb2e66a-37b6-4fda-9a3f-2a411f855924",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "ebdc9523-b5b9-433e-9c3d-b6b54fd1b783",
                "name": "Risk categorization",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "7b0aee7e-be97-4073-870e-d3cfabc63bb8",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "4c3debea-43a9-4e28-a490-cb1256deff68",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "39a70791-a6ca-4fb4-a4f2-a280a0f515d0",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "154a8840-43ca-410d-b286-ddf32ecc264b",
                "name": "SAEs and AESIs",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "4d5dde5a-b942-4729-af39-8bdd1faab2e5",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "00876b14-bc5a-434c-bbe9-7805ef2ac10c",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "bb99461b-6645-46f7-a771-02665a461302",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "b4a11ef6-d97e-4473-a862-44e7e310327e",
                "name": "Serum chemistry panel",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "1bd4d275-e91d-45d6-a4df-0aac351535c0",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures,soa"
                  },
                  {
                    "id": "92789ca1-9592-45f5-98d3-efbb1637b155",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "lab"
                  },
                  {
                    "id": "b4e18534-9df4-4334-9773-8d3106740c6a",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "44718c7f-1ff2-4383-9cef-8b9881c4fc7b",
                "name": "Serum for AZD7442 anti-drug antibodies",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "45f5787f-7e79-4583-a5ff-a4eca8c47fce",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "d13c2e3a-eed6-4075-a027-6f8a860e3d77",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "b6dc11bc-cde1-4117-b6e9-be5982682d86",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "3bfd3ab7-4798-42b2-ac6b-ca0507b20595",
                "name": "Serum for AZD7442 pharmacokinetics",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "e52ee613-2288-4e72-af58-d054c9788149",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "60cc2a4c-1e6e-4e8f-b718-5d2788e408e6",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "bd8d46b7-b57e-4f9b-96f5-20bcce0be68e",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "82d81992-06f3-4318-af87-e3b275cadd4e",
                "name": "Serum for SARS-CoV-2 serology",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "377d3626-f152-441a-a00c-2453d8c911d2",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "77d261f4-d57c-439b-8c46-b739dc226e4f",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "lab"
                  },
                  {
                    "id": "1c182887-ddc8-44de-91b3-00e419898c18",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "a44b76fc-8fcb-4150-a051-fa257f2be1e2",
                "name": "Smoking status",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "feb94652-9774-4dea-9337-f4c1af13cf71",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "d659a045-05cf-4623-8570-214db301c4eb",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "ecee621e-6f26-4f5e-ab3d-034a6888c4e5",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "34212ee1-810f-47bc-ade3-0f0286af921e",
                "name": "Staff review of participant-reported symptom diary",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "a34789cb-339e-4e96-9aec-bb6bd4c58688",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "30742d81-8efe-401d-932c-116518883d37",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "assessment"
                  },
                  {
                    "id": "eb3f2e26-b090-4d74-a143-f5747807ae53",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "df14be25-83dc-4d61-b863-7ab5bf3d1501",
                "name": "Study staff-collected mid-turbinate nasal swab for SARS-CoV-2 RT-PCR and sequencing",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "6151302a-5481-4ae2-bb7a-00c16b862dd6",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "882e87a9-1771-413b-8d68-541841f16aa0",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "00e07bf9-faf4-42ee-bfcd-0142926d574b",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "15df1add-c82f-4d43-8770-aed1012a77f1",
                "name": "Survival status check",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "f8e85b75-1550-41fd-976a-ba2fc31b6277",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "14ae19ef-5d72-422a-8fad-0713fe184cd9",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "6d4c271a-c083-45d1-8278-c38f527a29c0",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "95330b64-a79b-4169-a7d1-7d62795c54b7",
                "name": "Targeted physical examination",
                "instanceType": "Activity",
                "definedProcedures": [],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "fa6f10da-5ab5-42ac-ad82-764907cf25cb",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures,soa"
                  },
                  {
                    "id": "6a9493dc-a3a5-48ea-bd54-63ffd88ddf7f",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "6b1be16c-bd1c-4697-9f4b-5d45c0a1cf18",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "d9e2cd18-534f-4936-82d1-98efe6102386",
                "name": "Triplicate 12-lead ECG",
                "instanceType": "Activity",
                "definedProcedures": [],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "fa2b7fa0-c179-48b7-a40b-db41113a367f",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures,soa"
                  },
                  {
                    "id": "c58523f9-055b-4250-b560-9997aacd109c",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "2fe58519-b60c-4094-95b9-6c5847c17f74",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "9f66c671-1db6-45ff-ab34-089555fc95af",
                "name": "Urinalysis",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "60a73a4a-f7d6-4629-af76-c74ad12cfdd2",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures,soa"
                  },
                  {
                    "id": "e2885700-db85-4a12-9240-0670f00ede22",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "lab"
                  },
                  {
                    "id": "ba874ede-de0b-4ed4-9744-42bcd8cbb51d",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "9ee3b5bc-7531-449a-84e2-37729bf4a040",
                "name": "Urine pregnancy test",
                "instanceType": "Activity",
                "definedProcedures": [
                  {
                    "id": "9ee3b5bc-7531-449a-84e2-37729bf4a040",
                    "name": "Urine pregnancy test",
                    "procedureType": "Diagnostic Procedure",
                    "code": {
                      "id": "46bcfaa4-9785-4b09-a242-2ca666b09dc4",
                      "code": "C25391",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Diagnostic Procedure",
                      "instanceType": "Code"
                    },
                    "instanceType": "Procedure",
                    "label": "Pregnancy Test",
                    "description": "Local laboratory urine test for females of childbearing potential"
                  }
                ],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "b4ef15a1-be4d-4ff6-9382-6d016f319749",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures"
                  },
                  {
                    "id": "86454a0d-a56a-4b25-a0d7-c940c63c3a1a",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "fae912a7-63db-4c6b-9b4d-92b2e4146665",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "afcba381-9625-47ca-8020-49c5a439d257",
                "name": "Verify eligibility criteria",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "2e47931c-879d-4f53-8333-8c61f0c2807c",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "864ec08c-220c-4326-b23a-eb66d535abdc",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "9387e7ef-c775-4541-bb6b-d16f954cdb0a",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "5b92d203-1d22-4ffa-b75a-6d37da2e44ec",
                "name": "Vital signs",
                "instanceType": "Activity",
                "definedProcedures": [],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "c408ed26-381a-4624-a184-0e33418f4be2",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures,soa"
                  },
                  {
                    "id": "850f100e-e543-4dee-9e8b-fdb155b06858",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "073d6ac5-26cf-4477-a8dc-7a0b086a1a9a",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              }
            ],
            "epochs": [
              {
                "id": "53a15c62-adac-44cd-b692-c18c47a15dff",
                "name": "Screening",
                "instanceType": "StudyEpoch",
                "type": {
                  "id": "9c29aea1-af7f-449d-baec-3d1242b42cd5",
                  "code": "C98779",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Screening Epoch",
                  "instanceType": "Code"
                },
                "extensionAttributes": [
                  {
                    "id": "dab74ce2-ad38-452f-85e8-1762a88d2230",
                    "url": "https://protocol2usdm.io/extensions/x-studyepochSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "traversal,soa"
                  },
                  {
                    "id": "c47ccae0-f310-4788-bce7-0afd5ce768dc",
                    "url": "https://protocol2usdm.io/extensions/x-epochCategory",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "main"
                  },
                  {
                    "id": "54e16fea-d654-47e6-9d8f-961ef2d0767a",
                    "url": "https://protocol2usdm.io/extensions/x-epochSequenceOrder",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "1"
                  }
                ]
              },
              {
                "id": "a8d0739e-57f0-42e7-b817-e8a5df8ad89d",
                "name": "Treatment and Follow-up Period",
                "instanceType": "StudyEpoch",
                "type": {
                  "id": "f06c66d9-3cf6-44b6-969a-b54f729b5c5f",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Treatment Epoch",
                  "instanceType": "Code"
                },
                "extensionAttributes": [
                  {
                    "id": "b05d2d43-3bdf-4a92-880b-343e2c13e990",
                    "url": "https://protocol2usdm.io/extensions/x-studyepochSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "traversal,soa"
                  },
                  {
                    "id": "9985fd4b-c2da-4d32-81b6-5bdfe7525181",
                    "url": "https://protocol2usdm.io/extensions/x-epochCategory",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "main"
                  },
                  {
                    "id": "76bbf3ef-7f70-4d64-8713-728f20a2fe88",
                    "url": "https://protocol2usdm.io/extensions/x-epochSequenceOrder",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "2"
                  }
                ]
              },
              {
                "id": "bbe0336e-1237-4e88-9048-2ff87e699180",
                "name": "Early Discontinuation Visit",
                "instanceType": "StudyEpoch",
                "type": {
                  "id": "74cbb3a5-e36e-480b-a7aa-152bc7c2c38f",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Treatment Epoch",
                  "instanceType": "Code"
                },
                "extensionAttributes": [
                  {
                    "id": "78fba416-2e37-4299-9f2c-4f9eefec15fd",
                    "url": "https://protocol2usdm.io/extensions/x-studyepochSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "c28639e7-ddd0-4ad8-9d55-10f4a3c91821",
                    "url": "https://protocol2usdm.io/extensions/x-epochCategory",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "sub"
                  }
                ]
              }
            ],
            "activityGroups": [
              {
                "id": "e122d11b-481a-4225-9225-9764edd0ff31",
                "name": "Administrative and Eligibility",
                "description": null,
                "childIds": [
                  "bb2882cb-e26c-4ba3-8f91-3223cba1bd64",
                  "9ec5c9ea-56b6-46be-b5c8-ec7ba9f47f27",
                  "f3661f47-91e3-45f1-94a3-635bb32dda75",
                  "d5d6d1e6-c026-4306-8182-991d56a0a4fc",
                  "781656ca-5f56-4043-b07d-ddbb0f78e6a3",
                  "aa7c07f8-70e3-4a85-92ce-319099a03a0b",
                  "ebdc9523-b5b9-433e-9c3d-b6b54fd1b783",
                  "a44b76fc-8fcb-4150-a051-fa257f2be1e2",
                  "741e5aba-b42a-4fe4-ab71-f718d558e4b9"
                ],
                "instanceType": "Activity",
                "activityNames": [
                  "Informed consent",
                  "Assignment SID number",
                  "Documentation of SARS-CoV-2 infection",
                  "Respiratory sample for rapid SARS-CoV-2",
                  "COVID-19 Symptom screen",
                  "Medical/medication history",
                  "Risk categorization",
                  "Smoking status",
                  "Verify eligibility criteria",
                  "Randomization"
                ]
              },
              {
                "id": "da0ffcfe-8cd1-4307-8c82-c9aef8934fdd",
                "name": "Safety Assessments",
                "description": null,
                "childIds": [
                  "14d48173-9e23-42e2-9c17-c84cfcc8c4ff",
                  "2ea5e748-5a90-410d-a17b-44c09b746eb0",
                  "95330b64-a79b-4169-a7d1-7d62795c54b7",
                  "5b92d203-1d22-4ffa-b75a-6d37da2e44ec",
                  "a03d9030-cf77-451c-8c77-92c7067cbd1f",
                  "5fe922e9-278e-41a7-bd92-3ffff658cc95",
                  "37b3881e-fb81-4eb0-8957-637327bc87d9"
                ],
                "instanceType": "Activity",
                "activityNames": [
                  "Clinical assessments",
                  "Complete physical examination",
                  "Targeted physical examination",
                  "Vital signs",
                  "Triplicate 12-lead ECG",
                  "Hematology",
                  "Serum chemistry panel",
                  "Urinalysis",
                  "Pregnancy testing",
                  "Concomitant medications",
                  "Collect/update secondary contacts",
                  "Survival status check",
                  "Adverse events",
                  "SAEs and AESIs",
                  "Telephone contact for safety monitoring"
                ]
              },
              {
                "id": "3b39df65-58b5-4fde-8457-0d5bbce275db",
                "name": "Efficacy and Health Status",
                "description": null,
                "childIds": [
                  "df14be25-83dc-4d61-b863-7ab5bf3d1501"
                ],
                "instanceType": "Activity",
                "activityNames": [
                  "Participant-reported symptom diary",
                  "Participant-reported symptom reminder",
                  "Staff review of participant-reported symptom diary",
                  "Retrieval of participant-reported symptom diary",
                  "Return to usual (pre-COVID-19) health",
                  "Household infection report",
                  "Study staff-collected mid-turbinate nasal swab for SARS-CoV-2 RT-PCR and sequencing"
                ]
              },
              {
                "id": "43f76472-4b22-4357-8589-a3651c76c43e",
                "name": "Pharmacokinetics and Immunogenicity",
                "description": null,
                "childIds": [
                  "82d81992-06f3-4318-af87-e3b275cadd4e",
                  "3bfd3ab7-4798-42b2-ac6b-ca0507b20595",
                  "44718c7f-1ff2-4383-9cef-8b9881c4fc7b"
                ],
                "instanceType": "Activity",
                "activityNames": [
                  "Serum for SARS-CoV-2 serology",
                  "Serum for AZD7442 pharmacokinetics",
                  "Serum for AZD7442 anti-drug antibodies"
                ]
              },
              {
                "id": "c56739e6-c891-42a3-89ae-a1a0283f377b",
                "name": "Investigational Medicinal Product",
                "description": null,
                "childIds": [
                  "9880e31f-1d37-4c32-9741-7b9111bb98b3",
                  "20d687ab-2944-4a0f-b2d8-c4e45628deab"
                ],
                "instanceType": "Activity",
                "activityNames": [
                  "IMP administration",
                  "Check injection sites"
                ]
              }
            ],
            "notes": [
              {
                "id": "3dec9485-1ff3-4e38-9ca2-8375040618f7",
                "text": "a. Visits noted P/H can be performed either in-person at clinical site or at home depending on the participant's clinical status, availability of safe transfer to sites (eg, to avoid risk of infection spread), and local guidelines for travel restrictions/social distancing. For home visits, a nurse or HCP trained on study procedures will visit the participant at home; nasal swabs, blood collection (where at-home collection is possible), and inspection of injection sites will be performed by the nurse or HCP. Nurse or HCP will ensure shipment of specimens collected and reporting of AEs to study sites.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "368b6c91-aa06-4617-9cf5-c130375812f0",
                "text": "b. Perform if no documentation of SARS-CoV-2 infection available; tested locally.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "81af91dd-8ce8-441a-987f-9914ca64d48f",
                "text": "c. Assessment will be performed only for participants attending in-person visits, or if a nurse or HCP visiting the participant at home is properly trained for these assessments.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "54f8f47d-d4ee-4fa1-a994-7349a52aba62",
                "text": "d. Height is recorded only at the screening visit.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "9bf2e0f6-982e-4242-91bd-8612b1f89d78",
                "text": "e. Perform pre-dose and 15 minutes ( 5 minutes) after both injections are complete.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "0d27edfa-1691-481a-b243-b55013b69d9b",
                "text": "f. Perform pre-dose on Day 1.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "83280d5f-9140-48e8-9ea2-e404d1839e73",
                "text": "g. Hematology panel includes coagulation markers.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "a5ef384d-8b18-4629-af86-120fc0384f6f",
                "text": "h. Urine pregnancy test (local laboratory) at screening. Perform another urine test (local laboratory) on Day 1 if screening urine test was performed on Day -1. Single serum (central laboratory) must be performed on Day 1. Sample urine test must return negative result before dosing.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "68e2d5e5-5291-4fd0-99df-6a7768b4205a",
                "text": "i. Urine pregnancy test (local laboratory).",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "8759c493-d896-4477-8ae9-866595689118",
                "text": "j. Participants will report COVID-19-related symptoms daily in an electronic device, starting pre-dose and post-dose on Day 1.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "9009444b-fed3-4b43-a6d9-564d4190cf1b",
                "text": "k. Participant will be reminded every day through Day 29 to complete their diary. This reminder will be received through the electronic device.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "a4764560-b130-4093-9597-8481c26191fb",
                "text": "l. If Day 29 visit is conducted earlier in  4 day window, participant should retain symptom diary in order to complete required daily entries through Study Day 29.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "8c6de19c-ab4c-4a82-84f9-6e9a5c1876b4",
                "text": "m. Mid-turbinate nasal swab is tested centrally. Sequencing applies to nasal swabs collected through Day 15.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "9f3fd764-6f48-4a19-b3ee-a29804cb497d",
                "text": "n. Pre-dose sample and post-dose sample (ie, samples obtained prior to and upon completion of IMP administered via IM injections on Day 1).",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "9726932a-b978-40e5-893f-433f7d031698",
                "text": "o. Serum vitamin D, serum zinc, dependent on availability of laboratory kits.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "7f6e8950-f69d-4504-b067-1425e5596790",
                "text": "p. Perform 30 minutes ( 10 minutes) after the IMP has been administered and just prior to release from the study site or departure of the study staff.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "67c92d3e-346c-43fe-9052-99a862182017",
                "text": "q. If evidence of injection site reaction persists at the Day 6 visit, the injection site will be rechecked at each visit until no evidence of an active reaction remains.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "02261bd6-5974-4e5a-b0cc-3323ffbb5924",
                "text": "r. The first 20 participants dosed (ie, the sentinel group) will undergo safety monitoring for 4 hours post IMP administration before further participants are dosed. At each site, there will be an interval of 24 hours after dosing of the first participant in the sentinel group before the next participant can be dosed. The next 80 participants (21 to 100) will then undergo safety monitoring for 2 hours post IMP administration, otherwise the minimum safety monitoring time will be 1 hour. In addition, the sentinel group will be contacted daily (in-person or by telephone) for the first 4 days after IMP administration. Contact will be made by telephone on days when there is not an in-person visit.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "c6e22c44-f25a-4454-8402-3098137607ca",
                "text": "s. At Day 457 AE/SAE/AESI assessment will be made by telephone only.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "db33864c-cbca-4047-ba67-ee52df4350e8",
                "text": "t. Note: Remote (denoted by R) visit: either a phone call, or a web-based virtual assessment.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "f1dd3a39-a80e-4dbf-be35-b85ae0480618",
                "text": "u. Note: Day 6 and Day 8 assessments must be performed on different days.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "b9d37228-05b4-4f65-8886-789d9a27c881",
                "text": "s. At Day 457 AE/SAE/AESI assessment will be made by telephone only.",
                "instanceType": "Note"
              },
              {
                "id": "e3d7e3d5-84c1-4e19-8fe3-a2bbba5ec785",
                "text": "t. Note: Remote (denoted by R) visit: either a phone call, or a web-based virtual assessment.",
                "instanceType": "Note"
              }
            ],
            "model": {
              "id": "e2b4ac70-f0a9-4597-b33a-0ef186422be2",
              "code": "C82639",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-09-27",
              "decode": "Parallel Study",
              "instanceType": "Code"
            },
            "indications": [
              {
                "id": "e0607229-d722-44d7-aca0-17e022f1be92",
                "name": "COVID-19",
                "isRareDisease": false,
                "instanceType": "Indication",
                "description": "Treatment of COVID-19 in Non-hospitalized Adults"
              }
            ],
            "procedures": [
              {
                "id": "9ee3b5bc-7531-449a-84e2-37729bf4a040",
                "name": "Urine pregnancy test",
                "procedureType": "Diagnostic Procedure",
                "code": {
                  "id": "46bcfaa4-9785-4b09-a242-2ca666b09dc4",
                  "code": "C25391",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.01d",
                  "decode": "Diagnostic Procedure",
                  "instanceType": "Code"
                },
                "instanceType": "Procedure",
                "label": "Pregnancy Test",
                "description": "Local laboratory urine test for females of childbearing potential"
              },
              {
                "id": "c9c26977-2152-4f44-aa3b-c6b14975fd0c",
                "name": "Intramuscular injection",
                "procedureType": "Therapeutic Procedure",
                "code": {
                  "id": "55160c0d-e952-4e2d-a884-b1f0b0f6f582",
                  "code": "C49236",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.01d",
                  "decode": "Therapeutic Procedure",
                  "instanceType": "Code"
                },
                "instanceType": "Procedure",
                "label": "IM Injection",
                "description": "Administration of IMP as 2 separate injections in the gluteal region"
              },
              {
                "id": "b3783f2d-d68e-4029-84bc-56c6aa009d3a",
                "name": "Injection site inspection",
                "procedureType": "Monitoring",
                "code": {
                  "id": "fce2945e-b6c4-4e8e-b4de-b733ba12920a",
                  "code": "C25548",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.01d",
                  "decode": "Monitoring",
                  "instanceType": "Code"
                },
                "instanceType": "Procedure",
                "label": "Injection Site Check",
                "description": "Monitoring for reactions at the site of IMP administration"
              },
              {
                "id": "6c4da81a-31f4-4b9a-8441-446c6e0ee3f2",
                "name": "Pharmacokinetics Assessments",
                "procedureType": "Biospecimen Collection",
                "code": {
                  "id": "6f56aba7-7e09-482c-bbee-62e26ac8846c",
                  "code": "C70793",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.01d",
                  "decode": "Biospecimen Collection",
                  "instanceType": "Code"
                },
                "instanceType": "Procedure",
                "label": "PK Sampling",
                "description": "Serum collection for determination of drug concentration"
              },
              {
                "id": "9ea536b0-3542-485a-86c6-9e1946e766ff",
                "name": "Pulse Oximetry",
                "procedureType": "Monitoring",
                "code": {
                  "id": "c213be87-f582-44e9-9825-fbfe373df8fc",
                  "code": "C25548",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.01d",
                  "decode": "Monitoring",
                  "instanceType": "Code"
                },
                "instanceType": "Procedure",
                "label": "SpO2 Measurement",
                "description": "Measurement of oxygen saturation in room air"
              }
            ],
            "analysisPopulations": [
              {
                "id": "eab805dd-a0e2-495b-b6a3-6ce4fe856550",
                "name": "All participants analysis set",
                "text": "All participants screened for the study, to be used for reporting disposition and screening failures.",
                "populationType": "Other",
                "instanceType": "AnalysisPopulation",
                "label": "PAS",
                "populationDescription": "All participants screened for the study, to be used for reporting disposition and screening failures.",
                "criteria": "All screened participants"
              },
              {
                "id": "cb580e6e-7fee-4341-87f9-92b5eedbe604",
                "name": "Full analysis set",
                "text": "All randomized participants who received IMP, irrespective of their protocol adherence and continued participation in the study. Participants will be analyzed according to their randomized treatment, irrespective of whether or not they have prematurely discontinued, according to the intent-to-treat principle. Participants who withdraw consent or assent to participate in the study will be included up to the date of their study termination.",
                "populationType": "Efficacy",
                "instanceType": "AnalysisPopulation",
                "label": "FAS",
                "populationDescription": "All randomized participants who received IMP, irrespective of their protocol adherence and continued participation in the study. Participants will be analyzed according to their randomized treatment, irrespective of whether or not they have prematurely discontinued, according to the intent-to-treat principle. Participants who withdraw consent or assent to participate in the study will be included up to the date of their study termination.",
                "criteria": "Randomized AND received IMP"
              },
              {
                "id": "7b84007c-692f-4876-acb6-0c38595c32b0",
                "name": "Modified full analysis set",
                "text": "All participants in the full analysis set who received IMP  7 days from symptom onset and were not hospitalized at baseline ( Day 1) for isolation purpose.",
                "populationType": "Efficacy",
                "instanceType": "AnalysisPopulation",
                "label": "mFAS",
                "populationDescription": "All participants in the full analysis set who received IMP  7 days from symptom onset and were not hospitalized at baseline ( Day 1) for isolation purpose.",
                "criteria": "In FAS AND received IMP <= 7 days from symptom onset AND not hospitalized at baseline for isolation"
              },
              {
                "id": "943b938b-5933-40b3-b0a5-adcc79a318b2",
                "name": "Early Intervention Analysis Set",
                "text": "All participants in the modified full analysis set who received IMP  5 days from symptom onset.",
                "populationType": "Efficacy",
                "instanceType": "AnalysisPopulation",
                "label": "EIAS",
                "populationDescription": "All participants in the modified full analysis set who received IMP  5 days from symptom onset.",
                "criteria": "In mFAS AND received IMP <= 5 days from symptom onset"
              },
              {
                "id": "a0b8c726-fdd3-47a2-8c83-159c48515278",
                "name": "Seronegative Analysis Set",
                "text": "All participants in the modified full analysis set who were seronegative at baseline.",
                "populationType": "Efficacy",
                "instanceType": "AnalysisPopulation",
                "label": "SAS_Sero",
                "populationDescription": "All participants in the modified full analysis set who were seronegative at baseline.",
                "criteria": "In mFAS AND seronegative at baseline"
              },
              {
                "id": "3e48dc30-6bc4-4822-a56f-0bc279afb50b",
                "name": "Safety analysis set",
                "text": "The safety analysis set consists of all participants who have received IMP. Erroneously-treated participants (eg, those randomized to treatment A, but were actually given treatment B) are accounted for in this analysis set by assigning them to the treatment they actually received.",
                "populationType": "Safety",
                "instanceType": "AnalysisPopulation",
                "label": "SAF",
                "populationDescription": "The safety analysis set consists of all participants who have received IMP. Erroneously-treated participants (eg, those randomized to treatment A, but were actually given treatment B) are accounted for in this analysis set by assigning them to the treatment they actually received.",
                "criteria": "Received IMP"
              },
              {
                "id": "6c60c5ab-c8a8-4420-bd62-9703f39714f3",
                "name": "PK analysis set",
                "text": "Dosed participants for whom an adequate (measurable drug concentration) PK profile has been obtained. All participants who received AZD7442 and from whom PK blood samples are assumed not to be affected by factors such as protocol violations, and who had at least one quantifiable serum PK observation post dose, will be included in the PK analysis dataset.",
                "populationType": "PK/PD",
                "instanceType": "AnalysisPopulation",
                "label": "PKAS",
                "populationDescription": "Dosed participants for whom an adequate (measurable drug concentration) PK profile has been obtained. All participants who received AZD7442 and from whom PK blood samples are assumed not to be affected by factors such as protocol violations, and who had at least one quantifiable serum PK observation post dose, will be included in the PK analysis dataset.",
                "criteria": "Received AZD7442 AND evaluable PK profile AND >=1 quantifiable post-dose PK observation"
              },
              {
                "id": "ce819463-4a95-4213-9738-7d3d84814666",
                "name": "Virology analysis set",
                "text": "The Virology analysis set consists of all participants in Cohort 1, who undergo more intensive virologic and immunologic assessments. Participants will be analyzed according to their received treatment.",
                "populationType": "PK/PD",
                "instanceType": "AnalysisPopulation",
                "label": "VAS",
                "populationDescription": "The Virology analysis set consists of all participants in Cohort 1, who undergo more intensive virologic and immunologic assessments. Participants will be analyzed according to their received treatment.",
                "criteria": "In Cohort 1"
              },
              {
                "id": "92a2c72c-cf16-46de-b4d8-17c4799d06fa",
                "name": "ADA evaluable analysis set",
                "text": "The ADA evaluable analysis set contains all participants in the Safety analysis set who have a non-missing baseline AZD7442 ADA result and at least one non-missing post-baseline AZD7442 ADA result.",
                "populationType": "Safety",
                "instanceType": "AnalysisPopulation",
                "label": "ADA",
                "populationDescription": "The ADA evaluable analysis set contains all participants in the Safety analysis set who have a non-missing baseline AZD7442 ADA result and at least one non-missing post-baseline AZD7442 ADA result.",
                "criteria": "In Safety Set AND non-missing baseline ADA result AND >=1 non-missing post-baseline ADA result"
              }
            ],
            "characteristics": [
              {
                "id": "32b5efa4-d511-4e6b-904e-060e2357151a",
                "code": "AGE",
                "codeSystem": "http://www.cdisc.org/baseline-characteristics",
                "codeSystemVersion": "2024-03-29",
                "decode": "Age",
                "instanceType": "Code"
              },
              {
                "id": "dd0aebf1-bf77-4d87-ba64-731317af33da",
                "code": "TIME_FROM_SYMPTOM_ON",
                "codeSystem": "http://www.cdisc.org/baseline-characteristics",
                "codeSystemVersion": "2024-03-29",
                "decode": "Time from symptom onset",
                "instanceType": "Code"
              },
              {
                "id": "cba47dab-2ba5-4f6b-aa04-81aead215dbf",
                "code": "RISK_OF_PROGRESSION",
                "codeSystem": "http://www.cdisc.org/baseline-characteristics",
                "codeSystemVersion": "2024-03-29",
                "decode": "Risk of progression",
                "instanceType": "Code"
              },
              {
                "id": "5899d162-043c-4a4e-b626-8a457a882b5d",
                "code": "BMI",
                "codeSystem": "http://www.cdisc.org/baseline-characteristics",
                "codeSystemVersion": "2024-03-29",
                "decode": "BMI",
                "instanceType": "Code"
              },
              {
                "id": "d4d310d1-1b90-4185-896c-e4e311862de0",
                "code": "SMOKING_HISTORY",
                "codeSystem": "http://www.cdisc.org/baseline-characteristics",
                "codeSystemVersion": "2024-03-29",
                "decode": "Smoking History",
                "instanceType": "Code"
              }
            ],
            "extensionAttributes": [
              {
                "id": "538c4e3d-b658-41b3-9d52-01919768f65c",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-entityMaps",
                "instanceType": "ExtensionAttribute",
                "valueString": "{\"epochAliases\": {\"SCREENING\": \"epoch_1\", \"TREATMENT AND FOLLOW-UP PERIOD\": \"epoch_2\", \"TREATMENT_AND_FOLLOW-UP_PERIOD\": \"epoch_2\", \"TREATMENT\": \"epoch_2\", \"FOLLOW_UP\": \"epoch_2\", \"EARLY DISCONTINUATION VISIT\": \"epoch_3\", \"EARLY_DISCONTINUATION_VISIT\": \"epoch_3\", \"INTENSIVE_FOLLOW_UP\": \"epoch_2\", \"LIMITED_FOLLOW_UP\": \"epoch_2\"}, \"visitAliases\": {\"SCREENING (DAY -1 OR DAY 1)\": \"enc_1\", \"SCREENING_(DAY_-1_OR_DAY_1)\": \"enc_1\", \"DAY 1\": \"enc_2\", \"DAY_1\": \"enc_2\", \"DAY 3\": \"enc_3\", \"DAY_3\": \"enc_3\", \"DAY 6\": \"enc_4\", \"DAY_6\": \"enc_4\", \"DAY 8\": \"enc_5\", \"DAY_8\": \"enc_5\", \"DAY 15\": \"enc_6\", \"DAY_15\": \"enc_6\", \"DAY 29\": \"enc_7\", \"DAY_29\": \"enc_7\", \"DAY 85\": \"enc_8\", \"DAY_85\": \"enc_8\", \"DAY 169\": \"enc_9\", \"DAY_169\": \"enc_9\", \"DAY 366\": \"enc_10\", \"DAY_366\": \"enc_10\", \"DAY 457\": \"enc_11\", \"DAY_457\": \"enc_11\", \"EARLY DISCONTINUATION (BEFORE DAY 29)\": \"enc_12\", \"EARLY_DISCONTINUATION_(BEFORE_DAY_29)\": \"enc_12\", \"EARLY DISCONTINUATION (AFTER DAY 29)\": \"enc_13\", \"EARLY_DISCONTINUATION_(AFTER_DAY_29)\": \"enc_13\", \"screening\": \"enc_1\", \"randomization\": \"enc_2\", \"Day 3 (Sentinel Group Only)\": \"enc_3\", \"Day 6\": \"enc_4\", \"Day 8\": \"enc_5\", \"Day 15\": \"enc_6\", \"Day 29\": \"enc_7\", \"Day 30\": \"enc_3\", \"Day 169\": \"enc_9\", \"Day 457\": \"enc_11\"}}"
              },
              {
                "id": "6b561a6b-3661-491c-b480-26f8bfce700e",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-classifiedIssues",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"severity\": \"warning\", \"category\": \"traversal_resolution\", \"message\": \"Traversal step 'END_OF_STUDY' could not be resolved to an epoch ID\", \"affectedPath\": \"$.traversalConstraints[].requiredSequence\", \"affectedIds\": [\"911bf040-09b1-4ff4-9cf3-a88ccf441da7\"], \"suggestion\": \"Create epoch for 'END_OF_STUDY' or map to existing epoch\"}]"
              },
              {
                "id": "ext_conceptual_3e63e5dc-01af-4116-b6d6-0896074ed0bb",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-conceptualAnchors",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"eafacfc7-0d6e-4c51-a8b0-83b5b1a41d81\", \"name\": \"Surgery Exclusion Window\", \"classification\": \"Conceptual\", \"note\": \"Pure timing reference - no visit or activity instance\"}]"
              },
              {
                "id": "679aa723-3350-4cdd-aa1d-6e17d2e4df4b",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-promotionIssues",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"severity\": \"info\", \"category\": \"visit_anchor_created\", \"message\": \"Created VISIT anchor instance: c81e870c-23c5-4dcc-b174-b171816175b8 (encounter: enc_1)\", \"affectedPath\": \"$.scheduleTimelines[0].instances[-1]\"}, {\"severity\": \"info\", \"category\": \"visit_anchor_created\", \"message\": \"Created VISIT anchor instance: c66a35b0-2bc4-4467-92c4-c700c79ab7e2 (encounter: enc_1)\", \"affectedPath\": \"$.scheduleTimelines[0].instances[-1]\"}, {\"severity\": \"info\", \"category\": \"visit_anchor_created\", \"message\": \"Created VISIT anchor instance: 7f290bde-0ede-4baf-b9d4-8bac3b64a12a (encounter: enc_1)\", \"affectedPath\": \"$.scheduleTimelines[0].instances[-1]\"}, {\"severity\": \"info\", \"category\": \"visit_anchor_created\", \"message\": \"Created VISIT anchor instance: 0711a292-9eb0-430c-88bc-1d9531948fc1 (encounter: enc_1)\", \"affectedPath\": \"$.scheduleTimelines[0].instances[-1]\"}, {\"severity\": \"info\", \"category\": \"visit_anchor_created\", \"message\": \"Created VISIT anchor instance: 073ba115-532a-41bf-8e39-d3ca94ed73af (encounter: enc_1)\", \"affectedPath\": \"$.scheduleTimelines[0].instances[-1]\"}, {\"severity\": \"info\", \"category\": \"visit_anchor_created\", \"message\": \"Created VISIT anchor instance: ea634d80-804c-4ab1-853e-206f5305e94e (encounter: enc_1)\", \"affectedPath\": \"$.scheduleTimelines[0].instances[-1]\"}, {\"severity\": \"info\", \"category\": \"event_anchor_linked\", \"message\": \"EVENT anchor 'Vital Signs Post-Dose' linked to existing activity: anchor_inst_anchor_1\", \"affectedPath\": \"$.timings[?(@.id=='timing_7')]\"}, {\"severity\": \"info\", \"category\": \"conceptual_anchor_stored\", \"message\": \"CONCEPTUAL anchor 'Surgery Exclusion Window' stored as timing reference (no visit)\", \"affectedPath\": \"$.extensionAttributes[?(@.url contains 'conceptualAnchors')]\"}]"
              },
              {
                "id": "2e2d8940-13dc-4335-9ed4-e00868f7fd28",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-timeAnchors",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"3c65ad56-0637-4384-ac93-bdbb052ab7eb\", \"definition\": \"First administration of investigational product\", \"anchorType\": \"FirstDose\", \"classification\": \"Event\", \"timelineId\": null, \"dayValue\": 1, \"intraDayOrder\": 60, \"sourceText\": \"Day 1 \\nTreatment\", \"encounterId\": null, \"activityId\": null}, {\"id\": \"d1fa73c8-af72-4bb0-b53a-be4b873853d0\", \"definition\": \"Study entry and the start of symptom assessment\", \"anchorType\": \"Day1\", \"classification\": \"Visit\", \"timelineId\": null, \"dayValue\": 1, \"intraDayOrder\": 80, \"sourceText\": \"at study entry (\\u2018Day 1\\u2019 symptom count starts from the first day of symptoms), plus the presence of select symptoms within 24 hours prior to Day 1.\", \"encounterId\": null, \"activityId\": null}, {\"id\": \"78bb4a77-c8dd-4761-aee4-951b24cd4c97\", \"definition\": \"Screening visit\", \"anchorType\": \"Screening\", \"classification\": \"Visit\", \"timelineId\": null, \"dayValue\": 1, \"intraDayOrder\": 20, \"sourceText\": \"Screening \\n \\nDay\", \"encounterId\": null, \"activityId\": null}, {\"id\": \"a6a35c41-eedc-4238-9521-4a8c92501ae4\", \"definition\": \"Informed consent obtained\", \"anchorType\": \"InformedConsent\", \"classification\": \"Event\", \"timelineId\": null, \"dayValue\": 1, \"intraDayOrder\": 10, \"sourceText\": \"informed consent\", \"encounterId\": null, \"activityId\": null}, {\"id\": \"2777c1aa-ec74-4db3-9bdf-57b73f568a50\", \"definition\": \"Procedure\", \"anchorType\": \"Custom\", \"classification\": \"Conceptual\", \"timelineId\": null, \"dayValue\": 1, \"intraDayOrder\": 100, \"sourceText\": \"Procedure\", \"encounterId\": null, \"activityId\": null}]"
              },
              {
                "id": "eb9ded4f-7b4a-4dd3-8f54-fc29d89f0f18",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-repetitions",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"aa5a921a-1bb5-4e87-a465-a5ff2eb1cbee\", \"type\": \"Daily\", \"interval\": \"P1D\", \"sourceText\": \"every day\"}, {\"id\": \"3ff71708-8f2e-434b-9acf-116919dac0b0\", \"type\": \"Daily\", \"interval\": \"P1D\", \"sourceText\": \"od\"}, {\"id\": \"fc26317b-d2f4-4fde-90c8-ce318c33f005\", \"type\": \"Continuous\", \"sourceText\": \"Follow-up Period\"}, {\"id\": \"75e1d88c-4139-42bb-b418-8ddc09ed2f7e\", \"type\": \"Continuous\", \"sourceText\": \"4 hours post\"}, {\"id\": \"f1dc35e7-cb91-4da6-9bbf-a2071293a929\", \"type\": \"Continuous\", \"sourceText\": \"24 hours after\"}, {\"id\": \"a30f7430-09eb-4b76-a6e3-4d0cb8105739\", \"type\": \"Continuous\", \"sourceText\": \"2 hours post\"}, {\"id\": \"7528afbe-1331-4f3c-ae0a-ce8982c461a9\", \"type\": \"Continuous\", \"sourceText\": \"4 days after\"}, {\"id\": \"95deeb66-7785-41d2-8ce2-3692776f3874\", \"type\": \"Continuous\", \"sourceText\": \"30 days after\"}, {\"id\": \"5a13c52d-13a6-408a-88f1-7446e82aafe4\", \"type\": \"Daily\", \"startOffset\": \"P1D\", \"endOffset\": \"P29D\", \"interval\": \"P1D\", \"minObservations\": 29, \"exitCondition\": \"Completion of Day 29\", \"sourceText\": \"Participant-reported symptom diary Daily through Day 29\"}, {\"id\": \"ac5b7361-53e5-443b-baee-fe6b9711d542\", \"type\": \"Daily\", \"startOffset\": \"P1D\", \"endOffset\": \"P29D\", \"interval\": \"P1D\", \"minObservations\": 29, \"exitCondition\": \"Completion of Day 29\", \"sourceText\": \"Participant-reported symptom reminder Daily through Day 29\"}, {\"id\": \"f953b5ac-01ab-409f-828b-c7880afac3b7\", \"type\": \"Daily\", \"startOffset\": \"P1D\", \"endOffset\": \"P4D\", \"interval\": \"P1D\", \"minObservations\": 4, \"exitCondition\": \"Completion of first 4 days after IMP administration\", \"sourceText\": \"the sentinel group will be contacted daily (in-person or by telephone) for the first 4 days after IMP administration\"}, {\"id\": \"241b5090-f3ec-4f36-8798-7193dd47e567\", \"type\": \"Daily\", \"startOffset\": \"P1D\", \"endOffset\": \"P1D\", \"interval\": \"P1D\", \"minObservations\": 1, \"exitCondition\": \"Completion of Day 1 safety monitoring\", \"sourceText\": \"Telephone contact for safety monitoring Daily\"}, {\"id\": \"d1f766f9-d39f-4e14-807b-677d9b4b8025\", \"type\": \"Interval\", \"startOffset\": \"P0D\", \"endOffset\": \"P1D\", \"interval\": \"PT24H\", \"minObservations\": 2, \"exitCondition\": \"Dosing of second participant in sentinel group\", \"sourceText\": \"At each site, there will be an interval of 24 hours after dosing of the first participant in the sentinel group before the next participant can be dosed.\"}, {\"id\": \"a4e4e6f8-cd7f-401a-8d2d-9e748f4d35bd\", \"type\": \"Continuous\", \"startOffset\": \"-P7D\", \"endOffset\": \"P1D\", \"interval\": \"P7D\", \"minObservations\": 1, \"exitCondition\": \"IMP administration\", \"sourceText\": \"Following screening, and no more than 7 days (\\u2018Day 1\\u2019 symptom count starts from the first day of symptoms) from self-reported onset of COVID-19-related symptoms or measured fever, participants will receive a single dose of IMP.\"}]"
              },
              {
                "id": "00179b2c-4b67-4d52-9944-f4c535160209",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-traversalConstraints",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"911bf040-09b1-4ff4-9cf3-a88ccf441da7\", \"requiredSequence\": [\"epoch_1\", \"epoch_2\", \"epoch_2\", \"epoch_2\"], \"allowEarlyExit\": true, \"exitEpochIds\": [], \"mandatoryVisits\": [\"enc_10\", \"enc_7\", \"enc_3\", \"enc_1\", \"enc_6\", \"enc_4\", \"enc_5\", \"enc_8\", \"enc_9\", \"enc_2\", \"enc_11\"], \"sourceText\": \"[{'condition': 'Subject experiences AE or SAE', 'path': ['AE_REPORTING', 'FOLLOW_UP_UNTIL_RESOLUTION']}, {'condition': 'Early Termination or Withdrawal', 'path': ['EARLY_DISCONTINUATION_VISIT']}]\"}]"
              },
              {
                "id": "8233260c-4890-4192-8dff-e7677bcd0697",
                "url": "https://protocol2usdm.io/extensions/x-footnoteConditions",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"357fe756-d130-4701-8d3b-7a6d7231379f\", \"conditionType\": \"general\", \"text\": \"a. Visits noted P/H can be performed either in-person at clinical site or at home depending on the participant's clinical status, availability of safe transfer to sites (eg, to avoid risk of infection spread), and local guidelines for travel restrictions/social distancing. For home visits, a nurse or HCP trained on study procedures will visit the participant at home; nasal swabs, blood collection (where at-home collection is possible), and inspection of injection sites will be performed by the nurse or HCP. Nurse or HCP will ensure shipment of specimens collected and reporting of AEs to study sites.\", \"footnoteId\": \"659da20b-543f-4128-ae6f-e117cc94a73f\", \"structuredCondition\": \"location.choice(in-person, home) IF (participant_status == 'unstable' OR travel_restricted == true)\", \"appliesToActivityIds\": [\"20d687ab-2944-4a0f-b2d8-c4e45628deab\", \"14d48173-9e23-42e2-9c17-c84cfcc8c4ff\", \"df14be25-83dc-4d61-b863-7ab5bf3d1501\", \"05fb255c-e76c-48c6-bb28-79ae7172d70c\", \"f3661f47-91e3-45f1-94a3-635bb32dda75\", \"3b39df65-58b5-4fde-8457-0d5bbce275db\", \"ebdc9523-b5b9-433e-9c3d-b6b54fd1b783\"], \"sourceText\": \"a. Visits noted P/H can be performed either in-person at clinical site or at home depending on the p\"}, {\"id\": \"cde764ab-d207-4314-8179-748827948238\", \"conditionType\": \"general\", \"text\": \"b. Perform if no documentation of SARS-CoV-2 infection available; tested locally.\", \"footnoteId\": \"b9e52376-fb79-468f-baaf-d49816d84057\", \"structuredCondition\": \"procedure.required IF (documentation_sars_cov2 == false)\", \"appliesToActivityIds\": [\"f3661f47-91e3-45f1-94a3-635bb32dda75\"], \"sourceText\": \"b. Perform if no documentation of SARS-CoV-2 infection available; tested locally.\"}, {\"id\": \"c8b91ef0-829a-4cee-8651-e45e9e242154\", \"conditionType\": \"general\", \"text\": \"c. Assessment will be performed only for participants attending in-person visits, or if a nurse or HCP visiting the participant at home is properly trained for these assessments.\", \"footnoteId\": \"158aee1a-a203-4c99-8e6f-0e062dd5c7b5\", \"structuredCondition\": \"procedure.required IF (visit_type == 'in-person' OR staff_trained == true)\", \"appliesToActivityIds\": [\"da0ffcfe-8cd1-4307-8c82-c9aef8934fdd\"], \"sourceText\": \"c. Assessment will be performed only for participants attending in-person visits, or if a nurse or H\"}, {\"id\": \"7435dd12-c950-42bc-8ebf-06a413a06511\", \"conditionType\": \"general\", \"text\": \"d. Height is recorded only at the screening visit.\", \"footnoteId\": \"65b02545-6916-476c-8cd2-c2b77fc01190\", \"structuredCondition\": \"frequency.once(screening)\", \"appliesToActivityIds\": [\"781656ca-5f56-4043-b07d-ddbb0f78e6a3\"], \"sourceText\": \"d. Height is recorded only at the screening visit.\"}, {\"id\": \"017d3b09-1ad0-4d86-aa8c-2fd94889c48e\", \"conditionType\": \"timing_after\", \"text\": \"e. Perform pre-dose and 15 minutes (\\u00b1 5 minutes) after both injections are complete.\", \"footnoteId\": \"a4c674a2-bb63-445b-abd2-f1d930f7b5e2\", \"structuredCondition\": \"timing.pre_dose AND timing.post_dose(PT15M, window=PT5M)\", \"appliesToActivityIds\": [\"da0ffcfe-8cd1-4307-8c82-c9aef8934fdd\"], \"timingConstraint\": \"PT15M\", \"sourceText\": \"e. Perform pre-dose and 15 minutes (\\u00b1 5 minutes) after both injections are complete.\"}, {\"id\": \"375e0ef6-df39-4e88-8195-13d315c7353d\", \"conditionType\": \"timing_at\", \"text\": \"f. Perform pre-dose on Day 1.\", \"footnoteId\": \"09c3aa40-abb0-4b16-ab3d-3725988ccade\", \"structuredCondition\": \"timing.pre_dose(Day 1)\", \"appliesToActivityIds\": [\"da0ffcfe-8cd1-4307-8c82-c9aef8934fdd\"], \"sourceText\": \"f. Perform pre-dose on Day 1.\"}, {\"id\": \"4f382a52-3fcf-4ebf-9eb9-9557e810de47\", \"conditionType\": \"timing_before\", \"text\": \"h. Urine pregnancy test (local laboratory) at screening. Perform another urine test (local laboratory) on Day 1 if screening urine test was performed on Day -1. Single serum (central laboratory) must be performed on Day 1. Sample urine test must return negative result before dosing.\", \"footnoteId\": \"d6d87e07-bf96-44ea-a473-7aef9871e035\", \"structuredCondition\": \"timing.pre_dose(Day 1) IF (result_urine_pregnancy == 'negative')\", \"appliesToActivityIds\": [\"8b87483c-d65d-47b0-8d89-e662fc6b0a62\", \"781656ca-5f56-4043-b07d-ddbb0f78e6a3\", \"b4a11ef6-d97e-4473-a862-44e7e310327e\", \"5fe922e9-278e-41a7-bd92-3ffff658cc95\", \"d5d6d1e6-c026-4306-8182-991d56a0a4fc\"], \"sourceText\": \"h. Urine pregnancy test (local laboratory) at screening. Perform another urine test (local laborator\"}, {\"id\": \"e049d045-ed67-47b9-8901-eb9c0058d232\", \"conditionType\": \"general\", \"text\": \"i. Urine pregnancy test (local laboratory).\", \"footnoteId\": \"5744b077-df23-4f7b-8d29-9ba22e5f3e3a\", \"sourceText\": \"i. Urine pregnancy test (local laboratory).\", \"appliesToActivityIds\": [\"5fe922e9-278e-41a7-bd92-3ffff658cc95\"]}, {\"id\": \"b4b537ca-559f-4fd8-8149-2e2aa83527dc\", \"conditionType\": \"timing_at\", \"text\": \"j. Participants will report COVID-19-related symptoms daily in an electronic device, starting pre-dose and post-dose on Day 1.\", \"footnoteId\": \"5ab1f871-73a2-4930-8de6-37a9ae7ad076\", \"structuredCondition\": \"frequency.daily(START=Day 1 pre-dose)\", \"appliesToActivityIds\": [\"05fb255c-e76c-48c6-bb28-79ae7172d70c\", \"781656ca-5f56-4043-b07d-ddbb0f78e6a3\"], \"sourceText\": \"j. Participants will report COVID-19-related symptoms daily in an electronic device, starting pre-do\"}, {\"id\": \"fe28d93a-7315-44e6-a733-611465b81649\", \"conditionType\": \"frequency_daily\", \"text\": \"k. Participant will be reminded every day through Day 29 to complete their diary. This reminder will be received through the electronic device.\", \"footnoteId\": \"e2c4dda4-f480-4678-a2f4-8c6b80b5932b\", \"structuredCondition\": \"frequency.daily(UNTIL=Day 29)\", \"appliesToActivityIds\": [\"34212ee1-810f-47bc-ade3-0f0286af921e\", \"2ea5e748-5a90-410d-a17b-44c09b746eb0\"], \"sourceText\": \"k. Participant will be reminded every day through Day 29 to complete their diary. This reminder will\"}, {\"id\": \"5ea6252e-d763-46f7-9541-cee027736604\", \"conditionType\": \"frequency_daily\", \"text\": \"l. If Day 29 visit is conducted earlier in \\u00b1 4 day window, participant should retain symptom diary in order to complete required daily entries through Study Day 29.\", \"footnoteId\": \"96d67b16-da89-44a2-9725-a06e96364ddf\", \"structuredCondition\": \"timing.continue(UNTIL=Day 29) IF (visit_day < 29)\", \"appliesToActivityIds\": [\"34212ee1-810f-47bc-ade3-0f0286af921e\"], \"sourceText\": \"l. If Day 29 visit is conducted earlier in \\u00b1 4 day window, participant should retain symptom diary i\"}, {\"id\": \"afbddb86-5b32-4b67-a5ab-83c6cde45e7d\", \"conditionType\": \"general\", \"text\": \"m. Mid-turbinate nasal swab is tested centrally. Sequencing applies to nasal swabs collected through Day 15.\", \"footnoteId\": \"ea11375d-4c41-41d0-beb9-867f1f8fd1e5\", \"structuredCondition\": \"procedure.required IF (timing.current <= Day 15)\", \"appliesToActivityIds\": [\"df14be25-83dc-4d61-b863-7ab5bf3d1501\"], \"sourceText\": \"m. Mid-turbinate nasal swab is tested centrally. Sequencing applies to nasal swabs collected through\"}, {\"id\": \"67433959-954f-443c-98bb-3535247e7105\", \"conditionType\": \"timing_before\", \"text\": \"n. Pre-dose sample and post-dose sample (ie, samples obtained prior to and upon completion of IMP administered via IM injections on Day 1).\", \"footnoteId\": \"8808eb9e-574f-4e4f-ad56-ed5516a23a23\", \"sourceText\": \"n. Pre-dose sample and post-dose sample (ie, samples obtained prior to and upon completion of IMP ad\", \"appliesToActivityIds\": [\"20d687ab-2944-4a0f-b2d8-c4e45628deab\", \"d5d6d1e6-c026-4306-8182-991d56a0a4fc\"]}, {\"id\": \"ef4544db-f967-4102-a255-f46e4d9dbfe2\", \"conditionType\": \"general\", \"text\": \"o. Serum vitamin D, serum zinc, dependent on availability of laboratory kits.\", \"footnoteId\": \"7f14d34e-c568-4523-9281-28dbc2b17278\", \"structuredCondition\": \"procedure.required IF (lab_kits_available == true)\", \"appliesToActivityIds\": [\"b4a11ef6-d97e-4473-a862-44e7e310327e\"], \"sourceText\": \"o. Serum vitamin D, serum zinc, dependent on availability of laboratory kits.\"}, {\"id\": \"99c957d9-f32e-4d4c-9020-c4674e195dc8\", \"conditionType\": \"timing_before\", \"text\": \"p. Perform 30 minutes (\\u00b1 10 minutes) after the IMP has been administered and just prior to release from the study site or departure of the study staff.\", \"footnoteId\": \"cf30af4f-099f-4a6f-94d0-61ee492d9db5\", \"structuredCondition\": \"timing.post_dose(PT30M, window=PT10M) AND timing.before(release)\", \"appliesToActivityIds\": [\"da0ffcfe-8cd1-4307-8c82-c9aef8934fdd\"], \"timingConstraint\": \"PT30M\", \"sourceText\": \"p. Perform 30 minutes (\\u00b1 10 minutes) after the IMP has been administered and just prior to release f\"}, {\"id\": \"522e72ae-2b85-4501-bb70-ab527c8f1925\", \"conditionType\": \"timing_recurring\", \"text\": \"q. If evidence of injection site reaction persists at the Day 6 visit, the injection site will be rechecked at each visit until no evidence of an active reaction remains.\", \"footnoteId\": \"c011ffa8-16cd-4976-97f7-6febb5744283\", \"structuredCondition\": \"frequency.every_visit UNTIL (injection_site_reaction == false)\", \"appliesToActivityIds\": [\"20d687ab-2944-4a0f-b2d8-c4e45628deab\", \"15df1add-c82f-4d43-8770-aed1012a77f1\"], \"sourceText\": \"q. If evidence of injection site reaction persists at the Day 6 visit, the injection site will be re\"}, {\"id\": \"5273adc4-ebd0-4ce4-8c5f-f759b14a14a2\", \"conditionType\": \"timing_before\", \"text\": \"r. The first 20 participants dosed (ie, the sentinel group) will undergo safety monitoring for 4 hours post IMP administration before further participants are dosed. At each site, there will be an interval of 24 hours after dosing of the first participant in the sentinel group before the next participant can be dosed. The next 80 participants (21 to 100) will then undergo safety monitoring for 2 hours post IMP administration, otherwise the minimum safety monitoring time will be 1 hour. In addition, the sentinel group will be contacted daily (in-person or by telephone) for the first 4 days after IMP administration. Contact will be made by telephone on days when there is not an in-person visit.\", \"footnoteId\": \"5f071b24-2c43-4e51-b0b8-1c92219ce541\", \"structuredCondition\": \"timing.after(dosing of the first participant in the sentinel group before the next participant can be dosed. the next 80 participants (21 to 100) will then undergo safety monitoring for 2 hours post imp administration, otherwise the minimum safety monitoring time will be 1 hour. in addition, the sentinel group will be contacted daily (in-person or by telephone) for the first 4 days after imp administration. contact will be made by telephone on days when there is not an in-person visit., PT24M)\", \"appliesToActivityIds\": [\"9880e31f-1d37-4c32-9741-7b9111bb98b3\", \"da0ffcfe-8cd1-4307-8c82-c9aef8934fdd\"], \"timingConstraint\": \"PT4H\", \"sourceText\": \"r. The first 20 participants dosed (ie, the sentinel group) will undergo safety monitoring for 4 hou\"}, {\"id\": \"5f8861aa-23a1-4284-a232-289c5156b2b8\", \"conditionType\": \"timing_at\", \"text\": \"s. At Day 457 AE/SAE/AESI assessment will be made by telephone only.\", \"footnoteId\": \"8fd6c2f5-18a4-4ab6-9297-3f3f08301343\", \"structuredCondition\": \"visit_method.telephone IF (timing.current == Day 457)\", \"appliesToActivityIds\": [\"AE/SAE/AESI assessment\"], \"sourceText\": \"s. At Day 457 AE/SAE/AESI assessment will be made by telephone only.\"}, {\"id\": \"ea624ffc-df21-4376-b380-f0ec0ad83fc7\", \"conditionType\": \"general\", \"text\": \"t. Note: Remote (denoted by R) visit: either a phone call, or a web-based virtual assessment.\", \"footnoteId\": \"eeb8415c-ea0a-4a96-ad4b-49a9366cb65a\", \"sourceText\": \"t. Note: Remote (denoted by R) visit: either a phone call, or a web-based virtual assessment.\"}, {\"id\": \"bf4c9caa-8209-4fa6-9c0a-2608cc745e86\", \"conditionType\": \"general\", \"text\": \"u. Note: Day 6 and Day 8 assessments must be performed on different days.\", \"footnoteId\": \"1a92e9c4-c6dd-4e9e-aeff-33a4dcddccbb\", \"structuredCondition\": \"timing.distinct_days(Day 6, Day 8)\", \"appliesToActivityIds\": [\"da0ffcfe-8cd1-4307-8c82-c9aef8934fdd\"], \"sourceText\": \"u. Note: Day 6 and Day 8 assessments must be performed on different days.\"}]"
              },
              {
                "id": "af4fa462-31b2-42aa-bc02-fc8153226cab",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-endpointAlgorithms",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"47191c9c-8350-435a-a77d-bedcb7c3b915\", \"name\": \"Primary: Severe COVID-19 or Death from any cause\", \"endpointType\": \"Primary\", \"inputs\": [\"fever\", \"cough\", \"tachypnea\", \"dyspnea\", \"lung infiltrates\", \"SpO2\", \"respiratory distress\", \"WHO Clinical Progression Scale score\", \"vital status\", \"IMP_administration_date\"], \"timeWindow\": {\"reference\": \"Day 1 (IMP administration)\", \"duration\": \"P28D\"}, \"algorithm\": \"IF (death = TRUE) OR ((pneumonia = TRUE OR hypoxemia = TRUE) AND WHO_score >= 5) THEN 'Event' ELSE 'No Event'\", \"successCriteria\": \"A participant is classified as having the endpoint if they experience severe COVID-19 or death from any cause through Day 29.\", \"sourceText\": \"The primary efficacy endpoint is a composite of either severe COVID-19 or death from any cause through Day 29. Severe COVID-19 is characterized by a minimum of either pneumonia (fever, cough, tachypne\"}, {\"id\": \"17f4cbb6-ef49-4a4b-9b5d-8e117b25f840\", \"name\": \"Relative Risk Reduction (RRR)\", \"endpointType\": \"Primary\", \"inputs\": [\"incidence_AZD7442\", \"incidence_placebo\"], \"timeWindow\": {\"reference\": \"Primary Analysis Data Cut-off\", \"duration\": \"30 days after 43 primary endpoint events\"}, \"algorithm\": \"RRR = 1 - (Incidence in AZD7442 / Incidence in Placebo)\", \"successCriteria\": \"RRR not equal to zero (statistically significant difference between treatment groups).\", \"sourceText\": \"Efficacy will be calculated as the RRR, defined as 1-Relative Risk. The null hypothesis is that the RRR of severe COVID-19 or death from any cause through Day 29 in participants on AZD7442 compared wi\"}]"
              },
              {
                "id": "87f3c95c-b942-4ae4-8346-c3248421c868",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-derivedVariables",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"0c7c39f8-a186-4a3b-a227-a676138a3ce1\", \"name\": \"Key Secondary Composite Endpoint\", \"variableType\": \"Composite\", \"sourceVariables\": [\"Death from any cause\", \"Hospitalization for COVID-19 complications or sequelae\"], \"derivationRule\": \"Binary indicator (Yes/No) if either death from any cause OR hospitalization for COVID-19 complications/sequelae occurs\", \"baselineDefinition\": \"Post-dose period starting from Day 1\", \"baselineVisit\": \"Day 1\", \"analysisWindow\": \"Day 1 to Day 169\", \"imputationRule\": \"Not specified in text\", \"unit\": \"Binary\"}, {\"id\": \"a6cccb27-3636-4fb3-b2c8-834254a59f85\", \"name\": \"Relative Risk Reduction (RRR) of Key Secondary Endpoint\", \"variableType\": \"Custom\", \"sourceVariables\": [\"Key Secondary Composite Endpoint\", \"Treatment Group\"], \"derivationRule\": \"Calculated based on the proportion of events in AZD7442 vs placebo at Day 169\", \"baselineDefinition\": \"Randomized treatment assignment\", \"baselineVisit\": \"Day 1\", \"analysisWindow\": \"Through Day 169\", \"imputationRule\": \"Not specified in text\", \"unit\": \"%\"}, {\"id\": \"6b4aaff1-845e-4e0a-b626-306333145565\", \"name\": \"Time to death or first hospitalization\", \"variableType\": \"TimeToEvent\", \"sourceVariables\": [\"Date of Death\", \"Date of Hospitalization\", \"Date of IMP administration\"], \"derivationRule\": \"Min(Date of Death, Date of first Hospitalization) - Date of IMP administration\", \"baselineDefinition\": \"Day 1 (Post-dose)\", \"baselineVisit\": \"Day 1\", \"analysisWindow\": \"Day 1 to Day 169\", \"imputationRule\": \"Kaplan-Meier censoring for participants without events\", \"unit\": \"Days\"}, {\"id\": \"2cf820b4-6b7c-45ff-9ce8-5a4265055ef1\", \"name\": \"Proportion of participants with respiratory failure\", \"variableType\": \"Categorical\", \"sourceVariables\": [\"Mechanical ventilation requirement\", \"ECMO requirement\", \"Non-invasive ventilation requirement\", \"High flow cannula oxygen delivery\"], \"derivationRule\": \"Binary indicator (Yes/No) if any of the source requirements are met\", \"baselineDefinition\": \"Post-dose\", \"baselineVisit\": \"Day 1\", \"analysisWindow\": \"Through Day 29\", \"imputationRule\": \"Not specified in text\", \"unit\": \"Binary\"}, {\"id\": \"1788c721-0eb3-40b8-b503-7bf1182da2f2\", \"name\": \"Progression of COVID-19-associated symptoms\", \"variableType\": \"Categorical\", \"sourceVariables\": [\"Participant-reported symptom diary entry\"], \"derivationRule\": \"One or more symptoms progressing to a worse status than recorded in the diary entry prior to start of IMP\", \"baselineDefinition\": \"Symptom status recorded in diary prior to start of AZD7442 or placebo\", \"baselineVisit\": \"Pre-dose Day 1\", \"analysisWindow\": \"Through Day 29\", \"imputationRule\": \"Not specified in text\", \"unit\": \"Binary\"}, {\"id\": \"abac5bd5-3450-46c8-9572-996d40e20e47\", \"name\": \"Undetectable SARS-CoV-2 over time\", \"variableType\": \"TimeToEvent\", \"sourceVariables\": [\"SARS-CoV-2 viral load\"], \"derivationRule\": \"Time from Day 1 to the first instance where SARS-CoV-2 is undetectable\", \"baselineDefinition\": \"Baseline viral load status\", \"baselineVisit\": \"Day 1\", \"analysisWindow\": \"Through Day 29\", \"imputationRule\": \"Kaplan-Meier\", \"unit\": \"Days\"}]"
              },
              {
                "id": "274d15d8-e31e-4060-a29e-5efff4ec5180",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-stateMachine",
                "instanceType": "ExtensionAttribute",
                "valueString": "{\"id\": \"e38eff77-0952-435a-9568-c7deab86e661\", \"initialState\": \"Screening\", \"terminalStates\": [\"Early Termination\", \"Completed\"], \"states\": [\"Screening\", \"Treatment\", \"Intensive Follow Up\", \"Limited Follow Up\", \"End Of Study\", \"Early Termination\"], \"transitions\": [{\"fromState\": \"Screening\", \"toState\": \"Treatment\", \"trigger\": \"Progress to Treatment\"}, {\"fromState\": \"Treatment\", \"toState\": \"Intensive Follow Up\", \"trigger\": \"Progress to Intensive Follow Up\"}, {\"fromState\": \"Intensive Follow Up\", \"toState\": \"Limited Follow Up\", \"trigger\": \"Progress to Limited Follow Up\"}, {\"fromState\": \"Limited Follow Up\", \"toState\": \"End Of Study\", \"trigger\": \"Progress to End Of Study\"}, {\"fromState\": \"Treatment\", \"toState\": \"Early Termination\", \"trigger\": \"Subject exits to Early Termination\"}], \"epochIds\": {\"Screening\": \"SCREENING\", \"Treatment\": \"TREATMENT\", \"Intensive Follow Up\": \"INTENSIVE_FOLLOW_UP\", \"Limited Follow Up\": \"LIMITED_FOLLOW_UP\", \"End Of Study\": \"END_OF_STUDY\", \"Early Termination\": \"EARLY_TERMINATION\"}}"
              },
              {
                "id": "352c353d-1b9e-4f64-987f-cce979f52af4",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-dosingRegimens",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"6eec3e55-5f91-4394-ab1b-b890300c0bbd\", \"treatmentName\": \"AZD7442\", \"frequency\": \"Single\", \"route\": \"IM\", \"startDay\": 1, \"doseLevels\": [{\"amount\": 0.0, \"unit\": \"\", \"description\": \"Investigational Medicinal Product (IMP)\"}], \"durationDescription\": \"Single dose\"}, {\"id\": \"1e3ce611-88dd-44c8-afc3-60185bd4dfea\", \"treatmentName\": \"Placebo\", \"frequency\": \"Single\", \"route\": \"IM\", \"startDay\": 1, \"doseLevels\": [{\"amount\": 0.0, \"unit\": \"\", \"description\": \"Matching placebo\"}], \"durationDescription\": \"Single dose\"}]"
              },
              {
                "id": "d1674cab-af24-4f26-98ad-8b20239df68b",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-visitWindows",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"7307e9fa-6425-4b45-ac8c-58ef99a480f7\", \"visitName\": \"screening\", \"targetDay\": -14, \"windowBefore\": 7, \"windowAfter\": 0, \"isRequired\": true, \"visitNumber\": 1, \"epoch\": \"Screening\", \"sourceText\": \"Following screening, and no more than 7 days (\\u2018Day 1\\u2019 symptom count starts from the first day of symptoms) from self-reported onset of COVID-19-related symptoms or measured fever, participants will re\"}, {\"id\": \"89154f88-5eef-4193-9606-a089819b0d99\", \"visitName\": \"Early Termination\", \"targetDay\": null, \"windowBefore\": 0, \"windowAfter\": 0, \"isRequired\": true, \"visitNumber\": 2, \"sourceText\": \"CONFIDENTIAL AND PROPRIETARY9 of 115 LIST OF TABLES\"}, {\"id\": \"ff4eace6-7632-461a-adcd-83e23c1a88ba\", \"visitName\": \"End of Study\", \"targetDay\": null, \"windowBefore\": 3, \"windowAfter\": 7, \"isRequired\": true, \"visitNumber\": 3, \"sourceText\": \"End of Study Definition A participant is considered to have completed the study if he/she has completed all stages of the study, including the last scheduled procedure shown in the SoA (Table 1 for Co\"}, {\"id\": \"a0eb4c75-a8fd-4e48-87da-c792448b9593\", \"visitName\": \"baseline\", \"targetDay\": 0, \"windowBefore\": 1, \"windowAfter\": 1, \"isRequired\": true, \"visitNumber\": 4, \"sourceText\": \"Increased supplemental oxygen requirement (only for participants on baseline supplemental oxygen) 5\"}, {\"id\": \"d6049536-a493-4080-9e89-dd2f2b3e676a\", \"visitName\": \"Visit 1\", \"targetDay\": null, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 5, \"sourceText\": \"negative pregnancy test result at Visit 1 and during the study as in the SoA (Table 1 for Cohort 1 and Table 2 for Cohort 2).\"}, {\"id\": \"89686174-6870-49a6-a636-85dd7537511e\", \"visitName\": \"randomization\", \"targetDay\": 1, \"windowBefore\": 0, \"windowAfter\": 0, \"isRequired\": true, \"visitNumber\": 6, \"sourceText\": \"Persons aged 65 years and older at randomization x Persons aged < 65 years and having at least one of the following conditions:\"}, {\"id\": \"9b4ab936-08d4-422e-ac14-04e22bdfdd54\", \"visitName\": \"Day 2 (Sentinel Group Only)\", \"targetDay\": 2, \"windowBefore\": 0, \"windowAfter\": 0, \"isRequired\": false, \"visitNumber\": 3, \"targetWeek\": 1, \"epoch\": \"Intensive Follow-up\"}, {\"id\": \"25038068-da70-4d00-8f7e-b75b676962fb\", \"visitName\": \"Day 3 (Sentinel Group Only)\", \"targetDay\": 3, \"windowBefore\": 0, \"windowAfter\": 0, \"isRequired\": false, \"visitNumber\": 4, \"targetWeek\": 1, \"epoch\": \"Intensive Follow-up\"}, {\"id\": \"222f121f-30d8-47d9-b033-412658048b48\", \"visitName\": \"Day 4 (Sentinel Group Only)\", \"targetDay\": 4, \"windowBefore\": 0, \"windowAfter\": 0, \"isRequired\": false, \"visitNumber\": 5, \"targetWeek\": 1, \"epoch\": \"Intensive Follow-up\"}, {\"id\": \"2881552a-602d-4170-ad23-a3809f7220b6\", \"visitName\": \"Day 6\", \"targetDay\": 6, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 10, \"sourceText\": \"If evidence of injection site reaction persists at the Day 6 visit, the injection site will be rechecked at each visit until no evidence of an active reaction remains. r The first 20 participants dose\"}, {\"id\": \"e00dddfe-70bb-4c88-ab03-3a029ae5bf06\", \"visitName\": \"Day 8\", \"targetDay\": 8, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 11, \"epoch\": \"Intensive Follow-up\", \"sourceText\": \"group\\u2019s safety data through Day 8 has been reviewed by the DSMB in order to provide a recommendation to continue or to halt dosing of additional participants. Participants will be enrolled into one of\"}, {\"id\": \"5e118dfd-a055-41e8-99fa-dfbf69003b6e\", \"visitName\": \"Day 15\", \"targetDay\": 15, \"windowBefore\": 0, \"windowAfter\": 0, \"isRequired\": true, \"visitNumber\": 12, \"sourceText\": \"Mid-turbinate nasal swab is tested centrally. Sequencing applies to nasal swabs collected through Day 15. n Pre-dose sample and post-dose sample (ie, samples obtained prior to and upon completion of I\"}, {\"id\": \"e7e34338-fec2-4372-b6ff-493e74f97a51\", \"visitName\": \"Day 29\", \"targetDay\": 29, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 13, \"epoch\": \"Intensive Follow-up\", \"sourceText\": \"or death from any cause through Day 29. Severe COVID-19 is characterized by a minimum of either pneumonia (fever, cough, tachypnea, or dyspnea, AND lung infiltrates) or hypoxemia (SpO2 < 90% in room a\"}, {\"id\": \"dd1d1206-a881-4b6c-96a4-e5dfb674cc54\", \"visitName\": \"Day 30\", \"targetDay\": 30, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 14, \"sourceText\": \"appropriate that they can discuss with the investigator and others after Day 30 so as to make an informed choice. The following considerations apply: x\"}, {\"id\": \"ca9d883d-a8db-41ec-a646-c2b166210c00\", \"visitName\": \"Day 169\", \"targetDay\": 169, \"windowBefore\": 0, \"windowAfter\": 0, \"isRequired\": true, \"visitNumber\": 15, \"sourceText\": \"events have been confirmed in the primary analysis population. A Day 169 analysis will be conducted when all participants have been followed through Day 169. A final analysis will be conducted when al\"}, {\"id\": \"20543cea-d4bc-4b6c-a0e3-e4f49648d0fa\", \"visitName\": \"Follow-up\", \"targetDay\": 365, \"windowBefore\": 7, \"windowAfter\": 7, \"isRequired\": true, \"visitNumber\": 16, \"sourceText\": \"Follow-up, and Reporting ........................................................................... 82 Appendix C Handling of Human Biological Samples ................................................\"}, {\"id\": \"df759861-4d03-4cba-b1fd-f6793aec3256\", \"visitName\": \"Day 457\", \"targetDay\": 457, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 17, \"epoch\": \"Limited Follow-up\", \"sourceText\": \"28 days of intensive follow-up, followed by limited follow-up through Day 457. Disclosure Statement: This is a parallel-group treatment study with 2 arms that are double-blind.\"}]"
              },
              {
                "id": "d45207b8-817f-46da-a0fc-188ea0063de4",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-randomizationScheme",
                "instanceType": "ExtensionAttribute",
                "valueString": "{\"id\": \"c46f6ddc-391c-4154-aa69-6c782556a5f2\", \"ratio\": \"1:1\", \"method\": \"Stratified blocked randomization\", \"centralRandomization\": true, \"stratificationFactors\": [{\"id\": \"153c309f-c06b-4607-8c06-768d9fa4759d\", \"name\": \"Time from symptom onset\", \"categories\": [\"\\u2264 5 days\", \"> 5 days\"], \"isBlocking\": false}, {\"id\": \"57284d60-c21c-4e70-8c43-d909871d74e5\", \"name\": \"Risk of progression to severe COVID-19\", \"categories\": [\"High-risk\", \"Low-risk\"], \"isBlocking\": false}], \"sourceText\": \"Clinical Study Protocol - 7.0 \\nAstraZeneca \\nAZD7442 - D8851C00001 \\n \\nCONFIDENTIAL AND PROPRIETARY12 of 115 \\n \\nADA Anti-drug-antibody; AE Adverse event; AESI Adverse event of special interest; AUC Area\"}"
              },
              {
                "id": "ext_execution_model_df772fc7-0243-4fd7-a057-83ba6fc1b4db",
                "url": "https://protocol2usdm.io/extensions/x-executionModel",
                "instanceType": "ExtensionAttribute",
                "valueObject": {
                  "schemaVersion": "1.0.0",
                  "extractionTimestamp": "2026-01-23T05:14:36.251965",
                  "executionModel": {
                    "timeAnchors": [
                      {
                        "id": "3c65ad56-0637-4384-ac93-bdbb052ab7eb",
                        "definition": "First administration of investigational product",
                        "anchorType": "FirstDose",
                        "classification": "Event",
                        "timelineId": null,
                        "dayValue": 1,
                        "intraDayOrder": 60,
                        "sourceText": "Day 1 \nTreatment",
                        "encounterId": null,
                        "activityId": null
                      },
                      {
                        "id": "d1fa73c8-af72-4bb0-b53a-be4b873853d0",
                        "definition": "Study entry and the start of symptom assessment",
                        "anchorType": "Day1",
                        "classification": "Visit",
                        "timelineId": null,
                        "dayValue": 1,
                        "intraDayOrder": 80,
                        "sourceText": "at study entry (Day 1 symptom count starts from the first day of symptoms), plus the presence of select symptoms within 24 hours prior to Day 1.",
                        "encounterId": null,
                        "activityId": null
                      },
                      {
                        "id": "78bb4a77-c8dd-4761-aee4-951b24cd4c97",
                        "definition": "Screening visit",
                        "anchorType": "Screening",
                        "classification": "Visit",
                        "timelineId": null,
                        "dayValue": 1,
                        "intraDayOrder": 20,
                        "sourceText": "Screening \n \nDay",
                        "encounterId": null,
                        "activityId": null
                      },
                      {
                        "id": "a6a35c41-eedc-4238-9521-4a8c92501ae4",
                        "definition": "Informed consent obtained",
                        "anchorType": "InformedConsent",
                        "classification": "Event",
                        "timelineId": null,
                        "dayValue": 1,
                        "intraDayOrder": 10,
                        "sourceText": "informed consent",
                        "encounterId": null,
                        "activityId": null
                      },
                      {
                        "id": "2777c1aa-ec74-4db3-9bdf-57b73f568a50",
                        "definition": "Procedure",
                        "anchorType": "Custom",
                        "classification": "Conceptual",
                        "timelineId": null,
                        "dayValue": 1,
                        "intraDayOrder": 100,
                        "sourceText": "Procedure",
                        "encounterId": null,
                        "activityId": null
                      }
                    ],
                    "repetitions": [
                      {
                        "id": "aa5a921a-1bb5-4e87-a465-a5ff2eb1cbee",
                        "type": "Daily",
                        "interval": "P1D",
                        "sourceText": "every day"
                      },
                      {
                        "id": "3ff71708-8f2e-434b-9acf-116919dac0b0",
                        "type": "Daily",
                        "interval": "P1D",
                        "sourceText": "od"
                      },
                      {
                        "id": "fc26317b-d2f4-4fde-90c8-ce318c33f005",
                        "type": "Continuous",
                        "sourceText": "Follow-up Period"
                      },
                      {
                        "id": "75e1d88c-4139-42bb-b418-8ddc09ed2f7e",
                        "type": "Continuous",
                        "sourceText": "4 hours post"
                      },
                      {
                        "id": "f1dc35e7-cb91-4da6-9bbf-a2071293a929",
                        "type": "Continuous",
                        "sourceText": "24 hours after"
                      },
                      {
                        "id": "a30f7430-09eb-4b76-a6e3-4d0cb8105739",
                        "type": "Continuous",
                        "sourceText": "2 hours post"
                      },
                      {
                        "id": "7528afbe-1331-4f3c-ae0a-ce8982c461a9",
                        "type": "Continuous",
                        "sourceText": "4 days after"
                      },
                      {
                        "id": "95deeb66-7785-41d2-8ce2-3692776f3874",
                        "type": "Continuous",
                        "sourceText": "30 days after"
                      },
                      {
                        "id": "5a13c52d-13a6-408a-88f1-7446e82aafe4",
                        "type": "Daily",
                        "startOffset": "P1D",
                        "endOffset": "P29D",
                        "interval": "P1D",
                        "minObservations": 29,
                        "exitCondition": "Completion of Day 29",
                        "sourceText": "Participant-reported symptom diary Daily through Day 29"
                      },
                      {
                        "id": "ac5b7361-53e5-443b-baee-fe6b9711d542",
                        "type": "Daily",
                        "startOffset": "P1D",
                        "endOffset": "P29D",
                        "interval": "P1D",
                        "minObservations": 29,
                        "exitCondition": "Completion of Day 29",
                        "sourceText": "Participant-reported symptom reminder Daily through Day 29"
                      },
                      {
                        "id": "f953b5ac-01ab-409f-828b-c7880afac3b7",
                        "type": "Daily",
                        "startOffset": "P1D",
                        "endOffset": "P4D",
                        "interval": "P1D",
                        "minObservations": 4,
                        "exitCondition": "Completion of first 4 days after IMP administration",
                        "sourceText": "the sentinel group will be contacted daily (in-person or by telephone) for the first 4 days after IMP administration"
                      },
                      {
                        "id": "241b5090-f3ec-4f36-8798-7193dd47e567",
                        "type": "Daily",
                        "startOffset": "P1D",
                        "endOffset": "P1D",
                        "interval": "P1D",
                        "minObservations": 1,
                        "exitCondition": "Completion of Day 1 safety monitoring",
                        "sourceText": "Telephone contact for safety monitoring Daily"
                      },
                      {
                        "id": "d1f766f9-d39f-4e14-807b-677d9b4b8025",
                        "type": "Interval",
                        "startOffset": "P0D",
                        "endOffset": "P1D",
                        "interval": "PT24H",
                        "minObservations": 2,
                        "exitCondition": "Dosing of second participant in sentinel group",
                        "sourceText": "At each site, there will be an interval of 24 hours after dosing of the first participant in the sentinel group before the next participant can be dosed."
                      },
                      {
                        "id": "a4e4e6f8-cd7f-401a-8d2d-9e748f4d35bd",
                        "type": "Continuous",
                        "startOffset": "-P7D",
                        "endOffset": "P1D",
                        "interval": "P7D",
                        "minObservations": 1,
                        "exitCondition": "IMP administration",
                        "sourceText": "Following screening, and no more than 7 days (Day 1 symptom count starts from the first day of symptoms) from self-reported onset of COVID-19-related symptoms or measured fever, participants will receive a single dose of IMP."
                      }
                    ],
                    "samplingConstraints": [],
                    "traversalConstraints": [
                      {
                        "id": "911bf040-09b1-4ff4-9cf3-a88ccf441da7",
                        "requiredSequence": [
                          "epoch_1",
                          "epoch_2",
                          "epoch_2",
                          "epoch_2"
                        ],
                        "allowEarlyExit": true,
                        "exitEpochIds": [
                          "e226cb99-a1e0-4e1b-9238-f2be8329a524"
                        ],
                        "mandatoryVisits": [
                          "Day 366",
                          "Day 29",
                          "Day 3",
                          "Screening",
                          "Day 15",
                          "Day 6",
                          "Day 8",
                          "Day 85",
                          "Day 169",
                          "Day 1",
                          "Day 457",
                          "End of Study"
                        ],
                        "sourceText": "[{'condition': 'Subject experiences AE or SAE', 'path': ['AE_REPORTING', 'FOLLOW_UP_UNTIL_RESOLUTION']}, {'condition': 'Early Termination or Withdrawal', 'path': ['EARLY_DISCONTINUATION_VISIT']}]"
                      }
                    ],
                    "executionTypes": [
                      {
                        "activityId": "Serum Sample",
                        "executionType": "Single",
                        "rationale": "SINGLE signals: 5"
                      },
                      {
                        "activityId": "Vital Signs",
                        "executionType": "Single",
                        "rationale": "SINGLE signals: 2"
                      },
                      {
                        "activityId": "Electrocardiogram",
                        "executionType": "Recurring",
                        "rationale": "RECURRING signals: 2"
                      },
                      {
                        "activityId": "Pe",
                        "executionType": "Single",
                        "rationale": "SINGLE signals: 2"
                      },
                      {
                        "activityId": "Adverse Events",
                        "executionType": "Single",
                        "rationale": "No strong signals detected"
                      },
                      {
                        "activityId": "Concomitant Medications",
                        "executionType": "Single",
                        "rationale": "SINGLE signals: 5"
                      },
                      {
                        "activityId": "Laboratory Assessments",
                        "executionType": "Single",
                        "rationale": "No strong signals detected"
                      },
                      {
                        "activityId": "Pharmacokinetic",
                        "executionType": "Single",
                        "rationale": "SINGLE signals: 2"
                      },
                      {
                        "activityId": "Dosing",
                        "executionType": "Single",
                        "rationale": "SINGLE signals: 1"
                      },
                      {
                        "activityId": "Diary",
                        "executionType": "Single",
                        "rationale": "SINGLE signals: 2"
                      },
                      {
                        "activityId": "Screening Assessment",
                        "executionType": "Single",
                        "rationale": "Initial evaluation to determine eligibility performed only once at the start of the study."
                      },
                      {
                        "activityId": "Primary Endpoint Event Monitoring",
                        "executionType": "Single",
                        "rationale": "Continuous monitoring for events until the data cut-off of 30 days after 43 events are confirmed."
                      },
                      {
                        "activityId": "Symptom Onset Assessment",
                        "executionType": "Single",
                        "rationale": "Determination of the specific date of symptom onset used to define the early intervention analysis set."
                      },
                      {
                        "activityId": "Baseline Seronegative Testing",
                        "executionType": "Single",
                        "rationale": "One-time assessment at baseline to define the seronegative analysis set."
                      },
                      {
                        "activityId": "Schedule of Activities Assessments",
                        "executionType": "Single",
                        "rationale": "Standard clinical trial assessments performed at scheduled study visits as indicated in the Schedule of Activities."
                      }
                    ],
                    "footnoteConditions": [
                      {
                        "id": "357fe756-d130-4701-8d3b-7a6d7231379f",
                        "conditionType": "general",
                        "text": "a. Visits noted P/H can be performed either in-person at clinical site or at home depending on the participant's clinical status, availability of safe transfer to sites (eg, to avoid risk of infection spread), and local guidelines for travel restrictions/social distancing. For home visits, a nurse or HCP trained on study procedures will visit the participant at home; nasal swabs, blood collection (where at-home collection is possible), and inspection of injection sites will be performed by the nurse or HCP. Nurse or HCP will ensure shipment of specimens collected and reporting of AEs to study sites.",
                        "footnoteId": "659da20b-543f-4128-ae6f-e117cc94a73f",
                        "structuredCondition": "location.choice(in-person, home) IF (participant_status == 'unstable' OR travel_restricted == true)",
                        "appliesToActivityIds": [
                          "nasal swabs",
                          "blood collection",
                          "inspection of injection sites"
                        ],
                        "sourceText": "a. Visits noted P/H can be performed either in-person at clinical site or at home depending on the p"
                      },
                      {
                        "id": "cde764ab-d207-4314-8179-748827948238",
                        "conditionType": "general",
                        "text": "b. Perform if no documentation of SARS-CoV-2 infection available; tested locally.",
                        "footnoteId": "b9e52376-fb79-468f-baaf-d49816d84057",
                        "structuredCondition": "procedure.required IF (documentation_sars_cov2 == false)",
                        "appliesToActivityIds": [
                          "68ad57c6-eecd-4cf1-b073-992677090e51"
                        ],
                        "sourceText": "b. Perform if no documentation of SARS-CoV-2 infection available; tested locally."
                      },
                      {
                        "id": "c8b91ef0-829a-4cee-8651-e45e9e242154",
                        "conditionType": "general",
                        "text": "c. Assessment will be performed only for participants attending in-person visits, or if a nurse or HCP visiting the participant at home is properly trained for these assessments.",
                        "footnoteId": "158aee1a-a203-4c99-8e6f-0e062dd5c7b5",
                        "structuredCondition": "procedure.required IF (visit_type == 'in-person' OR staff_trained == true)",
                        "appliesToActivityIds": [
                          "Assessment"
                        ],
                        "sourceText": "c. Assessment will be performed only for participants attending in-person visits, or if a nurse or H"
                      },
                      {
                        "id": "7435dd12-c950-42bc-8ebf-06a413a06511",
                        "conditionType": "general",
                        "text": "d. Height is recorded only at the screening visit.",
                        "footnoteId": "65b02545-6916-476c-8cd2-c2b77fc01190",
                        "structuredCondition": "frequency.once(screening)",
                        "appliesToActivityIds": [
                          "Height"
                        ],
                        "sourceText": "d. Height is recorded only at the screening visit."
                      },
                      {
                        "id": "017d3b09-1ad0-4d86-aa8c-2fd94889c48e",
                        "conditionType": "timing_after",
                        "text": "e. Perform pre-dose and 15 minutes ( 5 minutes) after both injections are complete.",
                        "footnoteId": "a4c674a2-bb63-445b-abd2-f1d930f7b5e2",
                        "structuredCondition": "timing.pre_dose AND timing.post_dose(PT15M, window=PT5M)",
                        "appliesToActivityIds": [
                          "Assessment"
                        ],
                        "timingConstraint": "PT15M",
                        "sourceText": "e. Perform pre-dose and 15 minutes ( 5 minutes) after both injections are complete."
                      },
                      {
                        "id": "375e0ef6-df39-4e88-8195-13d315c7353d",
                        "conditionType": "timing_at",
                        "text": "f. Perform pre-dose on Day 1.",
                        "footnoteId": "09c3aa40-abb0-4b16-ab3d-3725988ccade",
                        "structuredCondition": "timing.pre_dose(Day 1)",
                        "appliesToActivityIds": [
                          "Assessment"
                        ],
                        "sourceText": "f. Perform pre-dose on Day 1."
                      },
                      {
                        "id": "4f382a52-3fcf-4ebf-9eb9-9557e810de47",
                        "conditionType": "timing_before",
                        "text": "h. Urine pregnancy test (local laboratory) at screening. Perform another urine test (local laboratory) on Day 1 if screening urine test was performed on Day -1. Single serum (central laboratory) must be performed on Day 1. Sample urine test must return negative result before dosing.",
                        "footnoteId": "d6d87e07-bf96-44ea-a473-7aef9871e035",
                        "structuredCondition": "timing.pre_dose(Day 1) IF (result_urine_pregnancy == 'negative')",
                        "appliesToActivityIds": [
                          "Dosing",
                          "Urine pregnancy test",
                          "Serum pregnancy test"
                        ],
                        "sourceText": "h. Urine pregnancy test (local laboratory) at screening. Perform another urine test (local laborator"
                      },
                      {
                        "id": "e049d045-ed67-47b9-8901-eb9c0058d232",
                        "conditionType": "general",
                        "text": "i. Urine pregnancy test (local laboratory).",
                        "footnoteId": "5744b077-df23-4f7b-8d29-9ba22e5f3e3a",
                        "sourceText": "i. Urine pregnancy test (local laboratory)."
                      },
                      {
                        "id": "b4b537ca-559f-4fd8-8149-2e2aa83527dc",
                        "conditionType": "timing_at",
                        "text": "j. Participants will report COVID-19-related symptoms daily in an electronic device, starting pre-dose and post-dose on Day 1.",
                        "footnoteId": "5ab1f871-73a2-4930-8de6-37a9ae7ad076",
                        "structuredCondition": "frequency.daily(START=Day 1 pre-dose)",
                        "appliesToActivityIds": [
                          "c7136a24-c02c-4419-bf74-1c795bb9996f"
                        ],
                        "sourceText": "j. Participants will report COVID-19-related symptoms daily in an electronic device, starting pre-do"
                      },
                      {
                        "id": "fe28d93a-7315-44e6-a733-611465b81649",
                        "conditionType": "frequency_daily",
                        "text": "k. Participant will be reminded every day through Day 29 to complete their diary. This reminder will be received through the electronic device.",
                        "footnoteId": "e2c4dda4-f480-4678-a2f4-8c6b80b5932b",
                        "structuredCondition": "frequency.daily(UNTIL=Day 29)",
                        "appliesToActivityIds": [
                          "Diary reminder"
                        ],
                        "sourceText": "k. Participant will be reminded every day through Day 29 to complete their diary. This reminder will"
                      },
                      {
                        "id": "5ea6252e-d763-46f7-9541-cee027736604",
                        "conditionType": "frequency_daily",
                        "text": "l. If Day 29 visit is conducted earlier in  4 day window, participant should retain symptom diary in order to complete required daily entries through Study Day 29.",
                        "footnoteId": "96d67b16-da89-44a2-9725-a06e96364ddf",
                        "structuredCondition": "timing.continue(UNTIL=Day 29) IF (visit_day < 29)",
                        "appliesToActivityIds": [
                          "Symptom diary"
                        ],
                        "sourceText": "l. If Day 29 visit is conducted earlier in  4 day window, participant should retain symptom diary i"
                      },
                      {
                        "id": "afbddb86-5b32-4b67-a5ab-83c6cde45e7d",
                        "conditionType": "general",
                        "text": "m. Mid-turbinate nasal swab is tested centrally. Sequencing applies to nasal swabs collected through Day 15.",
                        "footnoteId": "ea11375d-4c41-41d0-beb9-867f1f8fd1e5",
                        "structuredCondition": "procedure.required IF (timing.current <= Day 15)",
                        "appliesToActivityIds": [
                          "Sequencing"
                        ],
                        "sourceText": "m. Mid-turbinate nasal swab is tested centrally. Sequencing applies to nasal swabs collected through"
                      },
                      {
                        "id": "67433959-954f-443c-98bb-3535247e7105",
                        "conditionType": "timing_before",
                        "text": "n. Pre-dose sample and post-dose sample (ie, samples obtained prior to and upon completion of IMP administered via IM injections on Day 1).",
                        "footnoteId": "8808eb9e-574f-4e4f-ad56-ed5516a23a23",
                        "sourceText": "n. Pre-dose sample and post-dose sample (ie, samples obtained prior to and upon completion of IMP ad"
                      },
                      {
                        "id": "ef4544db-f967-4102-a255-f46e4d9dbfe2",
                        "conditionType": "general",
                        "text": "o. Serum vitamin D, serum zinc, dependent on availability of laboratory kits.",
                        "footnoteId": "7f14d34e-c568-4523-9281-28dbc2b17278",
                        "structuredCondition": "procedure.required IF (lab_kits_available == true)",
                        "appliesToActivityIds": [
                          "Serum vitamin D",
                          "Serum zinc"
                        ],
                        "sourceText": "o. Serum vitamin D, serum zinc, dependent on availability of laboratory kits."
                      },
                      {
                        "id": "99c957d9-f32e-4d4c-9020-c4674e195dc8",
                        "conditionType": "timing_before",
                        "text": "p. Perform 30 minutes ( 10 minutes) after the IMP has been administered and just prior to release from the study site or departure of the study staff.",
                        "footnoteId": "cf30af4f-099f-4a6f-94d0-61ee492d9db5",
                        "structuredCondition": "timing.post_dose(PT30M, window=PT10M) AND timing.before(release)",
                        "appliesToActivityIds": [
                          "Assessment"
                        ],
                        "timingConstraint": "PT30M",
                        "sourceText": "p. Perform 30 minutes ( 10 minutes) after the IMP has been administered and just prior to release f"
                      },
                      {
                        "id": "522e72ae-2b85-4501-bb70-ab527c8f1925",
                        "conditionType": "timing_recurring",
                        "text": "q. If evidence of injection site reaction persists at the Day 6 visit, the injection site will be rechecked at each visit until no evidence of an active reaction remains.",
                        "footnoteId": "c011ffa8-16cd-4976-97f7-6febb5744283",
                        "structuredCondition": "frequency.every_visit UNTIL (injection_site_reaction == false)",
                        "appliesToActivityIds": [
                          "Injection site recheck"
                        ],
                        "sourceText": "q. If evidence of injection site reaction persists at the Day 6 visit, the injection site will be re"
                      },
                      {
                        "id": "5273adc4-ebd0-4ce4-8c5f-f759b14a14a2",
                        "conditionType": "timing_before",
                        "text": "r. The first 20 participants dosed (ie, the sentinel group) will undergo safety monitoring for 4 hours post IMP administration before further participants are dosed. At each site, there will be an interval of 24 hours after dosing of the first participant in the sentinel group before the next participant can be dosed. The next 80 participants (21 to 100) will then undergo safety monitoring for 2 hours post IMP administration, otherwise the minimum safety monitoring time will be 1 hour. In addition, the sentinel group will be contacted daily (in-person or by telephone) for the first 4 days after IMP administration. Contact will be made by telephone on days when there is not an in-person visit.",
                        "footnoteId": "5f071b24-2c43-4e51-b0b8-1c92219ce541",
                        "structuredCondition": "timing.after(dosing of the first participant in the sentinel group before the next participant can be dosed. the next 80 participants (21 to 100) will then undergo safety monitoring for 2 hours post imp administration, otherwise the minimum safety monitoring time will be 1 hour. in addition, the sentinel group will be contacted daily (in-person or by telephone) for the first 4 days after imp administration. contact will be made by telephone on days when there is not an in-person visit., PT24M)",
                        "appliesToActivityIds": [
                          "Safety monitoring",
                          "Sentinel group contact"
                        ],
                        "timingConstraint": "PT4H",
                        "sourceText": "r. The first 20 participants dosed (ie, the sentinel group) will undergo safety monitoring for 4 hou"
                      },
                      {
                        "id": "5f8861aa-23a1-4284-a232-289c5156b2b8",
                        "conditionType": "timing_at",
                        "text": "s. At Day 457 AE/SAE/AESI assessment will be made by telephone only.",
                        "footnoteId": "8fd6c2f5-18a4-4ab6-9297-3f3f08301343",
                        "structuredCondition": "visit_method.telephone IF (timing.current == Day 457)",
                        "appliesToActivityIds": [
                          "AE/SAE/AESI assessment"
                        ],
                        "sourceText": "s. At Day 457 AE/SAE/AESI assessment will be made by telephone only."
                      },
                      {
                        "id": "ea624ffc-df21-4376-b380-f0ec0ad83fc7",
                        "conditionType": "general",
                        "text": "t. Note: Remote (denoted by R) visit: either a phone call, or a web-based virtual assessment.",
                        "footnoteId": "eeb8415c-ea0a-4a96-ad4b-49a9366cb65a",
                        "sourceText": "t. Note: Remote (denoted by R) visit: either a phone call, or a web-based virtual assessment."
                      },
                      {
                        "id": "bf4c9caa-8209-4fa6-9c0a-2608cc745e86",
                        "conditionType": "general",
                        "text": "u. Note: Day 6 and Day 8 assessments must be performed on different days.",
                        "footnoteId": "1a92e9c4-c6dd-4e9e-aeff-33a4dcddccbb",
                        "structuredCondition": "timing.distinct_days(Day 6, Day 8)",
                        "appliesToActivityIds": [
                          "Day 6 assessments",
                          "Day 8 assessments"
                        ],
                        "sourceText": "u. Note: Day 6 and Day 8 assessments must be performed on different days."
                      }
                    ],
                    "endpointAlgorithms": [
                      {
                        "id": "47191c9c-8350-435a-a77d-bedcb7c3b915",
                        "name": "Primary: Severe COVID-19 or Death from any cause",
                        "endpointType": "Primary",
                        "inputs": [
                          "fever",
                          "cough",
                          "tachypnea",
                          "dyspnea",
                          "lung infiltrates",
                          "SpO2",
                          "respiratory distress",
                          "WHO Clinical Progression Scale score",
                          "vital status",
                          "IMP_administration_date"
                        ],
                        "timeWindow": {
                          "reference": "Day 1 (IMP administration)",
                          "duration": "P28D"
                        },
                        "algorithm": "IF (death = TRUE) OR ((pneumonia = TRUE OR hypoxemia = TRUE) AND WHO_score >= 5) THEN 'Event' ELSE 'No Event'",
                        "successCriteria": "A participant is classified as having the endpoint if they experience severe COVID-19 or death from any cause through Day 29.",
                        "sourceText": "The primary efficacy endpoint is a composite of either severe COVID-19 or death from any cause through Day 29. Severe COVID-19 is characterized by a minimum of either pneumonia (fever, cough, tachypne"
                      },
                      {
                        "id": "17f4cbb6-ef49-4a4b-9b5d-8e117b25f840",
                        "name": "Relative Risk Reduction (RRR)",
                        "endpointType": "Primary",
                        "inputs": [
                          "incidence_AZD7442",
                          "incidence_placebo"
                        ],
                        "timeWindow": {
                          "reference": "Primary Analysis Data Cut-off",
                          "duration": "30 days after 43 primary endpoint events"
                        },
                        "algorithm": "RRR = 1 - (Incidence in AZD7442 / Incidence in Placebo)",
                        "successCriteria": "RRR not equal to zero (statistically significant difference between treatment groups).",
                        "sourceText": "Efficacy will be calculated as the RRR, defined as 1-Relative Risk. The null hypothesis is that the RRR of severe COVID-19 or death from any cause through Day 29 in participants on AZD7442 compared wi"
                      }
                    ],
                    "derivedVariables": [
                      {
                        "id": "0c7c39f8-a186-4a3b-a227-a676138a3ce1",
                        "name": "Key Secondary Composite Endpoint",
                        "variableType": "Composite",
                        "sourceVariables": [
                          "Death from any cause",
                          "Hospitalization for COVID-19 complications or sequelae"
                        ],
                        "derivationRule": "Binary indicator (Yes/No) if either death from any cause OR hospitalization for COVID-19 complications/sequelae occurs",
                        "baselineDefinition": "Post-dose period starting from Day 1",
                        "baselineVisit": "Day 1",
                        "analysisWindow": "Day 1 to Day 169",
                        "imputationRule": "Not specified in text",
                        "unit": "Binary"
                      },
                      {
                        "id": "a6cccb27-3636-4fb3-b2c8-834254a59f85",
                        "name": "Relative Risk Reduction (RRR) of Key Secondary Endpoint",
                        "variableType": "Custom",
                        "sourceVariables": [
                          "Key Secondary Composite Endpoint",
                          "Treatment Group"
                        ],
                        "derivationRule": "Calculated based on the proportion of events in AZD7442 vs placebo at Day 169",
                        "baselineDefinition": "Randomized treatment assignment",
                        "baselineVisit": "Day 1",
                        "analysisWindow": "Through Day 169",
                        "imputationRule": "Not specified in text",
                        "unit": "%"
                      },
                      {
                        "id": "6b4aaff1-845e-4e0a-b626-306333145565",
                        "name": "Time to death or first hospitalization",
                        "variableType": "TimeToEvent",
                        "sourceVariables": [
                          "Date of Death",
                          "Date of Hospitalization",
                          "Date of IMP administration"
                        ],
                        "derivationRule": "Min(Date of Death, Date of first Hospitalization) - Date of IMP administration",
                        "baselineDefinition": "Day 1 (Post-dose)",
                        "baselineVisit": "Day 1",
                        "analysisWindow": "Day 1 to Day 169",
                        "imputationRule": "Kaplan-Meier censoring for participants without events",
                        "unit": "Days"
                      },
                      {
                        "id": "2cf820b4-6b7c-45ff-9ce8-5a4265055ef1",
                        "name": "Proportion of participants with respiratory failure",
                        "variableType": "Categorical",
                        "sourceVariables": [
                          "Mechanical ventilation requirement",
                          "ECMO requirement",
                          "Non-invasive ventilation requirement",
                          "High flow cannula oxygen delivery"
                        ],
                        "derivationRule": "Binary indicator (Yes/No) if any of the source requirements are met",
                        "baselineDefinition": "Post-dose",
                        "baselineVisit": "Day 1",
                        "analysisWindow": "Through Day 29",
                        "imputationRule": "Not specified in text",
                        "unit": "Binary"
                      },
                      {
                        "id": "1788c721-0eb3-40b8-b503-7bf1182da2f2",
                        "name": "Progression of COVID-19-associated symptoms",
                        "variableType": "Categorical",
                        "sourceVariables": [
                          "Participant-reported symptom diary entry"
                        ],
                        "derivationRule": "One or more symptoms progressing to a worse status than recorded in the diary entry prior to start of IMP",
                        "baselineDefinition": "Symptom status recorded in diary prior to start of AZD7442 or placebo",
                        "baselineVisit": "Pre-dose Day 1",
                        "analysisWindow": "Through Day 29",
                        "imputationRule": "Not specified in text",
                        "unit": "Binary"
                      },
                      {
                        "id": "abac5bd5-3450-46c8-9572-996d40e20e47",
                        "name": "Undetectable SARS-CoV-2 over time",
                        "variableType": "TimeToEvent",
                        "sourceVariables": [
                          "SARS-CoV-2 viral load"
                        ],
                        "derivationRule": "Time from Day 1 to the first instance where SARS-CoV-2 is undetectable",
                        "baselineDefinition": "Baseline viral load status",
                        "baselineVisit": "Day 1",
                        "analysisWindow": "Through Day 29",
                        "imputationRule": "Kaplan-Meier",
                        "unit": "Days"
                      }
                    ],
                    "stateMachine": {
                      "id": "e38eff77-0952-435a-9568-c7deab86e661",
                      "initialState": "Screening",
                      "terminalStates": [
                        "Early Termination",
                        "Completed"
                      ],
                      "states": [
                        "Screening",
                        "Treatment",
                        "Intensive Follow Up",
                        "Limited Follow Up",
                        "End Of Study",
                        "Early Termination"
                      ],
                      "transitions": [
                        {
                          "fromState": "Screening",
                          "toState": "Treatment",
                          "trigger": "Progress to Treatment"
                        },
                        {
                          "fromState": "Treatment",
                          "toState": "Intensive Follow Up",
                          "trigger": "Progress to Intensive Follow Up"
                        },
                        {
                          "fromState": "Intensive Follow Up",
                          "toState": "Limited Follow Up",
                          "trigger": "Progress to Limited Follow Up"
                        },
                        {
                          "fromState": "Limited Follow Up",
                          "toState": "End Of Study",
                          "trigger": "Progress to End Of Study"
                        },
                        {
                          "fromState": "Treatment",
                          "toState": "Early Termination",
                          "trigger": "Subject exits to Early Termination"
                        }
                      ],
                      "epochIds": {
                        "Screening": "SCREENING",
                        "Treatment": "TREATMENT",
                        "Intensive Follow Up": "INTENSIVE_FOLLOW_UP",
                        "Limited Follow Up": "LIMITED_FOLLOW_UP",
                        "End Of Study": "END_OF_STUDY",
                        "Early Termination": "EARLY_TERMINATION"
                      }
                    },
                    "dosingRegimens": [
                      {
                        "id": "6eec3e55-5f91-4394-ab1b-b890300c0bbd",
                        "treatmentName": "AZD7442",
                        "frequency": "Single",
                        "route": "IM",
                        "startDay": 1,
                        "doseLevels": [
                          {
                            "amount": 0.0,
                            "unit": "",
                            "description": "Investigational Medicinal Product (IMP)"
                          }
                        ],
                        "durationDescription": "Single dose"
                      },
                      {
                        "id": "1e3ce611-88dd-44c8-afc3-60185bd4dfea",
                        "treatmentName": "Placebo",
                        "frequency": "Single",
                        "route": "IM",
                        "startDay": 1,
                        "doseLevels": [
                          {
                            "amount": 0.0,
                            "unit": "",
                            "description": "Matching placebo"
                          }
                        ],
                        "durationDescription": "Single dose"
                      }
                    ],
                    "visitWindows": [
                      {
                        "id": "7307e9fa-6425-4b45-ac8c-58ef99a480f7",
                        "visitName": "screening",
                        "targetDay": -14,
                        "windowBefore": 7,
                        "windowAfter": 0,
                        "isRequired": true,
                        "visitNumber": 1,
                        "epoch": "Screening",
                        "sourceText": "Following screening, and no more than 7 days (Day 1 symptom count starts from the first day of symptoms) from self-reported onset of COVID-19-related symptoms or measured fever, participants will re"
                      },
                      {
                        "id": "89154f88-5eef-4193-9606-a089819b0d99",
                        "visitName": "Early Termination",
                        "targetDay": null,
                        "windowBefore": 0,
                        "windowAfter": 0,
                        "isRequired": true,
                        "visitNumber": 2,
                        "sourceText": "CONFIDENTIAL AND PROPRIETARY9 of 115 LIST OF TABLES"
                      },
                      {
                        "id": "ff4eace6-7632-461a-adcd-83e23c1a88ba",
                        "visitName": "End of Study",
                        "targetDay": null,
                        "windowBefore": 3,
                        "windowAfter": 7,
                        "isRequired": true,
                        "visitNumber": 3,
                        "sourceText": "End of Study Definition A participant is considered to have completed the study if he/she has completed all stages of the study, including the last scheduled procedure shown in the SoA (Table 1 for Co"
                      },
                      {
                        "id": "a0eb4c75-a8fd-4e48-87da-c792448b9593",
                        "visitName": "baseline",
                        "targetDay": 0,
                        "windowBefore": 1,
                        "windowAfter": 1,
                        "isRequired": true,
                        "visitNumber": 4,
                        "sourceText": "Increased supplemental oxygen requirement (only for participants on baseline supplemental oxygen) 5"
                      },
                      {
                        "id": "d6049536-a493-4080-9e89-dd2f2b3e676a",
                        "visitName": "Visit 1",
                        "targetDay": null,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 5,
                        "sourceText": "negative pregnancy test result at Visit 1 and during the study as in the SoA (Table 1 for Cohort 1 and Table 2 for Cohort 2)."
                      },
                      {
                        "id": "89686174-6870-49a6-a636-85dd7537511e",
                        "visitName": "randomization",
                        "targetDay": 1,
                        "windowBefore": 0,
                        "windowAfter": 0,
                        "isRequired": true,
                        "visitNumber": 6,
                        "sourceText": "Persons aged 65 years and older at randomization x Persons aged < 65 years and having at least one of the following conditions:"
                      },
                      {
                        "id": "9b4ab936-08d4-422e-ac14-04e22bdfdd54",
                        "visitName": "Day 2 (Sentinel Group Only)",
                        "targetDay": 2,
                        "windowBefore": 0,
                        "windowAfter": 0,
                        "isRequired": false,
                        "visitNumber": 3,
                        "targetWeek": 1,
                        "epoch": "Intensive Follow-up"
                      },
                      {
                        "id": "25038068-da70-4d00-8f7e-b75b676962fb",
                        "visitName": "Day 3 (Sentinel Group Only)",
                        "targetDay": 3,
                        "windowBefore": 0,
                        "windowAfter": 0,
                        "isRequired": false,
                        "visitNumber": 4,
                        "targetWeek": 1,
                        "epoch": "Intensive Follow-up"
                      },
                      {
                        "id": "222f121f-30d8-47d9-b033-412658048b48",
                        "visitName": "Day 4 (Sentinel Group Only)",
                        "targetDay": 4,
                        "windowBefore": 0,
                        "windowAfter": 0,
                        "isRequired": false,
                        "visitNumber": 5,
                        "targetWeek": 1,
                        "epoch": "Intensive Follow-up"
                      },
                      {
                        "id": "2881552a-602d-4170-ad23-a3809f7220b6",
                        "visitName": "Day 6",
                        "targetDay": 6,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 10,
                        "sourceText": "If evidence of injection site reaction persists at the Day 6 visit, the injection site will be rechecked at each visit until no evidence of an active reaction remains. r The first 20 participants dose"
                      },
                      {
                        "id": "e00dddfe-70bb-4c88-ab03-3a029ae5bf06",
                        "visitName": "Day 8",
                        "targetDay": 8,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 11,
                        "epoch": "Intensive Follow-up",
                        "sourceText": "groups safety data through Day 8 has been reviewed by the DSMB in order to provide a recommendation to continue or to halt dosing of additional participants. Participants will be enrolled into one of"
                      },
                      {
                        "id": "5e118dfd-a055-41e8-99fa-dfbf69003b6e",
                        "visitName": "Day 15",
                        "targetDay": 15,
                        "windowBefore": 0,
                        "windowAfter": 0,
                        "isRequired": true,
                        "visitNumber": 12,
                        "sourceText": "Mid-turbinate nasal swab is tested centrally. Sequencing applies to nasal swabs collected through Day 15. n Pre-dose sample and post-dose sample (ie, samples obtained prior to and upon completion of I"
                      },
                      {
                        "id": "e7e34338-fec2-4372-b6ff-493e74f97a51",
                        "visitName": "Day 29",
                        "targetDay": 29,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 13,
                        "epoch": "Intensive Follow-up",
                        "sourceText": "or death from any cause through Day 29. Severe COVID-19 is characterized by a minimum of either pneumonia (fever, cough, tachypnea, or dyspnea, AND lung infiltrates) or hypoxemia (SpO2 < 90% in room a"
                      },
                      {
                        "id": "dd1d1206-a881-4b6c-96a4-e5dfb674cc54",
                        "visitName": "Day 30",
                        "targetDay": 30,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 14,
                        "sourceText": "appropriate that they can discuss with the investigator and others after Day 30 so as to make an informed choice. The following considerations apply: x"
                      },
                      {
                        "id": "ca9d883d-a8db-41ec-a646-c2b166210c00",
                        "visitName": "Day 169",
                        "targetDay": 169,
                        "windowBefore": 0,
                        "windowAfter": 0,
                        "isRequired": true,
                        "visitNumber": 15,
                        "sourceText": "events have been confirmed in the primary analysis population. A Day 169 analysis will be conducted when all participants have been followed through Day 169. A final analysis will be conducted when al"
                      },
                      {
                        "id": "20543cea-d4bc-4b6c-a0e3-e4f49648d0fa",
                        "visitName": "Follow-up",
                        "targetDay": 365,
                        "windowBefore": 7,
                        "windowAfter": 7,
                        "isRequired": true,
                        "visitNumber": 16,
                        "sourceText": "Follow-up, and Reporting ........................................................................... 82 Appendix C Handling of Human Biological Samples ................................................"
                      },
                      {
                        "id": "df759861-4d03-4cba-b1fd-f6793aec3256",
                        "visitName": "Day 457",
                        "targetDay": 457,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 17,
                        "epoch": "Limited Follow-up",
                        "sourceText": "28 days of intensive follow-up, followed by limited follow-up through Day 457. Disclosure Statement: This is a parallel-group treatment study with 2 arms that are double-blind."
                      }
                    ],
                    "randomizationScheme": {
                      "id": "c46f6ddc-391c-4154-aa69-6c782556a5f2",
                      "ratio": "1:1",
                      "method": "Stratified blocked randomization",
                      "centralRandomization": true,
                      "stratificationFactors": [
                        {
                          "id": "153c309f-c06b-4607-8c06-768d9fa4759d",
                          "name": "Time from symptom onset",
                          "categories": [
                            " 5 days",
                            "> 5 days"
                          ],
                          "isBlocking": false
                        },
                        {
                          "id": "57284d60-c21c-4e70-8c43-d909871d74e5",
                          "name": "Risk of progression to severe COVID-19",
                          "categories": [
                            "High-risk",
                            "Low-risk"
                          ],
                          "isBlocking": false
                        }
                      ],
                      "sourceText": "Clinical Study Protocol - 7.0 \nAstraZeneca \nAZD7442 - D8851C00001 \n \nCONFIDENTIAL AND PROPRIETARY12 of 115 \n \nADA Anti-drug-antibody; AE Adverse event; AESI Adverse event of special interest; AUC Area"
                    }
                  }
                }
              },
              {
                "id": "cabc9c8e-7c71-4410-b323-293bdd8d7fb8",
                "url": "https://protocol2usdm.io/extensions/x-soaFootnotes",
                "valueString": "[\"a. Visits noted P/H can be performed either in-person at clinical site or at home depending on the participant's clinical status, availability of safe transfer to sites (eg, to avoid risk of infection spread), and local guidelines for travel restrictions/social distancing. For home visits, a nurse or HCP trained on study procedures will visit the participant at home; nasal swabs, blood collection (where at-home collection is possible), and inspection of injection sites will be performed by the nurse or HCP. Nurse or HCP will ensure shipment of specimens collected and reporting of AEs to study sites.\", \"b. Perform if no documentation of SARS-CoV-2 infection available; tested locally.\", \"c. Assessment will be performed only for participants attending in-person visits, or if a nurse or HCP visiting the participant at home is properly trained for these assessments.\", \"d. Height is recorded only at the screening visit.\", \"e. Perform pre-dose and 15 minutes (\\u00b1 5 minutes) after both injections are complete.\", \"f. Perform pre-dose on Day 1.\", \"g. Hematology panel includes coagulation markers.\", \"h. Urine pregnancy test (local laboratory) at screening. Perform another urine test (local laboratory) on Day 1 if screening urine test was performed on Day -1. Single serum (central laboratory) must be performed on Day 1. Sample urine test must return negative result before dosing.\", \"i. Urine pregnancy test (local laboratory).\", \"j. Participants will report COVID-19-related symptoms daily in an electronic device, starting pre-dose and post-dose on Day 1.\", \"k. Participant will be reminded every day through Day 29 to complete their diary. This reminder will be received through the electronic device.\", \"l. If Day 29 visit is conducted earlier in \\u00b1 4 day window, participant should retain symptom diary in order to complete required daily entries through Study Day 29.\", \"m. Mid-turbinate nasal swab is tested centrally. Sequencing applies to nasal swabs collected through Day 15.\", \"n. Pre-dose sample and post-dose sample (ie, samples obtained prior to and upon completion of IMP administered via IM injections on Day 1).\", \"o. Serum vitamin D, serum zinc, dependent on availability of laboratory kits.\", \"p. Perform 30 minutes (\\u00b1 10 minutes) after the IMP has been administered and just prior to release from the study site or departure of the study staff.\", \"q. If evidence of injection site reaction persists at the Day 6 visit, the injection site will be rechecked at each visit until no evidence of an active reaction remains.\", \"r. The first 20 participants dosed (ie, the sentinel group) will undergo safety monitoring for 4 hours post IMP administration before further participants are dosed. At each site, there will be an interval of 24 hours after dosing of the first participant in the sentinel group before the next participant can be dosed. The next 80 participants (21 to 100) will then undergo safety monitoring for 2 hours post IMP administration, otherwise the minimum safety monitoring time will be 1 hour. In addition, the sentinel group will be contacted daily (in-person or by telephone) for the first 4 days after IMP administration. Contact will be made by telephone on days when there is not an in-person visit.\", \"s. At Day 457 AE/SAE/AESI assessment will be made by telephone only.\", \"t. Note: Remote (denoted by R) visit: either a phone call, or a web-based virtual assessment.\", \"u. Note: Day 6 and Day 8 assessments must be performed on different days.\"]",
                "instanceType": "ExtensionAttribute"
              }
            ],
            "administrations": [
              {
                "id": "012d8877-f2db-438f-918b-76a44acd5abc",
                "name": "AZD7442 Administration",
                "instanceType": "Administration",
                "dose": "0.0 ",
                "doseFrequency": "Single",
                "route": {
                  "id": "f1654b89-42cc-409b-9429-76eba5f2804b",
                  "code": "IM",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "IM",
                  "instanceType": "Code"
                },
                "duration": "Single dose"
              },
              {
                "id": "95485f5a-7265-44a5-bc3e-ae436778c825",
                "name": "Placebo Administration",
                "instanceType": "Administration",
                "dose": "0.0 ",
                "doseFrequency": "Single",
                "route": {
                  "id": "3734efa8-754e-4c15-8651-c78d1ea7e002",
                  "code": "IM",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "IM",
                  "instanceType": "Code"
                },
                "duration": "Single dose"
              }
            ]
          }
        ],
        "titles": [
          {
            "id": "0046e436-21b5-42d4-88a5-2e45cd5e397a",
            "text": "A Phase III Randomized, Double-blind, Placebo-controlled, Multicenter Study to Determine the Safety and Efficacy of AZD7442 for the Treatment of COVID-19 in Non-hospitalized Adults",
            "type": {
              "id": "c2a013cb-39ec-4027-8c5a-44c441003596",
              "code": "Official Study Title",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Official Study Title",
              "instanceType": "Code"
            },
            "instanceType": "StudyTitle"
          },
          {
            "id": "43f302f1-8050-4cdd-990e-8e92cc7adba5",
            "text": "Phase III Double-blind, Placebo-controlled Study of AZD7442 for Treatment of COVID-19 in Outpatient Adults",
            "type": {
              "id": "ad03a246-a031-476e-9d14-9a4ab6b24059",
              "code": "Brief Study Title",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Brief Study Title",
              "instanceType": "Code"
            },
            "instanceType": "StudyTitle"
          },
          {
            "id": "f352f1e0-7d3b-4cf4-a583-10d9d20ac883",
            "text": "TACKLE",
            "type": {
              "id": "023cba03-2a19-4b0d-a524-403d32b84c4b",
              "code": "Study Acronym",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Study Acronym",
              "instanceType": "Code"
            },
            "instanceType": "StudyTitle"
          }
        ],
        "studyIdentifiers": [
          {
            "id": "12e61bfc-85c4-45f5-a047-858cb4c8bb7e",
            "text": "D8851C00001",
            "instanceType": "StudyIdentifier",
            "scopeId": "882219a6-76cb-4394-8b66-7635009792f5",
            "type": {
              "code": "C132351",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-09-27",
              "decode": "Sponsor Protocol Identifier",
              "instanceType": "Code"
            }
          },
          {
            "id": "f1e8348d-a8ad-4b28-9029-d5f0d19e6ae6",
            "text": "2020-005315-44",
            "instanceType": "StudyIdentifier",
            "scopeId": "d27b9780-be8d-493d-bbd1-0f2809dcfb79",
            "type": {
              "code": "C98714",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-09-27",
              "decode": "Clinical Trial Registry Identifier",
              "instanceType": "Code"
            }
          },
          {
            "id": "b2565ac3-df27-436d-923d-ee436c1e7df4",
            "text": "150712",
            "instanceType": "StudyIdentifier",
            "scopeId": "52d41dad-b964-43c8-b134-71fd7eb7bed1",
            "type": {
              "code": "C218685",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-09-27",
              "decode": "US FDA Investigational New Drug Application Number",
              "instanceType": "Code"
            }
          }
        ],
        "organizations": [
          {
            "id": "882219a6-76cb-4394-8b66-7635009792f5",
            "name": "AstraZeneca AB",
            "type": {
              "id": "c7fb9475-6bb7-4266-8073-6dbfaa5f93da",
              "code": "C54086",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Pharmaceutical Company",
              "instanceType": "Code"
            },
            "identifier": "AstraZeneca AB",
            "identifierScheme": "DUNS",
            "instanceType": "Organization"
          },
          {
            "id": "ace7b8ac-e4bf-4902-bae4-29ec19b24ff5",
            "name": "University College London",
            "type": {
              "id": "7695f867-ab9c-4fd2-ab7e-8b633bb241a3",
              "code": "C25516",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Academic Institution",
              "instanceType": "Code"
            },
            "identifier": "University College London",
            "identifierScheme": "DUNS",
            "instanceType": "Organization"
          },
          {
            "id": "882219a6-76cb-4394-8b66-7635009792f5",
            "name": "Research Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "1",
            "type": {
              "id": "3a8158fb-da84-4469-8e3e-4bc7fe3f03d8",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "ace7b8ac-e4bf-4902-bae4-29ec19b24ff5",
            "name": "Research Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "2",
            "type": {
              "id": "68e82724-e9cb-4baf-b7d6-b7aa857fe3c5",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "8f0e11b5-33b5-47d4-b80e-32d5d404b46e",
            "name": "Research Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "3",
            "type": {
              "id": "e62e7333-05f1-4527-bd9f-9071e424e15c",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "5ee33def-e8a6-4ec7-8814-5502410e1a6d",
            "name": "Research Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "4",
            "type": {
              "id": "25b8198e-8358-40fb-ae0b-4f10a8fd43bf",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "0bd4a3ae-176b-4815-ade3-b1cb099e0db7",
            "name": "Research Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "5",
            "type": {
              "id": "760ae964-4e0f-474a-88fa-b8b0ddba47d1",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "64a01b64-a783-43a8-9481-991ee11bac3a",
            "name": "Research Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "6",
            "type": {
              "id": "8337b3eb-00af-4b21-b3b1-97c395515d58",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "d4150868-7e4e-4f72-bd8a-18d30e85a978",
            "name": "Research Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "7",
            "type": {
              "id": "deeafaed-b802-4e75-9a9f-9350cc5367e0",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "4919f7ae-9fe2-4519-af63-7c6e77ecee38",
            "name": "Research Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "8",
            "type": {
              "id": "e45f5234-42d3-4530-97b7-f9becdbb05de",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "32e85079-b835-4a7b-9a55-faaef2099e8f",
            "name": "Research Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "9",
            "type": {
              "id": "fb834a7b-8648-414b-9688-4ce17969d041",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "94454203-1cf4-4548-9b8c-d99daa5822d2",
            "name": "Research Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "10",
            "type": {
              "id": "199dcc5d-1ec0-47de-87c3-79eb8d274852",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "f51e992a-37a7-4042-b61e-3f40a8f0c15d",
            "name": "Research Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "11",
            "type": {
              "id": "9366d6ce-d325-4565-8f13-0c282e2dd1e6",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "f3ae763d-0505-4cc1-b84f-ce9153b5c5d8",
            "name": "Research Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "12",
            "type": {
              "id": "4d498fec-6f9f-4635-987f-f3385f93ddbe",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "119569f4-cb19-4c14-9389-9b8f789611bc",
            "name": "Research Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "13",
            "type": {
              "id": "46ac440b-71ce-47c8-9ea8-d76ce22937f0",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "f717e6ed-5c37-4ce6-a771-2656c9934cb5",
            "name": "Research Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "14",
            "type": {
              "id": "07e2e6a4-1a78-43f7-8d46-ef3e12d3da4b",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "7ec62e6f-31f3-4f65-ab02-4a8746875584",
            "name": "Research Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "15",
            "type": {
              "id": "6ff99e71-6d46-4cfd-926b-e046369a4e41",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "96fd5547-2c94-4fe3-a9c2-18faed247e96",
            "name": "Research Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "16",
            "type": {
              "id": "294455d6-49c4-4035-a7c4-22dce195e2f5",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "4ed03cb9-1700-444f-afe1-4b45c191f917",
            "name": "Research Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "17",
            "type": {
              "id": "e12a3123-f595-4e15-b0eb-df4b68144999",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "1bb20026-0a7a-44af-a24f-ba7a875fdc2c",
            "name": "Research Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "18",
            "type": {
              "id": "0a6e7cc8-ffc6-413e-b6b0-d5763310be77",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "8b39f0b0-b828-48d3-854e-5bd16caa336b",
            "name": "Research Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "19",
            "type": {
              "id": "7b81896c-2618-4aea-9e28-c674d0e3ff8a",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "e2847672-593a-4818-9bb8-0fb0bac74886",
            "name": "Research Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "20",
            "type": {
              "id": "5c671f8c-2fad-4604-a150-12fc3c7268ff",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "508b4abb-80a0-42c2-a434-e5bcc41a3703",
            "name": "Research Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "21",
            "type": {
              "id": "b93e8588-52aa-4631-b3c6-af08ca022963",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "b1e803e5-2022-446e-a8ae-03129674ab10",
            "name": "Research Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "22",
            "type": {
              "id": "12b9ddbc-f0d4-4036-803a-d4fb247601f9",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "6be544ce-71aa-4dfd-8797-3f4a6f5b472e",
            "name": "Research Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "23",
            "type": {
              "id": "1abb869d-9312-4583-b96d-4b499b8f9715",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "5c285a84-51ce-4b34-a97e-9fba50627bb5",
            "name": "Research Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "24",
            "type": {
              "id": "caa7e5da-3c6d-4e93-a214-b4ed0c7d3293",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "ff0b34b9-7782-44ef-b703-669871a21075",
            "name": "Research Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "25",
            "type": {
              "id": "d80e510e-9fab-4da2-831c-e46abfb2b9fa",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "bec3484e-6258-4262-9804-a244c48c7f88",
            "name": "Research Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "26",
            "type": {
              "id": "8c98f449-0299-4bfc-82d4-4a1b88826a18",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "d6f1b729-b8d7-4c32-98fc-b92710927dd5",
            "name": "Research Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "27",
            "type": {
              "id": "7e921cd1-3d53-4025-935c-43fd440f821b",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "27732123-4fd2-4f83-8dd5-05a47132c215",
            "name": "Research Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "28",
            "type": {
              "id": "f0c401a8-6061-4c28-9080-961c02f927cf",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "c9edb5f9-22c6-4c8c-a556-2e60b9a52985",
            "name": "Research Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "29",
            "type": {
              "id": "feb0318e-a800-4ca6-be0a-4146c094953c",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "a5762fa9-c79b-49a3-9c00-bea2066c14cd",
            "name": "Research Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "30",
            "type": {
              "id": "5ac4ae5e-7e84-4eb4-9884-cbd622146e19",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "f4bc5504-23d8-43d3-9a89-df5354ada5c4",
            "name": "Research Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "31",
            "type": {
              "id": "0c44ab9e-531a-4fc6-af66-c24ab6073bae",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "4c8bfea3-5744-4879-b8df-c8653abb558b",
            "name": "Research Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "32",
            "type": {
              "id": "9263724e-d581-443f-846b-1f223aacf995",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "eff4c94c-e61b-4346-bb62-c52401098c31",
            "name": "Research Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "33",
            "type": {
              "id": "60c0a190-20ab-4d96-9a53-27784c30e184",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "3ba68494-52fd-4c6f-ac87-a1383683fa3d",
            "name": "Research Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "34",
            "type": {
              "id": "80ed6d65-b086-478a-b5aa-d40cc8d7ac21",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "8818736a-80b4-4b44-a76c-724b7e87d679",
            "name": "Research Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "35",
            "type": {
              "id": "f5ab09a1-a37e-4573-967a-56d3988cb7d1",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "26882c63-104f-439a-8bce-218edc8a0936",
            "name": "Research Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "36",
            "type": {
              "id": "05d573ba-6b75-4d2f-90c7-6e2428196e9e",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "da76271c-973a-4936-bab6-9f8368404d61",
            "name": "Research Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "37",
            "type": {
              "id": "0550ff55-bc56-48fd-a75b-b63031f13e78",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "4479a614-2de7-4fb8-9bad-ab5018ded920",
            "name": "Research Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "38",
            "type": {
              "id": "b7cdfccd-b148-4666-98b6-e6d72ca08201",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "8e9abe65-8714-4cec-86e2-5ac2aa67d285",
            "name": "Research Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "39",
            "type": {
              "id": "6a9224de-5084-404f-a364-4815c8182551",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "25849749-fe0a-4c3d-a37c-4356033d72a5",
            "name": "Research Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "40",
            "type": {
              "id": "8d4a5fc5-b3d8-47c9-b036-a2802cfdb213",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "f4ddc439-28ae-4a82-bcca-782547f0c722",
            "name": "Research Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "41",
            "type": {
              "id": "c86c2247-926a-4484-b109-295e2c3902c2",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "cab58cb7-75d6-41e4-ae67-bc2c7c95fb83",
            "name": "Research Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "42",
            "type": {
              "id": "a2dee603-24fa-4af0-9dce-cde59574b56c",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "959aa95a-fac9-4c21-9ef3-48e6979494b6",
            "name": "Research Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "43",
            "type": {
              "id": "1f944ff8-2fcd-44dc-bace-9ce301c7ef7f",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "295c4a77-5d40-42d3-a928-c54381953bf4",
            "name": "Research Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "44",
            "type": {
              "id": "fe447a7e-4542-4e71-b339-380ef58f5e89",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "0610d92e-5423-491c-9ca2-3cb556a7362c",
            "name": "Research Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "45",
            "type": {
              "id": "f137046d-63cb-4556-a3c8-a6069feb3249",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "eab62be3-5db0-4dfd-acaf-e214de6ebdaf",
            "name": "Research Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "46",
            "type": {
              "id": "4659e012-b91c-440e-9524-4f5fed225a7f",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "1b12397e-2466-45ee-a0ec-654403c30696",
            "name": "Research Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "47",
            "type": {
              "id": "9da1866e-6540-4cd2-b6aa-2ab92bfe522d",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "29d81e58-5565-4105-8dfb-c49839c06767",
            "name": "Research Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "48",
            "type": {
              "id": "bec6bbef-393f-45e9-ba3f-00f3be052131",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "cf9e386b-bc96-4536-b67e-bcd13cee993b",
            "name": "Research Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "49",
            "type": {
              "id": "c64d662c-243e-4a67-9970-f46158682a01",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "f6d7369e-5ace-475c-aaca-457e9a3dbe67",
            "name": "Research Site",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "50",
            "type": {
              "id": "af80d042-d34e-4507-a103-2f7294b04f84",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          }
        ],
        "studyPhase": {
          "id": "aebef77e-0aef-4527-b21e-c6baeb65cb74",
          "code": "Phase3",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Phase3",
          "instanceType": "Code"
        },
        "eligibilityCriterionItems": [
          {
            "id": "b05cc249-8720-44d3-9e3c-0ce74487868c",
            "name": "Age requirement",
            "text": "Participant must be  18 years of age inclusive at the time of signing the informed consent.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "76fdca09-823e-4974-bedc-fe00ee81aaf4",
            "name": "SARS-CoV-2 infection confirmation",
            "text": "Participant who has a documented laboratory-confirmed SARS-CoV-2 infection, as determined by a molecular test (antigen or nucleic acid) from any respiratory tract specimen (eg, oropharyngeal, NP, or nasal swab, or saliva) collected  3 days prior to Day 1.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "4426ab23-6000-4df5-8635-7de88f2eb48e",
            "name": "WHO Clinical Progression Scale score",
            "text": "WHO Clinical Progression Scale score > 1 and < 4.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "ea9bca90-ec08-4040-9b40-07fa8df21924",
            "name": "Symptom onset timing",
            "text": "Participant must be dosed with IMP no more than 7 days from self-reported onset of COVID-19-related symptoms (mild to moderate COVID) or measured fever, defined as the self-reported date of first reported sign/symptom from the following list: Subjective fever or feeling feverish; Cough; Shortness of breath or difficulty breathing at rest or with activity; Sore throat; Body pain or muscle pain/aches; Fatigue; Headache; Chills; Nasal obstruction or congestion; Nasal discharge; New loss of taste or smell; Nausea or vomiting; Diarrhea; Documented temperature > 37.8C/100F; New onset confusion (only for participants  60 years old); Appetite loss or decreased food intake (only for participants  60 years old); Increased supplemental oxygen requirement (only for participants on baseline supplemental oxygen).",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "eaba9859-5892-4d5b-8b01-ad065c2bc3ca",
            "name": "Current symptoms",
            "text": "One or more of the following signs/symptoms must be present within 24 hours prior to Day 1: Cough; Sore throat; Shortness of breath or difficulty breathing at rest or with activity; Body pain or muscle pain/aches; Fatigue; Headache; Chills; Nasal obstruction or congestion; Nasal discharge; Nausea or vomiting; Diarrhea; New loss of taste or smell.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "0f62467c-de44-4f1a-8a7d-9a58db731b6b",
            "name": "Oxygen saturation",
            "text": "Oxygenation saturation of  92% obtained at rest by study staff within 24 hours prior to Day 1, unless the potential participant regularly receives chronic supplementary oxygen for an underlying lung condition.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "d110e501-830d-4b47-a752-89807e1cadc9",
            "name": "Trial participation restriction",
            "text": "Agrees not to participate in another clinical trial for the treatment of COVID-19 or SARS-CoV-2 during the study period until reaching hospitalization or 28 days post-entry, whichever is earliest.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "7103ba26-d847-4cb2-b3b6-43072eb1cd10",
            "name": "Prior COVID-19 vaccine or mAb",
            "text": "Any prior receipt of investigational or licensed vaccine or other mAb/biologic indicated for the prevention of SARS-CoV-2 or COVID-19 or expected administration immediately after enrollment",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "2cbd8e46-3c5f-4907-8340-8766f2a88109",
            "name": "Mechanical ventilation",
            "text": "Current requirement for mechanical ventilation or anticipated impending need for mechanical ventilation.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "c75cb07a-6e70-48ef-aeca-58fa7caf2116",
            "name": "Bleeding disorder",
            "text": "Clinically significant bleeding disorder (eg, factor deficiency, coagulopathy, or platelet disorder), or prior history of significant bleeding or bruising following IM injections or venepuncture.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "8591354c-f6cd-4a04-bdb6-b356f756ef82",
            "name": "Other significant disease",
            "text": "Any other significant disease, disorder, or finding that may significantly increase the risk to the participant because of participation in the study, affect the ability of the participant to participate in the study, or impair interpretation of the study data.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "9df66f66-597f-48db-9d56-7b6e9f3dd4c4",
            "name": "Allergy or hypersensitivity",
            "text": "Known allergy/sensitivity or any hypersensitivity to components of the IMP or placebo.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "f3b200ca-e7cb-4852-9ece-032ade546cfb",
            "name": "Recent surgery or life-threatening comorbidity",
            "text": "Any co-morbidity requiring surgery within 7 days prior to study entry, or that is considered life-threatening in the opinion of the site investigator within 30 days prior to study entry.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "740a26b3-49d9-491e-8620-989d5799d0cd",
            "name": "Prohibited medication",
            "text": "Use of any prohibited medication listed in Section 6.5 within 30 days or 5 half-lives, whichever is longer, prior to study entry.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "73dfc624-56f3-4e94-a55b-2d6abf5caf3f",
            "name": "Convalescent plasma",
            "text": "Receipt of convalescent COVID-19 plasma treatment at any time prior to study entry.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "98ded995-efff-4bc2-817c-92c14554dc84",
            "name": "Steroid use",
            "text": "Receipt of systemic steroids (eg, prednisone, dexamethasone) or inhaled steroids within 30 days prior to study entry unless a stable dose used for a chronic condition.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "47d50c37-e8dd-4172-bddf-f4f0c3d92904",
            "name": "Recent IMP receipt",
            "text": "Receipt of any IMP in the preceding 90 days or 5 half-lives, whichever is longer, or expected receipt of IMP during the period of study follow-up, or concurrent participation in another interventional study.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "e325c180-4a23-42c8-a1db-45b28f921eab",
            "name": "Investigator judgment",
            "text": "Judgment by the investigator that the participant should not participate in the study if the participant is unlikely to comply with study procedures, restrictions, and requirements.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "fbb0c1ab-565c-45b7-8753-44c514de142d",
            "name": "Previous randomization",
            "text": "Previous randomization in the present study.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "6dc8a355-093e-447a-a2d1-c4b782e4c8eb",
            "name": "Pregnancy or breastfeeding",
            "text": "For women only, currently pregnant (confirmed with positive pregnancy test) or breast feeding.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "a2b786c6-e411-49a0-b2c1-e4aba306f9d5",
            "name": "Recent blood draw",
            "text": "Blood drawn in excess of a total of 450 mL (1 unit) for any reason within 30 days prior to randomization.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "368e5c23-904c-4d30-9db2-c797f69f0bfa",
            "name": "Sponsor or site staff",
            "text": "Employees of the Sponsor involved in planning executing, supervising, or reviewing the AZD7442 program, clinical study site staff, or any other individuals involved with the conduct of the study, or immediate family members of such individuals.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "8f9fd424-3d39-47cf-8334-d298f1e2249c",
            "name": "Lack of capacity for consent",
            "text": "In nations, states, or other jurisdictions that for legal or ethical reasons bar the enrollment of participants who lack capacity to provide their own informed consent, such subjects are excluded.",
            "instanceType": "EligibilityCriterionItem"
          }
        ],
        "studyInterventions": [
          {
            "id": "83c7b081-1bd6-42aa-aacc-713ef791e0dd",
            "name": "AZD7442",
            "type": {
              "id": "510f12e5-1377-4ac0-919c-923f65583c3d",
              "code": "C54121",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Investigational Product",
              "instanceType": "Code"
            },
            "role": {
              "id": "b9dc17b3-fea5-4b7d-a3af-15d0efe9ca3f",
              "code": "C54121",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Investigational Product",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "A combination product of 2 monoclonal antibodies (AZD8895 and AZD1061) for the treatment of COVID-19.",
            "productIds": [
              "c0a8b2b9-2e69-4169-91a9-8269176a0e30"
            ],
            "administrationIds": [
              "e99d5565-81b4-477e-a7a3-28b4214002d4",
              "5baea1e0-f49c-421c-b846-5e9233cd30dd"
            ]
          },
          {
            "id": "217a7bf0-2b24-4e1d-854c-610f9c06341a",
            "name": "Saline placebo",
            "type": {
              "id": "e4d8bb59-5125-4c84-8ffb-6c450d882ad8",
              "code": "C41132",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Placebo",
              "instanceType": "Code"
            },
            "role": {
              "id": "ee9fd1c6-1381-48ac-a995-325010e2a2fa",
              "code": "C41132",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Placebo",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "Visually distinct saline solution administered as 2 separate 3 mL IM injections.",
            "productIds": [
              "73ef6635-c3e6-430d-8641-06d5bc65c495"
            ],
            "administrationIds": [
              "1a091dd4-5504-42fd-b795-4a37ee3b5d51",
              "e76a8152-207e-4afe-84a0-8e95c9d9f307"
            ]
          },
          {
            "id": "5fce5b17-8b3e-41b6-be6c-4e94ac3b0f2b",
            "name": "Local standard of care",
            "type": {
              "id": "c969287f-cecf-41ea-bca9-16807a9c1a70",
              "code": "C54127",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Background Therapy",
              "instanceType": "Code"
            },
            "role": {
              "id": "977fe7a3-ee79-4334-a81f-14981e8dfba3",
              "code": "C54127",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Background Therapy",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "Background therapy according to participating institution/hospital regardless of randomization group.",
            "productIds": [
              "feb03509-e803-41d3-b5d7-66cab35c5195"
            ],
            "administrationIds": [
              "228e54d1-ad9b-4a77-a183-4099d44d8d1b"
            ]
          },
          {
            "id": "8ebdb97b-8f3c-4369-a098-449af3f66414",
            "name": "Influenza vaccines",
            "type": {
              "id": "ccd2843e-9f60-4c6f-a74f-2bd42a51aaa1",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "role": {
              "id": "6f78ade2-3480-4afc-a0e6-51d70b32054a",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "Licensed influenza vaccines are permitted at any time.",
            "administrationIds": [
              "e59051d4-b2e8-45b7-84b9-3cb39f364c4e"
            ]
          },
          {
            "id": "117d0ef8-f764-4105-bd62-594dc1b57880",
            "name": "Allergen immunotherapy",
            "type": {
              "id": "44e1f288-d6c9-46f4-9d98-9ec2cb917ad5",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "role": {
              "id": "32fc79eb-26e0-4db9-8199-79594bf4da9c",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "Allowed if participant has been receiving stable desensitization therapy for at least 30 days prior to Day 1."
          },
          {
            "id": "1c15dd94-688c-45c8-aafb-c6395ba79a3b",
            "name": "Commercial biologics/immunosuppressants",
            "type": {
              "id": "301efe6c-0441-4d0e-b4d1-76ad18b9485f",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "role": {
              "id": "b0827828-5f65-4320-bcbe-0f427595814d",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "Includes prednisone, azathioprine, tacrolimus, cyclosporine, methotrexate, hydroxychloroquine, or cytotoxic chemotherapy if stable on maintenance dose."
          },
          {
            "id": "be4e2bea-ddab-4628-bcf0-54820ee67e5a",
            "name": "SARS-CoV-2 vaccines",
            "type": {
              "id": "26106185-8c47-4216-94bc-30a9b0156d7b",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "role": {
              "id": "03f14460-6715-40b5-8477-e523e2f37f93",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "Prohibited prior to study entry; restricted during acute illness; requires unblinding and counseling if requested after recovery."
          },
          {
            "id": "6a276985-52c9-41c1-9c79-872a343231ec",
            "name": "Convalescent COVID-19 plasma",
            "type": {
              "id": "664c43f0-b680-4171-824b-772fab88c7fc",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "role": {
              "id": "5d5a4791-8997-4165-bc5f-93650928b299",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "Prohibited at any time prior to study entry."
          },
          {
            "id": "e2d67b9b-cf0a-40de-85a2-6b781f33c616",
            "name": "Systemic or inhaled steroids",
            "type": {
              "id": "750add91-555f-4654-92f5-9fe7feab9554",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "role": {
              "id": "6b925051-52c7-4455-b2bc-2363f93d00a4",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "Prohibited within 30 days prior to study entry unless a stable dose is used for a chronic condition."
          }
        ],
        "administrableProducts": [
          {
            "id": "c0a8b2b9-2e69-4169-91a9-8269176a0e30",
            "name": "AZD8895",
            "administrableDoseForm": {
              "id": "d9305e83-6251-4878-b762-c22deb658ef0",
              "code": "C42945",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Injection",
              "instanceType": "Code",
              "standardCode": {
                "id": "2d22ea5c-a26d-438f-bc65-57ee2e9f6f91",
                "code": "C42945",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Injection",
                "instanceType": "Code"
              }
            },
            "productDesignation": {
              "id": "e79816cf-86f8-4388-b6ff-2be05ac5acc5",
              "code": "C54121",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Investigational Product",
              "instanceType": "Code"
            },
            "instanceType": "AdministrableProduct",
            "strength": "100 mg/mL",
            "substanceIds": [
              "da3b4c53-97ca-4a5f-af14-f3786c850a4f"
            ],
            "manufacturer": "AstraZeneca"
          },
          {
            "id": "73ef6635-c3e6-430d-8641-06d5bc65c495",
            "name": "AZD1061",
            "administrableDoseForm": {
              "id": "a81f91c1-032d-483d-8461-73d2bb507370",
              "code": "C42945",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Injection",
              "instanceType": "Code",
              "standardCode": {
                "id": "7c5cc85c-4910-4f10-9550-4e908e247999",
                "code": "C42945",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Injection",
                "instanceType": "Code"
              }
            },
            "productDesignation": {
              "id": "7d931c47-6697-4490-b538-ad2c196e9b66",
              "code": "C54121",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Investigational Product",
              "instanceType": "Code"
            },
            "instanceType": "AdministrableProduct",
            "strength": "100 mg/mL",
            "substanceIds": [
              "51d9b4ba-8ef7-4e28-8d31-ce32f93a6d4e"
            ],
            "manufacturer": "AstraZeneca"
          },
          {
            "id": "feb03509-e803-41d3-b5d7-66cab35c5195",
            "name": "Saline placebo",
            "administrableDoseForm": {
              "id": "203bf99f-932c-4d6a-ace1-a27a6c05fbaf",
              "code": "C42945",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Injection",
              "instanceType": "Code",
              "standardCode": {
                "id": "68b78633-25cd-49dd-84d2-4c37f4f9245e",
                "code": "C42945",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Injection",
                "instanceType": "Code"
              }
            },
            "productDesignation": {
              "id": "efdae1ed-5ba3-4cd8-98bf-dd7cbf729304",
              "code": "C54121",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Investigational Product",
              "instanceType": "Code"
            },
            "instanceType": "AdministrableProduct",
            "strength": "0.9% w/v",
            "manufacturer": "AstraZeneca"
          }
        ],
        "narrativeContents": [
          {
            "id": "de052169-e842-40fc-8bac-e4b38ebc5eb2",
            "name": "PROTOCOL SUMMARY",
            "text": "PROTOCOL SUMMARY",
            "order": 0,
            "instanceType": "NarrativeContent",
            "sectionNumber": "1",
            "sectionTitle": "PROTOCOL SUMMARY",
            "sectionType": {
              "id": "b57b7cad-4ded-43a2-baf1-3fefad663389",
              "code": "Synopsis",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Synopsis",
              "instanceType": "Code"
            },
            "childIds": [
              "878b5484-7f54-4f42-a12c-0030ab548aad",
              "98c45474-21aa-4d4e-b646-fedaf7368ba7",
              "2423b896-f4ab-4be6-8dca-4a7a385983be"
            ]
          },
          {
            "id": "3c158b85-d453-48ff-8609-52ef8faa7c18",
            "name": "INTRODUCTION",
            "text": "INTRODUCTION",
            "order": 1,
            "instanceType": "NarrativeContent",
            "sectionNumber": "2",
            "sectionTitle": "INTRODUCTION",
            "sectionType": {
              "id": "5aa86209-e36d-4c4f-8999-d5888de7946f",
              "code": "Introduction",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Introduction",
              "instanceType": "Code"
            },
            "childIds": [
              "32a96167-3e5c-46aa-b39a-04d0c01cc2da",
              "a85d8ce2-35c2-4559-af4e-7a70a3f6b0a0",
              "c6272db9-14df-4c05-83ac-34d38dd5a0b8"
            ]
          },
          {
            "id": "efeeecf3-8b90-4060-afe1-077276a0ebef",
            "name": "OBJECTIVES AND ENDPOINTS",
            "text": "OBJECTIVES AND ENDPOINTS",
            "order": 2,
            "instanceType": "NarrativeContent",
            "sectionNumber": "3",
            "sectionTitle": "OBJECTIVES AND ENDPOINTS",
            "sectionType": {
              "id": "d4cc870e-5612-4c6c-8bae-c47ac178ce35",
              "code": "Objectives",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Objectives",
              "instanceType": "Code"
            }
          },
          {
            "id": "d6dbc4f3-25f0-4abb-b3bf-2dbd4d9184e7",
            "name": "STUDY DESIGN",
            "text": "STUDY DESIGN",
            "order": 3,
            "instanceType": "NarrativeContent",
            "sectionNumber": "4",
            "sectionTitle": "STUDY DESIGN",
            "sectionType": {
              "id": "e89ef5bd-5d24-4ddb-90cb-f1a8e585f2d6",
              "code": "Study Design",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Study Design",
              "instanceType": "Code"
            },
            "childIds": [
              "fca6d4ba-c67d-42ec-b5b9-cf4d153ec7f7",
              "247ec1b6-3707-41c5-9939-15cf70123523"
            ]
          },
          {
            "id": "be1bb1da-032e-4798-a02e-09a0e1276181",
            "name": "STUDY POPULATION",
            "text": "STUDY POPULATION",
            "order": 4,
            "instanceType": "NarrativeContent",
            "sectionNumber": "5",
            "sectionTitle": "STUDY POPULATION",
            "sectionType": {
              "id": "55e4cc06-7e03-48a6-aca3-cf74687c653b",
              "code": "Study Population",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Study Population",
              "instanceType": "Code"
            },
            "childIds": [
              "cb25584a-247f-40e3-871c-a421a10c3867",
              "2418f44e-92b3-48e2-b36a-2760aa7c464a",
              "1858f54b-6bf9-427e-bc65-6ba24a123713",
              "be4be002-3da6-4187-8a53-5cc977f3c4da"
            ]
          },
          {
            "id": "a2b59804-fe1e-4afe-ba9d-1f2df9e079a9",
            "name": "STUDY INTERVENTION",
            "text": "STUDY INTERVENTION",
            "order": 5,
            "instanceType": "NarrativeContent",
            "sectionNumber": "6",
            "sectionTitle": "STUDY INTERVENTION",
            "sectionType": {
              "id": "07897dd8-95a4-4edf-aa74-6a41a6987f28",
              "code": "Treatment",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Treatment",
              "instanceType": "Code"
            },
            "childIds": [
              "d6586411-ff60-4288-9e00-8698a5c1911e",
              "0ff453f0-2aed-43bc-bd0c-6ed925cb8d13",
              "d78a5de6-ea56-406a-8d8c-7e5a279f48d8",
              "b9252ac7-5b05-4cfb-88a8-8cb4bfa395e2",
              "8a2b775d-0906-45de-9bf5-4c97e55cb501"
            ]
          },
          {
            "id": "c24c67ac-20dc-45c3-a1eb-ebfd5ef45bdd",
            "name": "STUDY ASSESSMENTS AND PROCEDURES",
            "text": "STUDY ASSESSMENTS AND PROCEDURES",
            "order": 6,
            "instanceType": "NarrativeContent",
            "sectionNumber": "8",
            "sectionTitle": "STUDY ASSESSMENTS AND PROCEDURES",
            "sectionType": {
              "id": "58fab9ca-46d4-4367-a033-80d524715006",
              "code": "Assessments",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Assessments",
              "instanceType": "Code"
            },
            "childIds": [
              "3ca19b36-953e-4308-8c4b-2d67c99a68c9",
              "f368197e-354f-4d44-bccc-a045a3cb4191",
              "1fd396a4-20d6-4d9b-b373-15e229cf6eeb",
              "2bce9548-3923-4340-a0ac-c52b2b28d036"
            ]
          },
          {
            "id": "ece03924-f100-46f5-96ac-a75b3d8e8f28",
            "name": "STATISTICAL CONSIDERATIONS",
            "text": "STATISTICAL CONSIDERATIONS",
            "order": 7,
            "instanceType": "NarrativeContent",
            "sectionNumber": "9",
            "sectionTitle": "STATISTICAL CONSIDERATIONS",
            "sectionType": {
              "id": "4f2cafc6-23f5-496a-b519-bf03c3d07f6d",
              "code": "Statistics",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Statistics",
              "instanceType": "Code"
            },
            "childIds": [
              "0b447158-a8da-47df-a781-ff02303a98cc",
              "92f25cd6-e010-48e3-bc20-309dd938e7f2",
              "63042388-8bf4-487b-85ba-d9d2cb92ea84",
              "771126be-4543-4369-b777-76aa151bbc3c"
            ]
          },
          {
            "id": "74d46e09-ed37-454b-8d9e-fb836aedfc46",
            "name": "Regulatory, Ethical, and Study Oversight Considerations",
            "text": "Regulatory, Ethical, and Study Oversight Considerations",
            "order": 8,
            "instanceType": "NarrativeContent",
            "sectionNumber": "Appendix A",
            "sectionTitle": "Regulatory, Ethical, and Study Oversight Considerations",
            "sectionType": {
              "id": "7c6b6dd4-062f-4a90-afb2-bba84aec446d",
              "code": "Ethics",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Ethics",
              "instanceType": "Code"
            }
          },
          {
            "id": "55760f6b-eee0-4f74-bf3e-278b34518163",
            "name": "Adverse Events: Definitions and Procedures",
            "text": "Adverse Events: Definitions and Procedures",
            "order": 9,
            "instanceType": "NarrativeContent",
            "sectionNumber": "Appendix B",
            "sectionTitle": "Adverse Events: Definitions and Procedures",
            "sectionType": {
              "id": "98cdf4e5-62b4-4fce-b337-0bd112df258e",
              "code": "Safety",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Safety",
              "instanceType": "Code"
            }
          },
          {
            "id": "d1939a1d-4c37-44cc-a7d6-fa3ebe7a2673",
            "name": "Abbreviations",
            "text": "Abbreviations",
            "order": 10,
            "instanceType": "NarrativeContent",
            "sectionNumber": "Appendix E",
            "sectionTitle": "Abbreviations",
            "sectionType": {
              "id": "0c70ae99-a2da-4f70-b39d-b9fc50912491",
              "code": "Other",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Other",
              "instanceType": "Code"
            }
          },
          {
            "id": "0afe71aa-66cd-467f-858c-401a528bb81b",
            "name": "Amendment History",
            "text": "Amendment History",
            "order": 11,
            "instanceType": "NarrativeContent",
            "sectionNumber": "Appendix I",
            "sectionTitle": "Amendment History",
            "sectionType": {
              "id": "87985a13-35bf-433c-84e1-9200cf9b3ed9",
              "code": "Other",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Other",
              "instanceType": "Code"
            }
          }
        ],
        "narrativeContentItems": [
          {
            "id": "878b5484-7f54-4f42-a12c-0030ab548aad",
            "name": "Synopsis",
            "text": "",
            "order": 0,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "1.1",
            "sectionTitle": "Synopsis"
          },
          {
            "id": "98c45474-21aa-4d4e-b646-fedaf7368ba7",
            "name": "Schema",
            "text": "",
            "order": 1,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "1.2",
            "sectionTitle": "Schema"
          },
          {
            "id": "2423b896-f4ab-4be6-8dca-4a7a385983be",
            "name": "Schedule of Activities",
            "text": "",
            "order": 2,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "1.3",
            "sectionTitle": "Schedule of Activities"
          },
          {
            "id": "32a96167-3e5c-46aa-b39a-04d0c01cc2da",
            "name": "Study Rationale",
            "text": "",
            "order": 0,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "2.1",
            "sectionTitle": "Study Rationale"
          },
          {
            "id": "a85d8ce2-35c2-4559-af4e-7a70a3f6b0a0",
            "name": "Background",
            "text": "",
            "order": 1,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "2.2",
            "sectionTitle": "Background"
          },
          {
            "id": "c6272db9-14df-4c05-83ac-34d38dd5a0b8",
            "name": "Benefit/Risk Assessment",
            "text": "",
            "order": 2,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "2.3",
            "sectionTitle": "Benefit/Risk Assessment"
          },
          {
            "id": "fca6d4ba-c67d-42ec-b5b9-cf4d153ec7f7",
            "name": "Overall Design",
            "text": "",
            "order": 0,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "4.1",
            "sectionTitle": "Overall Design"
          },
          {
            "id": "247ec1b6-3707-41c5-9939-15cf70123523",
            "name": "End of Study Definition",
            "text": "",
            "order": 1,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "4.4",
            "sectionTitle": "End of Study Definition"
          },
          {
            "id": "cb25584a-247f-40e3-871c-a421a10c3867",
            "name": "Inclusion Criteria",
            "text": "",
            "order": 0,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "5.1",
            "sectionTitle": "Inclusion Criteria"
          },
          {
            "id": "2418f44e-92b3-48e2-b36a-2760aa7c464a",
            "name": "Exclusion Criteria",
            "text": "",
            "order": 1,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "5.2",
            "sectionTitle": "Exclusion Criteria"
          },
          {
            "id": "1858f54b-6bf9-427e-bc65-6ba24a123713",
            "name": "Lifestyle Considerations",
            "text": "",
            "order": 2,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "5.3",
            "sectionTitle": "Lifestyle Considerations"
          },
          {
            "id": "be4be002-3da6-4187-8a53-5cc977f3c4da",
            "name": "Screen Failures",
            "text": "",
            "order": 3,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "5.4",
            "sectionTitle": "Screen Failures"
          },
          {
            "id": "d6586411-ff60-4288-9e00-8698a5c1911e",
            "name": "Investigational Medicinal Products Administered",
            "text": "",
            "order": 0,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "6.1",
            "sectionTitle": "Investigational Medicinal Products Administered"
          },
          {
            "id": "0ff453f0-2aed-43bc-bd0c-6ed925cb8d13",
            "name": "Preparation/Handling/Storage/Accountability",
            "text": "",
            "order": 1,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "6.2",
            "sectionTitle": "Preparation/Handling/Storage/Accountability"
          },
          {
            "id": "d78a5de6-ea56-406a-8d8c-7e5a279f48d8",
            "name": "Measures to Minimize Bias: Randomization and Blinding",
            "text": "",
            "order": 2,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "6.3",
            "sectionTitle": "Measures to Minimize Bias: Randomization and Blinding"
          },
          {
            "id": "b9252ac7-5b05-4cfb-88a8-8cb4bfa395e2",
            "name": "Investigational Medicinal Product Compliance",
            "text": "",
            "order": 3,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "6.4",
            "sectionTitle": "Investigational Medicinal Product Compliance"
          },
          {
            "id": "8a2b775d-0906-45de-9bf5-4c97e55cb501",
            "name": "Concomitant Therapy",
            "text": "",
            "order": 4,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "6.5",
            "sectionTitle": "Concomitant Therapy"
          },
          {
            "id": "3ca19b36-953e-4308-8c4b-2d67c99a68c9",
            "name": "Efficacy Assessments",
            "text": "",
            "order": 0,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "8.1",
            "sectionTitle": "Efficacy Assessments"
          },
          {
            "id": "f368197e-354f-4d44-bccc-a045a3cb4191",
            "name": "Safety Assessments",
            "text": "",
            "order": 1,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "8.2",
            "sectionTitle": "Safety Assessments"
          },
          {
            "id": "1fd396a4-20d6-4d9b-b373-15e229cf6eeb",
            "name": "Adverse Events and Serious Adverse Events",
            "text": "",
            "order": 2,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "8.3",
            "sectionTitle": "Adverse Events and Serious Adverse Events"
          },
          {
            "id": "2bce9548-3923-4340-a0ac-c52b2b28d036",
            "name": "Pharmacokinetics and Other Biomarkers",
            "text": "",
            "order": 3,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "8.5",
            "sectionTitle": "Pharmacokinetics and Other Biomarkers"
          },
          {
            "id": "0b447158-a8da-47df-a781-ff02303a98cc",
            "name": "Statistical Hypotheses",
            "text": "",
            "order": 0,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "9.1",
            "sectionTitle": "Statistical Hypotheses"
          },
          {
            "id": "92f25cd6-e010-48e3-bc20-309dd938e7f2",
            "name": "Sample Size Determination",
            "text": "",
            "order": 1,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "9.2",
            "sectionTitle": "Sample Size Determination"
          },
          {
            "id": "63042388-8bf4-487b-85ba-d9d2cb92ea84",
            "name": "Populations for Analysis",
            "text": "",
            "order": 2,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "9.3",
            "sectionTitle": "Populations for Analysis"
          },
          {
            "id": "771126be-4543-4369-b777-76aa151bbc3c",
            "name": "Statistical Analyses",
            "text": "",
            "order": 3,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "9.4",
            "sectionTitle": "Statistical Analyses"
          }
        ],
        "abbreviations": [
          {
            "id": "4d7f0c79-d9a0-46ed-aa7f-33293422fb89",
            "abbreviatedText": "IMP",
            "expandedText": "investigational medicinal product",
            "instanceType": "Abbreviation"
          },
          {
            "id": "a518298a-12c1-4f37-9683-02f4ae14726c",
            "abbreviatedText": "CMH",
            "expandedText": "Cochran-Mantel-Haenszel",
            "instanceType": "Abbreviation"
          },
          {
            "id": "16ed2b04-32cb-4f23-92e7-c168648ec3cd",
            "abbreviatedText": "SoA",
            "expandedText": "Schedule of Activities",
            "instanceType": "Abbreviation"
          },
          {
            "id": "694a556a-ad10-42ad-8413-6093c5d2cc02",
            "abbreviatedText": "CSP",
            "expandedText": "Clinical Study Protocol",
            "instanceType": "Abbreviation"
          },
          {
            "id": "fee2e3d1-6a69-48d6-b74b-62f62f64a594",
            "abbreviatedText": "SID",
            "expandedText": "Subject Identification",
            "instanceType": "Abbreviation"
          },
          {
            "id": "9800f9a4-5f83-48ab-abaf-3d23d93eac10",
            "abbreviatedText": "SARS-CoV-2",
            "expandedText": "Severe Acute Respiratory Syndrome Coronavirus 2",
            "instanceType": "Abbreviation"
          },
          {
            "id": "361903cb-52fe-41cc-b3a2-8caa9a27fdd1",
            "abbreviatedText": "COVID-19",
            "expandedText": "Coronavirus Disease 2019",
            "instanceType": "Abbreviation"
          },
          {
            "id": "4121a86e-de15-4c2c-86e4-f40a823bf208",
            "abbreviatedText": "ECG",
            "expandedText": "Electrocardiogram",
            "instanceType": "Abbreviation"
          },
          {
            "id": "e8a54571-8317-4dfa-b693-fb3cd5a14a77",
            "abbreviatedText": "RT-PCR",
            "expandedText": "Reverse Transcription Polymerase Chain Reaction",
            "instanceType": "Abbreviation"
          },
          {
            "id": "0712ff82-3a57-4e0e-856b-40d3e3a944d8",
            "abbreviatedText": "AE",
            "expandedText": "Adverse Event",
            "instanceType": "Abbreviation"
          },
          {
            "id": "eb7e8574-c9a9-4949-aa89-60e63d39461d",
            "abbreviatedText": "SAE",
            "expandedText": "Serious Adverse Event",
            "instanceType": "Abbreviation"
          },
          {
            "id": "224eb95d-d311-4448-b839-5e4ca68b7b50",
            "abbreviatedText": "AESI",
            "expandedText": "Adverse Event of Special Interest",
            "instanceType": "Abbreviation"
          },
          {
            "id": "3e959774-3d1d-4c05-bcd7-5224b5dd7ff7",
            "abbreviatedText": "HCP",
            "expandedText": "Healthcare Professional",
            "instanceType": "Abbreviation"
          },
          {
            "id": "a7369957-1cfb-47fd-ac39-150702d160a5",
            "abbreviatedText": "NA",
            "expandedText": "Not Applicable",
            "instanceType": "Abbreviation"
          },
          {
            "id": "1f5a4a07-8268-45f9-885c-da24d67c8141",
            "abbreviatedText": "P",
            "expandedText": "In-Person Visit",
            "instanceType": "Abbreviation"
          },
          {
            "id": "cf49b68f-6ba7-48ef-888a-f35a28aa6c94",
            "abbreviatedText": "H",
            "expandedText": "Home Visit",
            "instanceType": "Abbreviation"
          },
          {
            "id": "2e3c6b15-7719-48b7-a2a7-b4f979d511b1",
            "abbreviatedText": "R",
            "expandedText": "Remote Visit",
            "instanceType": "Abbreviation"
          }
        ],
        "amendments": [
          {
            "id": "6ccdc0f8-a28d-479e-9897-b00c6d23062c",
            "number": "6",
            "name": "Amendment 6",
            "scope": {
              "id": "2cd6ff3e-9b77-45ef-9d43-fa84f12a997a",
              "code": "Global",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Global",
              "instanceType": "Code"
            },
            "primaryReason": {
              "id": "38fcd504-5fc3-4c2b-bbb7-e65bbf39686e",
              "code": {
                "id": "d2b57236-e911-46d3-953d-ef3a9dabf16c",
                "code": "C98782",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Protocol Amendment",
                "instanceType": "Code"
              },
              "otherReason": "Protocol Amendment",
              "instanceType": "StudyAmendmentReason"
            },
            "geographicScopes": [
              {
                "id": "23246387-796f-468e-b595-00e06854d976",
                "type": {
                  "id": "dba21708-fc8e-452c-b7a2-5ff030883de8",
                  "code": "Global",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Global",
                  "instanceType": "Code"
                },
                "instanceType": "GeographicScope"
              }
            ],
            "instanceType": "StudyAmendment",
            "summary": "The number of primary endpoint events required for the primary analysis has been reduced from 52 to 43 to provide 90% power. Enrollment will stop when approximately 43 primary events have been confirmed. Analysis populations were redefined to accommodate clarification of the primary endpoint population and inclusion of additional supportive estimands. The primary analysis method was changed from a Poisson regression model to the CMH method.",
            "effectiveDate": "2021-06-30",
            "reasonIds": [
              "33ffd749-9938-4a46-b703-29794a09f6b6",
              "5385aaf1-7ea7-4380-b283-8dc812ee023e",
              "b6881be3-197c-49d4-80ac-4ba6f7b225ad"
            ],
            "previousVersion": "6.0",
            "newVersion": "7.0"
          }
        ],
        "medicalDevices": [
          {
            "id": "e36e906e-7159-47b1-a77d-4aa2066d37ea",
            "name": "Electronic device",
            "instanceType": "MedicalDevice",
            "label": "eDiary Device",
            "description": "Device used by participants to report COVID-19-related symptoms daily",
            "deviceType": {
              "id": "e83d5d27-f328-4cab-963d-a87410e50a79",
              "code": "Wearable Device",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Wearable Device",
              "instanceType": "Code"
            }
          },
          {
            "id": "1e86ffff-0aa5-456a-99c1-8626e30bf8f7",
            "name": "Emergency kit",
            "instanceType": "MedicalDevice",
            "label": "Anaphylaxis Kit",
            "description": "Kits for treatment of severe anaphylactic reactions/shock",
            "deviceType": {
              "id": "0a0c3dfc-7fc6-4b8c-8930-c321765af51f",
              "code": "Drug Delivery Device",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Drug Delivery Device",
              "instanceType": "Code"
            }
          },
          {
            "id": "0e2dbf5e-6e9a-4fb5-85a8-39d505fb4a4a",
            "name": "12-lead ECG machine",
            "instanceType": "MedicalDevice",
            "label": "ECG Device",
            "description": "Equipment used to perform electrocardiograms",
            "deviceType": {
              "id": "0ae81e01-533b-4486-a03d-6dbdc12b06f5",
              "code": "Diagnostic Device",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Diagnostic Device",
              "instanceType": "Code"
            }
          },
          {
            "id": "5fc478ae-dac0-4da4-ad85-d84010e9c423",
            "name": "Pulse Oximeter",
            "instanceType": "MedicalDevice",
            "label": "SpO2 Monitor",
            "description": "Device used to measure SpO2 levels",
            "deviceType": {
              "id": "a22d972f-5678-4882-b1a2-f0780fa867a7",
              "code": "Monitoring Device",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Monitoring Device",
              "instanceType": "Code"
            }
          },
          {
            "id": "44c20d87-844a-4bde-adb0-4835dd99a7da",
            "name": "Mechanical ventilator",
            "instanceType": "MedicalDevice",
            "label": "Ventilator",
            "description": "Device for respiratory support (exclusion criteria if required)"
          }
        ],
        "conditions": [
          {
            "id": "2602bee3-9892-40a1-9c1c-8c4d66043131",
            "name": "Vaccination Unblinding Criteria",
            "instanceType": "Condition",
            "description": "Criteria for unblinding to receive SARS-CoV-2 vaccine",
            "text": "Participant wishes to be vaccinated after recovery from COVID-19"
          },
          {
            "id": "25027680-4fcb-445e-8129-c4db25146522",
            "name": "Safety Suspension - Hypersensitivity",
            "instanceType": "Condition",
            "description": "Criteria for study suspension based on hypersensitivity",
            "text": "One or more participants experience a grade 4 hypersensitivity reaction or SAE"
          },
          {
            "id": "af74988e-a004-4df7-8ebc-96eafd97b09e",
            "name": "Safety Suspension - Injection Site",
            "instanceType": "Condition",
            "description": "Criteria for study suspension based on injection site reactions",
            "text": "2 or more participants within the first 100 experience a grade 3 or higher injection site reaction"
          }
        ],
        "studySites": [
          {
            "id": "666d41e1-90ba-485b-9b41-dc457fb8ec34",
            "name": "Research Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "1",
            "organizationId": "882219a6-76cb-4394-8b66-7635009792f5",
            "country": "United States"
          },
          {
            "id": "8353cfef-39fe-46f6-ab19-c22ab0cf639e",
            "name": "Research Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "2",
            "organizationId": "ace7b8ac-e4bf-4902-bae4-29ec19b24ff5",
            "country": "United States"
          },
          {
            "id": "cf63d354-af58-4e92-94b4-0951fb0fa225",
            "name": "Research Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "3",
            "organizationId": "8f0e11b5-33b5-47d4-b80e-32d5d404b46e",
            "country": "United States"
          },
          {
            "id": "85c3459b-4b77-4125-a605-6a4a792267b9",
            "name": "Research Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "4",
            "organizationId": "5ee33def-e8a6-4ec7-8814-5502410e1a6d",
            "country": "United States"
          },
          {
            "id": "d227be58-8388-436b-9836-b21afa19b8cb",
            "name": "Research Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "5",
            "organizationId": "0bd4a3ae-176b-4815-ade3-b1cb099e0db7",
            "country": "United States"
          },
          {
            "id": "593f3aeb-b981-4a7e-874b-bea5f09d0246",
            "name": "Research Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "6",
            "organizationId": "64a01b64-a783-43a8-9481-991ee11bac3a",
            "country": "United States"
          },
          {
            "id": "962dc24f-717d-4a2a-923f-5d889d80de4f",
            "name": "Research Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "7",
            "organizationId": "d4150868-7e4e-4f72-bd8a-18d30e85a978",
            "country": "United States"
          },
          {
            "id": "063779fb-0e4e-4537-82be-eac4d4707798",
            "name": "Research Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "8",
            "organizationId": "4919f7ae-9fe2-4519-af63-7c6e77ecee38",
            "country": "United States"
          },
          {
            "id": "9a7d0bd8-52f8-4c1c-87f0-43188b010d38",
            "name": "Research Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "9",
            "organizationId": "32e85079-b835-4a7b-9a55-faaef2099e8f",
            "country": "United States"
          },
          {
            "id": "f54e2394-cb45-452a-809d-8dfa8c9ef6cb",
            "name": "Research Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "10",
            "organizationId": "94454203-1cf4-4548-9b8c-d99daa5822d2",
            "country": "United States"
          },
          {
            "id": "59caca21-991e-46e9-bdee-875ab7cfef7d",
            "name": "Research Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "11",
            "organizationId": "f51e992a-37a7-4042-b61e-3f40a8f0c15d",
            "country": "United States"
          },
          {
            "id": "9d63a509-dc1a-42fc-ac88-64c80a210384",
            "name": "Research Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "12",
            "organizationId": "f3ae763d-0505-4cc1-b84f-ce9153b5c5d8",
            "country": "United States"
          },
          {
            "id": "bb84d44d-7374-4578-9f1b-397c2be18df3",
            "name": "Research Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "13",
            "organizationId": "119569f4-cb19-4c14-9389-9b8f789611bc",
            "country": "United States"
          },
          {
            "id": "4455f4b4-db05-4601-a79c-67df448f4fdd",
            "name": "Research Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "14",
            "organizationId": "f717e6ed-5c37-4ce6-a771-2656c9934cb5",
            "country": "United States"
          },
          {
            "id": "27d0479a-a1fa-4fe5-8068-ec9ea9add635",
            "name": "Research Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "15",
            "organizationId": "7ec62e6f-31f3-4f65-ab02-4a8746875584",
            "country": "United States"
          },
          {
            "id": "75ab49e2-3d58-4308-9664-b3a5689992c3",
            "name": "Research Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "16",
            "organizationId": "96fd5547-2c94-4fe3-a9c2-18faed247e96",
            "country": "United States"
          },
          {
            "id": "863e7e35-8374-4d9e-877d-3d8efdaaf828",
            "name": "Research Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "17",
            "organizationId": "4ed03cb9-1700-444f-afe1-4b45c191f917",
            "country": "United States"
          },
          {
            "id": "b9203073-5590-4a67-8242-708b9ba4ef01",
            "name": "Research Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "18",
            "organizationId": "1bb20026-0a7a-44af-a24f-ba7a875fdc2c",
            "country": "United States"
          },
          {
            "id": "0d0ebf6e-8350-49a8-9c0f-8dbd42362d05",
            "name": "Research Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "19",
            "organizationId": "8b39f0b0-b828-48d3-854e-5bd16caa336b",
            "country": "United States"
          },
          {
            "id": "43f946d6-1d35-40d1-8222-8b6e706880d0",
            "name": "Research Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "20",
            "organizationId": "e2847672-593a-4818-9bb8-0fb0bac74886",
            "country": "United States"
          },
          {
            "id": "3a27f304-60b8-4b75-aaf1-d1b57dc50291",
            "name": "Research Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "21",
            "organizationId": "508b4abb-80a0-42c2-a434-e5bcc41a3703",
            "country": "United States"
          },
          {
            "id": "e8e2d27c-4a92-4d8a-b6ad-93431931940c",
            "name": "Research Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "22",
            "organizationId": "b1e803e5-2022-446e-a8ae-03129674ab10",
            "country": "United States"
          },
          {
            "id": "52f3f9e2-d99d-48dc-b759-e5cdfddc71f0",
            "name": "Research Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "23",
            "organizationId": "6be544ce-71aa-4dfd-8797-3f4a6f5b472e",
            "country": "United States"
          },
          {
            "id": "579e4bd1-f4c7-4d93-9290-7c2a913a8eb5",
            "name": "Research Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "24",
            "organizationId": "5c285a84-51ce-4b34-a97e-9fba50627bb5",
            "country": "United States"
          },
          {
            "id": "65efd3b7-0f9f-48da-85a3-b87561b6b129",
            "name": "Research Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "25",
            "organizationId": "ff0b34b9-7782-44ef-b703-669871a21075",
            "country": "Argentina"
          },
          {
            "id": "1be19f78-be13-4642-a129-f798d186a19a",
            "name": "Research Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "26",
            "organizationId": "bec3484e-6258-4262-9804-a244c48c7f88",
            "country": "Argentina"
          },
          {
            "id": "fe655935-5db0-46fb-95c5-8ff6248bf032",
            "name": "Research Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "27",
            "organizationId": "d6f1b729-b8d7-4c32-98fc-b92710927dd5",
            "country": "Argentina"
          },
          {
            "id": "3335b5ed-3843-4bd7-b81f-e7c85e5eff69",
            "name": "Research Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "28",
            "organizationId": "27732123-4fd2-4f83-8dd5-05a47132c215",
            "country": "Argentina"
          },
          {
            "id": "c33c6397-f1b3-4394-9503-698bb2c7ba0c",
            "name": "Research Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "29",
            "organizationId": "c9edb5f9-22c6-4c8c-a556-2e60b9a52985",
            "country": "Brazil"
          },
          {
            "id": "4db8c5e6-9bbf-43d8-ace0-53396ebacb92",
            "name": "Research Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "30",
            "organizationId": "a5762fa9-c79b-49a3-9c00-bea2066c14cd",
            "country": "Brazil"
          },
          {
            "id": "54382129-ba90-403f-b24a-2c4d17c12391",
            "name": "Research Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "31",
            "organizationId": "f4bc5504-23d8-43d3-9a89-df5354ada5c4",
            "country": "Brazil"
          },
          {
            "id": "923ae33e-5f99-4f1a-8cd8-c305570197fe",
            "name": "Research Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "32",
            "organizationId": "4c8bfea3-5744-4879-b8df-c8653abb558b",
            "country": "Brazil"
          },
          {
            "id": "00ee13d2-eac1-4768-b6cd-0516f9490cdc",
            "name": "Research Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "33",
            "organizationId": "eff4c94c-e61b-4346-bb62-c52401098c31",
            "country": "Brazil"
          },
          {
            "id": "43559c0a-2bf6-42f0-bea6-e1244e41768d",
            "name": "Research Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "34",
            "organizationId": "3ba68494-52fd-4c6f-ac87-a1383683fa3d",
            "country": "Czechia"
          },
          {
            "id": "20b4641c-8420-4fa1-96a1-f8e3493ed768",
            "name": "Research Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "35",
            "organizationId": "8818736a-80b4-4b44-a76c-724b7e87d679",
            "country": "Czechia"
          },
          {
            "id": "b59d7764-77fb-4f06-b17c-f4451a3ff135",
            "name": "Research Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "36",
            "organizationId": "26882c63-104f-439a-8bce-218edc8a0936",
            "country": "Czechia"
          },
          {
            "id": "17e93790-9ce2-4d28-9984-d9fcbd099b20",
            "name": "Research Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "37",
            "organizationId": "da76271c-973a-4936-bab6-9f8368404d61",
            "country": "Germany"
          },
          {
            "id": "85b99ee9-18c3-4e96-bdb0-a6e6f401fdfc",
            "name": "Research Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "38",
            "organizationId": "4479a614-2de7-4fb8-9bad-ab5018ded920",
            "country": "Germany"
          },
          {
            "id": "5daafe30-bab4-434e-ba6a-4d23eb8f5bab",
            "name": "Research Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "39",
            "organizationId": "8e9abe65-8714-4cec-86e2-5ac2aa67d285",
            "country": "Germany"
          },
          {
            "id": "c9f3ea29-285f-4563-a87b-59955338f59e",
            "name": "Research Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "40",
            "organizationId": "25849749-fe0a-4c3d-a37c-4356033d72a5",
            "country": "Germany"
          },
          {
            "id": "c7201df8-3fa8-481a-99d6-717a4094640f",
            "name": "Research Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "41",
            "organizationId": "f4ddc439-28ae-4a82-bcca-782547f0c722",
            "country": "Germany"
          },
          {
            "id": "f19e95c1-12b2-4986-ad1d-c5548b0ae56d",
            "name": "Research Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "42",
            "organizationId": "cab58cb7-75d6-41e4-ae67-bc2c7c95fb83",
            "country": "Germany"
          },
          {
            "id": "ed37bb03-2c31-4455-b791-38ce817c362d",
            "name": "Research Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "43",
            "organizationId": "959aa95a-fac9-4c21-9ef3-48e6979494b6",
            "country": "Germany"
          },
          {
            "id": "73436fcc-d9a3-4f45-b866-f50b15609604",
            "name": "Research Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "44",
            "organizationId": "295c4a77-5d40-42d3-a928-c54381953bf4",
            "country": "Germany"
          },
          {
            "id": "4fb67046-2aae-4d2f-8ee5-34c85d99625f",
            "name": "Research Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "45",
            "organizationId": "0610d92e-5423-491c-9ca2-3cb556a7362c",
            "country": "Germany"
          },
          {
            "id": "72569dd0-bf2d-4f04-8b1c-b1be540841c4",
            "name": "Research Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "46",
            "organizationId": "eab62be3-5db0-4dfd-acaf-e214de6ebdaf",
            "country": "Germany"
          },
          {
            "id": "9395f840-d8fb-4eea-bf55-ae58bc5a6453",
            "name": "Research Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "47",
            "organizationId": "1b12397e-2466-45ee-a0ec-654403c30696",
            "country": "Germany"
          },
          {
            "id": "960de2a7-ad01-4361-82f4-970feccaea43",
            "name": "Research Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "48",
            "organizationId": "29d81e58-5565-4105-8dfb-c49839c06767",
            "country": "Germany"
          },
          {
            "id": "0307ee69-d77d-4b8d-885c-0d2901e5a3ac",
            "name": "Research Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "49",
            "organizationId": "cf9e386b-bc96-4536-b67e-bcd13cee993b",
            "country": "United Kingdom"
          },
          {
            "id": "3d08645d-886c-477d-8888-48517936eb4e",
            "name": "Research Site",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "50",
            "organizationId": "f6d7369e-5ace-475c-aaca-457e9a3dbe67",
            "country": "United Kingdom"
          }
        ],
        "administrations": [
          {
            "id": "5baea1e0-f49c-421c-b846-5e9233cd30dd",
            "name": "Administration of AZD7442",
            "description": "RouteOfAdministration.INTRAMUSCULAR DosingFrequency.SINGLE_DOSE",
            "instanceType": "Administration",
            "route": {
              "id": "e0c7f5cb-88f1-4f3d-9c0e-3162bdec62e6",
              "code": "C38288",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "2024-09-27",
              "decode": "IM",
              "instanceType": "Code"
            }
          },
          {
            "id": "e76a8152-207e-4afe-84a0-8e95c9d9f307",
            "name": "Administration of Placebo",
            "description": "RouteOfAdministration.INTRAMUSCULAR DosingFrequency.SINGLE_DOSE",
            "instanceType": "Administration",
            "route": {
              "id": "9ecfd9dd-72e5-452c-9e89-793fadb7508d",
              "code": "C38288",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "2024-09-27",
              "decode": "IM",
              "instanceType": "Code"
            }
          }
        ],
        "rationale": "Protocol version"
      }
    ],
    "name": "A Phase III Randomized, Double-blind, Placebo-controlled, Multicenter Study to Determine the Safety and Efficacy of AZD7442 for the Treatment of COVID-19 in Non-hospitalized Adults"
  },
  "administrations": [
    {
      "id": "e99d5565-81b4-477e-a7a3-28b4214002d4",
      "name": "AZD7442 600 mg IM",
      "instanceType": "Administration",
      "dose": "600 mg",
      "doseFrequency": "Single dose",
      "route": {
        "id": "ea8447d7-604e-461f-bbfa-e95179368800",
        "code": "Intramuscular",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Intramuscular",
        "instanceType": "Code"
      },
      "duration": "Day 1 only (monitored for 456 days)"
    },
    {
      "id": "1a091dd4-5504-42fd-b795-4a37ee3b5d51",
      "name": "AZD8895 component",
      "instanceType": "Administration",
      "dose": "300 mg",
      "doseFrequency": "Single dose",
      "route": {
        "id": "165d7008-02c9-4f11-a039-4116f7a9c75b",
        "code": "Intramuscular",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Intramuscular",
        "instanceType": "Code"
      },
      "duration": "Administered as a 3 mL injection in the gluteal region"
    },
    {
      "id": "228e54d1-ad9b-4a77-a183-4099d44d8d1b",
      "name": "AZD1061 component",
      "instanceType": "Administration",
      "dose": "300 mg",
      "doseFrequency": "Single dose",
      "route": {
        "id": "63258781-1dc0-4e4d-855f-33aab0a2c2ec",
        "code": "Intramuscular",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Intramuscular",
        "instanceType": "Code"
      },
      "duration": "Administered as a 3 mL injection in the gluteal region"
    },
    {
      "id": "e59051d4-b2e8-45b7-84b9-3cb39f364c4e",
      "name": "Placebo administration",
      "instanceType": "Administration",
      "dose": "6 mL total",
      "doseFrequency": "Single dose",
      "route": {
        "id": "13b43418-4fcc-442a-9696-73fe883383bf",
        "code": "Intramuscular",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Intramuscular",
        "instanceType": "Code"
      },
      "duration": "Two separate 3 mL injections in the gluteal region"
    }
  ],
  "substances": [
    {
      "id": "da3b4c53-97ca-4a5f-af14-f3786c850a4f",
      "name": "AZD8895",
      "instanceType": "Substance",
      "description": "Monoclonal antibody component of AZD7442"
    },
    {
      "id": "51d9b4ba-8ef7-4e28-8d31-ce32f93a6d4e",
      "name": "AZD1061",
      "instanceType": "Substance",
      "description": "Monoclonal antibody component of AZD7442"
    }
  ],
  "studyDefinitionDocument": {
    "id": "67e10ad8-3220-470f-bfe9-7f963cbda3be",
    "name": "AZD7442 - D8851C00001",
    "documentType": "Protocol",
    "language": "en",
    "instanceType": "StudyDefinitionDocument",
    "version": "7.0",
    "contentIds": [
      "de052169-e842-40fc-8bac-e4b38ebc5eb2",
      "3c158b85-d453-48ff-8609-52ef8faa7c18",
      "efeeecf3-8b90-4060-afe1-077276a0ebef",
      "d6dbc4f3-25f0-4abb-b3bf-2dbd4d9184e7",
      "be1bb1da-032e-4798-a02e-09a0e1276181",
      "a2b59804-fe1e-4afe-ba9d-1f2df9e079a9",
      "c24c67ac-20dc-45c3-a1eb-ebfd5ef45bdd",
      "ece03924-f100-46f5-96ac-a75b3d8e8f28",
      "74d46e09-ed37-454b-8d9e-fb836aedfc46",
      "55760f6b-eee0-4f74-bf3e-278b34518163",
      "d1939a1d-4c37-44cc-a7d6-fa3ebe7a2673",
      "0afe71aa-66cd-467f-858c-401a528bb81b"
    ]
  },
  "geographicScope": {
    "id": "5863917c-db2e-4289-b518-6b1d2f1e4494",
    "name": "Study Geographic Scope",
    "scopeType": "Global",
    "instanceType": "GeographicScope",
    "countryIds": [
      "56ac9a84-d37b-4313-a758-e3f9e86c8610",
      "b1081042-e498-41a2-8845-22119c0ce327"
    ],
    "regions": [
      "Europe"
    ]
  },
  "countries": [
    {
      "id": "56ac9a84-d37b-4313-a758-e3f9e86c8610",
      "name": "Sweden",
      "instanceType": "Country",
      "code": "SE"
    },
    {
      "id": "b1081042-e498-41a2-8845-22119c0ce327",
      "name": "United Kingdom",
      "instanceType": "Country",
      "code": "GB"
    }
  ],
  "ingredients": [
    {
      "id": "91b757b3-0b09-4273-98ef-a9d02f40dabd",
      "name": "AZD7442",
      "role": "Active",
      "instanceType": "Ingredient",
      "substanceId": "AZD7442"
    },
    {
      "id": "746721c4-a8a1-4027-8d40-f813d2091dc9",
      "name": "AZD8895",
      "role": "Active",
      "instanceType": "Ingredient",
      "substanceId": "AZD8895"
    },
    {
      "id": "201c3e95-7cc7-4863-94ea-fec75e037dd2",
      "name": "AZD1061",
      "role": "Active",
      "instanceType": "Ingredient",
      "substanceId": "AZD1061"
    }
  ],
  "strengths": [
    {
      "id": "e0a8b9c3-3a60-454a-b146-ddac7bb3e2bc",
      "instanceType": "Strength",
      "value": 600,
      "unit": "mg",
      "numerator": {
        "value": 600,
        "unit": "mg"
      },
      "denominator": {
        "value": 1,
        "unit": "dose"
      }
    }
  ],
  "transitionRules": [
    {
      "id": "9aee6547-f9aa-429f-a5b5-0ef2d3a29ec8",
      "name": "Screening to Randomization",
      "instanceType": "TransitionRule",
      "transitionType": "Epoch Transition",
      "fromElementId": "c0e8485f-a4f0-475d-806c-4fefaa9865d8",
      "toElementId": "a44f8539-a9d2-4ec6-9c3f-9302ad493fda",
      "text": "Verify eligibility criteria and negative urine pregnancy test on Day 1"
    },
    {
      "id": "628f5481-609b-46ae-a44a-96a6248790a6",
      "name": "Dose Modification Restriction",
      "instanceType": "TransitionRule",
      "transitionType": "Dose Modification",
      "text": "Dose modification is not permitted; re-administration (re-challenge) is not permitted"
    },
    {
      "id": "abf6bbc7-7da3-4933-bae2-42f5e610b844",
      "name": "Vaccination Delay for AZD7442",
      "instanceType": "TransitionRule",
      "transitionType": "Rescue Therapy",
      "text": "Unblinded participants receiving AZD7442 advised to wait 9 to 12 months before vaccination"
    }
  ],
  "documentContentReferences": [
    {
      "id": "ded1a1a5-3805-4fe4-9c48-d31ab534fa5b",
      "name": "Schema Reference",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "1.2",
      "sectionTitle": "Schema",
      "description": "Reference to study schema for primary endpoint analysis"
    },
    {
      "id": "8df1ab5e-db3e-418e-a7e3-255a693b2efd",
      "name": "Study Design Reference",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "4.1",
      "sectionTitle": "Study Design",
      "description": "Reference to overall study design regarding primary analysis data cut-off"
    },
    {
      "id": "d80aa013-1d3a-458d-9f7a-a170ca146404",
      "name": "Statistical Hypotheses Reference",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "9.1",
      "sectionTitle": "Statistical Hypotheses",
      "description": "Reference to primary endpoint events and power calculations"
    },
    {
      "id": "f052d3d9-1518-45a5-9159-eea848ac2534",
      "name": "Sample Size Reference",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "9.2",
      "sectionTitle": "Sample Size Determination",
      "description": "Reference to reduction in statistical power and event requirements"
    },
    {
      "id": "9bb30d43-2442-4fee-854c-6c08c27817bb",
      "name": "Inclusion Criteria Reference",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "5.1",
      "sectionTitle": "Inclusion Criteria",
      "description": "Reference for contraceptive methods in medication summary table"
    },
    {
      "id": "441886bf-5534-4d80-8e69-c0904e97fa9e",
      "name": "Hospitalization Definition Reference",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "Appendix H",
      "sectionTitle": "Hospitalization Definition",
      "description": "Guidance on the definition of hospitalization for exclusion criteria"
    },
    {
      "id": "c48c4db1-b9de-4bce-b20f-996e5b7b0a4e",
      "name": "Schedule of Activities Reference",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "Table 1",
      "sectionTitle": "Schedule of Activities for Cohort 1",
      "description": "Reference for timing of injection site inspections and AESI collection"
    },
    {
      "id": "c789ed3d-109c-46b5-922b-a0a726d1e10c",
      "name": "Liver Biochemistry Reference",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "Appendix D",
      "sectionTitle": "Actions Required in Cases of Increases in Liver Biochemistry and Evaluation of Hys Law",
      "description": "Instructions for handling elevated AST, ALT, or TBL levels"
    }
  ],
  "commentAnnotations": [
    {
      "id": "f000f55a-fbbf-4be3-a1fd-e38cf813a383",
      "text": "The potential impact of AZD7442 on COVID-19 vaccines is not known and has not been studied.",
      "annotationType": "Footnote",
      "instanceType": "CommentAnnotation",
      "sourceSection": "Summary of Permitted, Prohibited, or Restricted Medications",
      "pageNumber": 45
    },
    {
      "id": "63fa2de1-f339-4bdb-bb3d-70be92de9da6",
      "text": "In case a participant shows an AST or ALT  3  ULN together with TBL  2  ULN please refer to Appendix D.",
      "annotationType": "Note",
      "instanceType": "CommentAnnotation",
      "sourceSection": "Coagulation",
      "pageNumber": 55
    },
    {
      "id": "5762ee30-d567-4823-a304-b53f5c06e123",
      "text": "Sexual abstinence is considered a highly effective method only if defined as refraining from heterosexual intercourse during the entire period of the study.",
      "annotationType": "Clarification",
      "instanceType": "CommentAnnotation",
      "sourceSection": "Inclusion Criteria",
      "pageNumber": 38
    }
  ],
  "studyDefinitionDocumentVersions": [
    {
      "id": "6ee7860f-8617-4038-ba23-bcf950562a63",
      "versionNumber": "7.0",
      "status": "Approved",
      "instanceType": "StudyDefinitionDocumentVersion",
      "versionDate": "2021-06-30",
      "description": "Phase III Randomized, Double-blind, Placebo-controlled, Multicenter Study to Determine the Safety and Efficacy of AZD7442",
      "amendmentNumber": "Amendment 6"
    }
  ],
  "studyAmendmentImpacts": [
    {
      "id": "f132e383-cf6b-4750-bf70-b797c374fac2",
      "amendmentId": "ac7a7360-2e74-4339-b47e-286d0ddfa9af",
      "affectedSection": "Section 6.5.1 - COVID-19 Vaccination",
      "impactLevel": "Minor",
      "instanceType": "StudyAmendmentImpact",
      "description": "Updated guidance on participant unblinding for the purpose of receiving COVID-19 vaccinations and subsequent study participation."
    },
    {
      "id": "ec048671-c63d-4ab8-abdc-5bb941a5007d",
      "amendmentId": "ac7a7360-2e74-4339-b47e-286d0ddfa9af",
      "affectedSection": "Section 6.3.3 - Procedures for Unblinding",
      "impactLevel": "Minor",
      "instanceType": "StudyAmendmentImpact",
      "description": "Clarified the process for unblinding participants who wish to be vaccinated."
    }
  ],
  "studyAmendmentReasons": [
    {
      "id": "ae34714e-70c6-4e8b-b7b0-b502a6ef5d3c",
      "amendmentId": "ac7a7360-2e74-4339-b47e-286d0ddfa9af",
      "reasonText": "To provide clinical guidance and counseling for participants wishing to receive a SARS-CoV-2 vaccine during the study period.",
      "category": "Operational",
      "isPrimary": true,
      "instanceType": "StudyAmendmentReason"
    },
    {
      "id": "f2e717b5-52f0-42d9-801d-2ff7d7b69fb1",
      "amendmentId": "ac7a7360-2e74-4339-b47e-286d0ddfa9af",
      "reasonText": "To address potential interference between AZD7442 monoclonal antibodies and vaccine-induced immune responses.",
      "category": "Scientific",
      "isPrimary": false,
      "instanceType": "StudyAmendmentReason"
    }
  ],
  "studyChanges": [
    {
      "id": "aaa06d0c-69db-42f7-8ac5-d9d5baa96cf5",
      "amendmentId": "ac7a7360-2e74-4339-b47e-286d0ddfa9af",
      "changeType": "Addition",
      "instanceType": "StudyChange",
      "sectionNumber": "6.5.1",
      "afterText": "Participants may wish to be vaccinated. If so, they may be unblinded as to their randomized investigational treatment in this study as per study unblinding procedure (Section 6.3.3), counselled, and referred outside the study for possible vaccination.",
      "summary": "Added provision for unblinding participants for vaccination purposes."
    },
    {
      "id": "ac515718-30d5-420e-a72f-0f29381931a0",
      "amendmentId": "ac7a7360-2e74-4339-b47e-286d0ddfa9af",
      "changeType": "Modification",
      "instanceType": "StudyChange",
      "sectionNumber": "6.5.1",
      "afterText": "Unblinded participants who received AZD7442 should be advised to consider waiting an appropriate length of time (9 to 12 months) before receiving an anti-SARS-CoV-2 vaccine.",
      "summary": "Specified a 9 to 12 month waiting period for vaccinated participants who received the active study drug to avoid interference."
    },
    {
      "id": "3ec6f66e-7469-4c1d-8e73-6efa2c1a9763",
      "amendmentId": "ac7a7360-2e74-4339-b47e-286d0ddfa9af",
      "changeType": "Clarification",
      "instanceType": "StudyChange",
      "sectionNumber": "6.5.1",
      "afterText": "Participants who have been unblinded in order to receive vaccination can and should remain in the study after being unblinded.",
      "summary": "Clarified that unblinded participants should continue study participation."
    }
  ],
  "computationalExecution": {
    "ready": true,
    "supportedSystems": [
      "EDC",
      "ePRO",
      "CTMS",
      "RTSM"
    ],
    "validationStatus": "complete"
  }
}